
<html lang="en"     class="pb-page"  data-request-id="d6ca5c30-d187-4a24-8daf-ff71bc4471a2"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2017.60.issue-11;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b00533;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Characterization of R/S-N-3-Cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines" /></meta><meta name="dc.Creator" content="Michael  Schnekenburger" /></meta><meta name="dc.Creator" content="Eric  Goffin" /></meta><meta name="dc.Creator" content="Jin-Young  Lee" /></meta><meta name="dc.Creator" content="Jun Young  Jang" /></meta><meta name="dc.Creator" content="Aloran  Mazumder" /></meta><meta name="dc.Creator" content="Seungwon  Ji" /></meta><meta name="dc.Creator" content="Bernard  Rogister" /></meta><meta name="dc.Creator" content="Nafila  Bouider" /></meta><meta name="dc.Creator" content="Florence  Lefranc" /></meta><meta name="dc.Creator" content="Walter  Miklos" /></meta><meta name="dc.Creator" content="Véronique  Mathieu" /></meta><meta name="dc.Creator" content="Pascal  de Tullio" /></meta><meta name="dc.Creator" content="Kyu-Won  Kim" /></meta><meta name="dc.Creator" content="Mario  Dicato" /></meta><meta name="dc.Creator" content="Walter  Berger" /></meta><meta name="dc.Creator" content="Byung Woo  Han" /></meta><meta name="dc.Creator" content="Robert  Kiss" /></meta><meta name="dc.Creator" content="Bernard  Pirotte" /></meta><meta name="dc.Creator" content="Marc  Diederich" /></meta><meta name="dc.Description" content="A new series of N-aryl-N′-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)ureas bearing an alkoxycarbonylamino group at the 6-position were synthesized and examined as putative anticancer agents targ..." /></meta><meta name="Description" content="A new series of N-aryl-N′-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)ureas bearing an alkoxycarbonylamino group at the 6-position were synthesized and examined as putative anticancer agents targ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 25, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00533" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00533" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00533" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00533" /></link>
        
    
    

<title>Discovery and Characterization of R/S-N-3-Cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00533" /></meta><meta property="og:title" content="Discovery and Characterization of R/S-N-3-Cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0020.jpeg" /></meta><meta property="og:description" content="A new series of N-aryl-N′-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)ureas bearing an alkoxycarbonylamino group at the 6-position were synthesized and examined as putative anticancer agents targeting sirtuins in glioma cells. On the basis of computational docking combined to in vitro sirtuin 1/2 inhibition assays, we selected compound 18 [R/S-N-3-cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea] which displays a potent antiproliferative activity on various glioma cell types, assessed by quantitative videomicroscopy, eventually triggering senescence. The impact on normal glial cells was lower with a selectivity index of &gt;10. Furthermore, human U373 and Hs683 glioblastoma cell lines served to demonstrate the inhibitory activity of 18 against histone deacetylase (HDAC) class III sirtuins 1 and 2 (SIRT1/2) by quantifying acetylation levels of histone and non-histone proteins. The translational potential of 18 was validated by an NCI-60 cell line screen and validation of growth inhibition of drug resistant cancer cell models. Eventually, the anticancer potential of 18 was validated in 3D glioblastoma spheroids and in vivo by zebrafish xenografts. In summary, compound 18 is the first representative of a new class of SIRT inhibitors opening new perspectives in the medicinal chemistry of HDAC inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00533"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00533">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00533&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00533&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00533&amp;href=/doi/10.1021/acs.jmedchem.7b00533" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4714-4733</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00363" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00690" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Characterization of <i>R</i>/<i>S</i>-<i>N</i>-3-Cyanophenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Schnekenburger">Michael Schnekenburger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Goffin">Eric Goffin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jin-Young++Lee">Jin-Young Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jun+Young++Jang">Jun Young Jang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aloran++Mazumder">Aloran Mazumder</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seungwon++Ji">Seungwon Ji</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bernard++Rogister">Bernard Rogister</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nafila++Bouider">Nafila Bouider</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Florence++Lefranc">Florence Lefranc</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Walter++Miklos">Walter Miklos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=V%C3%A9ronique++Mathieu">Véronique Mathieu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pascal++de+Tullio">Pascal de Tullio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kyu-Won++Kim">Kyu-Won Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mario++Dicato">Mario Dicato</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Walter++Berger">Walter Berger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Byung+Woo++Han">Byung Woo Han</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Kiss">Robert Kiss</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bernard++Pirotte">Bernard Pirotte</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>¶</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Diederich">Marc Diederich</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol "><sup>¶</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-0115-4725" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg, 9, Rue Edward Steichen, L-2540 Luxembourg, Luxembourg</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Laboratory of Medicinal Chemistry, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, 4000 Liège, Belgium</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Pharmacy, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Nervous System Diseases and Treatment, GIGA-Neurosciences, University of Liège, 4000 Liège, Belgium</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Service de Neurochirurgie, Hôpital Erasme, Université Libre de Bruxelles, 1070 Brussels, Belgium</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Department of Medicine I, Comprehensive Cancer Center and Institute of Cancer Research, Medical University of Vienna, 1090 Vienna, Austria</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">∇</span> <span class="aff-text">SNU-Harvard Neurovascular Protection Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Korea</span></div><div class="aff-info" id="aff8"><span class="aff-symbol">○</span> <span class="aff-text">Laboratoire de Cancérologie et de Toxicologie Expérimentale, Faculté de Pharmacie, Université Libre de Bruxelles, 1050 Brussels, Belgium</span></div><div class="corresp-info"><strong>*</strong>B.P. (chemistry): phone, + 32 4 366 43 65; fax, + 32 4 366 43 62; email, <a href="/cdn-cgi/l/email-protection#50327e2039223f24243510253c377e31337e3235"><span class="__cf_email__" data-cfemail="b2d09cc2dbc0ddc6c6d7f2c7ded59cd3d19cd0d7">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>M.D.: (biology): phone, +82 2 880 8919; e-mail, <a href="/cdn-cgi/l/email-protection#dbb6baa9b8bfb2bebfbea9b2b8b39ba8b5aef5bab8f5b0a9"><span class="__cf_email__" data-cfemail="bdd0dccfded9d4d8d9d8cfd4ded5fdced3c893dcde93d6cf">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00533&amp;href=/doi/10.1021%2Facs.jmedchem.7b00533" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4714–4733</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 5, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 April 2017</li><li><span class="item_label"><b>Published</b> online</span>25 May 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 June 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00533" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00533</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4714%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichael%2BSchnekenburger%252C%2BEric%2BGoffin%252C%2BJin-Young%2BLee%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D11%26contentID%3Dacs.jmedchem.7b00533%26title%3DDiscovery%2Band%2BCharacterization%2Bof%2BR%252FS-N-3-Cyanophenyl-N%25E2%2580%25B2-%25286-tert-butoxycarbonylamino-3%252C4-dihydro-2%252C2-dimethyl-2H-1-benzopyran-4-yl%2529urea%252C%2Ba%2BNew%2BHistone%2BDeacetylase%2BClass%2BIII%2BInhibitor%2BExerting%2BAntiproliferative%2BActivity%2Bagainst%2BCancer%2BCell%2BLines%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4733%26publicationDate%3DJune%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00533"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1433</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00533" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Characterization of R/S-N-3-Cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Schnekenburger&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Goffin&quot;},{&quot;first_name&quot;:&quot;Jin-Young&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Young Jang&quot;},{&quot;first_name&quot;:&quot;Aloran&quot;,&quot;last_name&quot;:&quot;Mazumder&quot;},{&quot;first_name&quot;:&quot;Seungwon&quot;,&quot;last_name&quot;:&quot;Ji&quot;},{&quot;first_name&quot;:&quot;Bernard&quot;,&quot;last_name&quot;:&quot;Rogister&quot;},{&quot;first_name&quot;:&quot;Nafila&quot;,&quot;last_name&quot;:&quot;Bouider&quot;},{&quot;first_name&quot;:&quot;Florence&quot;,&quot;last_name&quot;:&quot;Lefranc&quot;},{&quot;first_name&quot;:&quot;Walter&quot;,&quot;last_name&quot;:&quot;Miklos&quot;},{&quot;first_name&quot;:&quot;Véronique&quot;,&quot;last_name&quot;:&quot;Mathieu&quot;},{&quot;first_name&quot;:&quot;Pascal&quot;,&quot;last_name&quot;:&quot;de Tullio&quot;},{&quot;first_name&quot;:&quot;Kyu-Won&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Mario&quot;,&quot;last_name&quot;:&quot;Dicato&quot;},{&quot;first_name&quot;:&quot;Walter&quot;,&quot;last_name&quot;:&quot;Berger&quot;},{&quot;first_name&quot;:&quot;Byung&quot;,&quot;last_name&quot;:&quot;Woo Han&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Kiss&quot;},{&quot;first_name&quot;:&quot;Bernard&quot;,&quot;last_name&quot;:&quot;Pirotte&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Diederich&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;4714-4733&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00533&quot;},&quot;abstract&quot;:&quot;A new series of N-aryl-N′-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)ureas bearing an alkoxycarbonylamino group at the 6-position were synthesized and examined as putative anticancer agents targeting sirtuins in glioma cells. On the basis of computational docking combined to in vitro sirtuin 1/2 inhibition assays, we selected compound 18 [R/S-N-3-cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea] which displays a potent antiproliferative activity on various glioma cell types, assessed by quantitative videomicroscopy, eventually triggering senescence. The impact on normal glial cells was lower with a selectivity index of &gt;10. Furthermore, human U373 and Hs683 glioblastoma cell lines served to demonstrate the inhibitory activity of 18 against histone deacetylase (HDAC) class III sirtuins 1 and 2 (SIRT1/2) by quantifying acetylation levels of histone and non-histone proteins. The translational potential of 18 was validated by an NCI-60 cell line screen and validatio&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00533&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00533" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00533&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00533" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00533&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00533" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00533&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00533&amp;href=/doi/10.1021/acs.jmedchem.7b00533" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00533" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00533" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00533%26sid%3Dliteratum%253Aachs%26pmid%3D28475330%26genre%3Darticle%26aulast%3DSchnekenburger%26date%3D2017%26atitle%3DDiscovery%2Band%2BCharacterization%2Bof%2BR%252FS-N-3-Cyanophenyl-N%25E2%2580%25B2-%25286-tert-butoxycarbonylamino-3%252C4-dihydro-2%252C2-dimethyl-2H-1-benzopyran-4-yl%2529urea%252C%2Ba%2BNew%2BHistone%2BDeacetylase%2BClass%2BIII%2BInhibitor%2BExerting%2BAntiproliferative%2BActivity%2Bagainst%2BCancer%2BCell%2BLines%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D11%26spage%3D4714%26epage%3D4733%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/jmcmar.2017.60.issue-11/20170608/jmcmar.2017.60.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A new series of <i>N</i>-aryl-<i>N</i>′-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)ureas bearing an alkoxycarbonylamino group at the 6-position were synthesized and examined as putative anticancer agents targeting sirtuins in glioma cells. On the basis of computational docking combined to in vitro sirtuin 1/2 inhibition assays, we selected compound <b>18</b> [<i>R</i>/<i>S</i>-<i>N</i>-3-cyanophenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea] which displays a potent antiproliferative activity on various glioma cell types, assessed by quantitative videomicroscopy, eventually triggering senescence. The impact on normal glial cells was lower with a selectivity index of >10. Furthermore, human U373 and Hs683 glioblastoma cell lines served to demonstrate the inhibitory activity of <b>18</b> against histone deacetylase (HDAC) class III sirtuins 1 and 2 (SIRT1/2) by quantifying acetylation levels of histone and non-histone proteins. The translational potential of <b>18</b> was validated by an NCI-60 cell line screen and validation of growth inhibition of drug resistant cancer cell models. Eventually, the anticancer potential of <b>18</b> was validated in 3D glioblastoma spheroids and in vivo by zebrafish xenografts. In summary, compound <b>18</b> is the first representative of a new class of SIRT inhibitors opening new perspectives in the medicinal chemistry of HDAC inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21236" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21236" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Glioblastomas are associated with dismal prognoses due to their intrinsic resistance to proapoptotic stimuli,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and temozolomide, a generic compound, remains today the most efficient chemotherapeutic agent to fight glioblastoma once maximal surgery and radiotherapy have already been performed.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Considering the absence of chemotherapeutically active drugs against glioblastoma, the reduced life expectancy of the patients, and the specific molecular characteristics of this type of cancer, it becomes increasingly clear that new compound groups and molecular targets need to be investigated. Recently, histone deacetylase (HDAC) and sirtuin (SIRT) inhibitors (SIRTi) were shown to trigger metabolic effects in glioblastoma independently or combined with temozolomide,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> allowing speculation about the potential impact of SIRTi on this cancer type.</div><div class="NLM_p">NAD<sup>+</sup>-dependent deacetylase class III of HDACs comprises a family of seven members, namely, SIRT1–7, known to deacetylate histones and other target proteins. Intracellular localization characterizes the different isoforms (SIRT1/2, nucleus or cytoplasm; SIRT3–5, mitochondria; SIRT6, nucleus; SIRT7, nucleolus) as well as substrate specificity: besides histones, many transcriptional regulators and mitochondrial proteins are deacetylated by SIRTs.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a></div><div class="NLM_p">SIRTs are emerging targets for the treatment of various chronic diseases including cancer.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> Especially, both SIRT1 and -2 have been reported to play a key role in the development of cancer.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Accordingly, first inhibitors comprised compounds resembling the physiological substrates such as NAD<sup>+</sup> analogs that were described as competitive SIRTi compounds that compete with NAD<sup>+</sup> for the NAD<sup>+</sup>-binding domain, thus inhibiting enzymatic activity of multiple SIRTs. Such compounds showed anticancer activity in B-cell chronic lymphoblastic leukemia or prostate cancer.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Suramin (<b>1</b>) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), an adenosine receptor antagonist, acts as a SIRTi by binding the C pocket, B pocket, and partially the enzyme’s substrate-binding site.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a><b>1</b> was shown to possess anticancer potential in combination with cytotoxic agents in xenografted prostate, lung, and breast cancer cells.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Similarly, sirtinol (<b>2</b>) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), a well described SIRT1 and -2 selective inhibitor, displays anticancer properties against various cancer models.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Although, most SIRTi compounds lack selectivity against a specific isoform, EX-527 (<b>3</b>) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) was reported to inhibit SIRT1 but is less active against SIRT2 and SIRT3.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> A combination treatment using <b>3</b> and other HDAC inhibitors was found to induce apoptosis in acute myeloid leukemia cells.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The selective inhibition of SIRT2 by AGK2 (<b>4</b>) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> has been reported to induce anticancer effects by suppressing tumor cell growth and migration.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reference HDAC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, some of our structural analogs of the ATP-sensitive potassium (K<sub>ATP</sub>) channel opener cromakalim (<b>5</b>), 6-halo-substituted 3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyrans (or 2,2-dimethylchromans), bearing an arylurea or arylthiourea moiety at the 4-position (<b>6</b>: X = F, Cl, Br), were described as potent inhibitors of glioma. Here we synthesized a series of <i>N</i>-aryl-<i>N</i>′-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)ureas and thioureas bearing an alkoxycarbonylamino group (“carbamate” group) at the 6-position (<b>6</b>: X = NHCOOR) and investigated their anticancer effects on glial tumor cells (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Our results show that compound <b>18</b> [<i>R</i>/<i>S</i>-<i>N</i>-3-cyanophenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea] inhibits SIRT1/2 activity associated with a potent antiproliferative activity on glioblastoma cells while having a lower impact on normal glial cells, thus demonstrating an excellent differential toxicity. For the first time, we document here the in vitro characterization of <b>18</b> as a novel SIRT inhibitor and its in cellulo epigenetic effect combined with its anticancer potential in 2D and 3D cell culture. Our results are validated in vivo by zebrafish glioblastoma xenografts.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structure of cromakalim (<b>5</b>) and general formula of 4-arylurea/arylthiourea-substituted 2,2-dimethylchromans (<b>6</b>) previously reported as K<sub>ATP</sub> channel openers. Compounds <b>7</b> and <b>8</b> are examples of 2,2-dimethylchromans exerting antiproliferative activity against glioma cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65264" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65264" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The synthesis of the key intermediate <b>9</b> has been previously described.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The target compounds <b>10</b>–<b>28</b> were prepared in good yields by reaction of <b>9</b> with the appropriate monosubstituted phenyl isocyanate in methylene chloride at room temperature (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0014.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) X-C<sub>6</sub>H<sub>4</sub>-N═C═O, CH<sub>2</sub>Cl<sub>2</sub>, rt, 75–85%.</p></p></figure><div class="NLM_p">Starting from the <i>N</i>-3-cyanophenyl-substituted urea <b>18</b>, the corresponding <i>N</i>-3-aminomethyl-substituted analog <b>22</b> was obtained after reduction of the cyano group using hydrogen gas in the presence of Raney nickel<sup>0</sup> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). On the other hand, acid-catalyzed deprotection of the <i>tert</i>-butyl carbamate group of <b>18</b> provided the corresponding 6-amino-substituted chroman <b>33</b>, which by formylation gave access to the 6-formamido-substituted analog <b>34</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0015.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) 5 N HCl in EtOH, rt, 80% ; (ii) HCOOH, Ac<sub>2</sub>O, THF, rt., 80–85%; (iii) H<sub>2</sub>, Raney nickel<sup>0</sup>, EtOH, 65%.</p></p></figure><div class="NLM_p">Reduction of the nitro group of compound <b>19</b> into the amino-substituted compound <b>23</b> was performed with iron powder in the presence of ammonium chloride in ethanol/water 3:1 (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0016.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, 50%.</p></p></figure><div class="NLM_p">The target compound <b>32</b> was obtained by reaction of the previously described compound <b>31</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> with 3-cyanophenyl isocyanate (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0017.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) 3-cyanophenyl isocyanate, CH<sub>2</sub>Cl<sub>2</sub>, rt, 90–95%.</p></p></figure><div class="NLM_p last">All the compounds were crystallized from appropriate solvents and characterized by <sup>1</sup>H and <sup>13</sup>C NMR. Their purity was assessed by elemental analysis to obtain the final materials with the chemical purity required before pharmacological evaluations.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Growth Inhibitory Activity against Glioma Cells</h3><div class="NLM_p">The in vitro effects of the 2,2-dimethylchromans <b>10</b>–<b>28</b> and <b>32</b>–<b>37</b> on the growth of three human high-grade glioma cell lines, i.e., U373 and T98G from astroglial origin and Hs683 from oligodendroglial origin, were examined (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>; see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details). Moreover, the selective toxicity between normal astrocytes and glioma cells regarding in vitro growth inhibition was also investigated for several compounds listed in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Growth Inhibitory Activity against Three Human Glioma Cell Lines and Determination of Cell Selectivity Using Murine Normal Astrocytes (Modulation of the 4-Position)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0018.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">in vitro IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">U373</th><th class="colsep0 rowsep0" align="center">T98G</th><th class="colsep0 rowsep0" align="center">Hs683</th><th class="colsep0 rowsep0" align="center">mean<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">Sel<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">AclogP<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">59 ± 11</td><td class="colsep0 rowsep0" align="left">88 ± 24</td><td class="colsep0 rowsep0" align="left">34 ± 3</td><td class="colsep0 rowsep0" align="left">60 ± 27</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">4.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">2-CN</td><td class="colsep0 rowsep0" align="left">45 ± 8</td><td class="colsep0 rowsep0" align="left">67 ± 7</td><td class="colsep0 rowsep0" align="left">54 ± 5</td><td class="colsep0 rowsep0" align="left">55 ± 11</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">3.99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">2-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">12 ± 1</td><td class="colsep0 rowsep0" align="left">22 ± 2</td><td class="colsep0 rowsep0" align="left">13 ± 1</td><td class="colsep0 rowsep0" align="left">16 ± 6</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">4.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">4.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">30 ± 1</td><td class="colsep0 rowsep0" align="left">39 ± 1</td><td class="colsep0 rowsep0" align="left">59 ± 4</td><td class="colsep0 rowsep0" align="left">43 ± 15</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">3.96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">20 ± 1</td><td class="colsep0 rowsep0" align="left">26 ± 1</td><td class="colsep0 rowsep0" align="left">19 ± 2</td><td class="colsep0 rowsep0" align="left">22 ± 4</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">4.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">18 ± 2</td><td class="colsep0 rowsep0" align="left">20 ± 3</td><td class="colsep0 rowsep0" align="left">12 ± 3</td><td class="colsep0 rowsep0" align="left">17 ± 4</td><td class="colsep0 rowsep0" align="left">>12</td><td class="colsep0 rowsep0" align="left">4.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-Br</td><td class="colsep0 rowsep0" align="left">22 ± 1</td><td class="colsep0 rowsep0" align="left">26 ± 3</td><td class="colsep0 rowsep0" align="left">18 ± 1</td><td class="colsep0 rowsep0" align="left">22 ± 4</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">4.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="left">6 ± 1</td><td class="colsep0 rowsep0" align="left">14 ± 1</td><td class="colsep0 rowsep0" align="left">4 ± 1</td><td class="colsep0 rowsep0" align="left">8 ± 5</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">3.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">1 ± 1</td><td class="colsep0 rowsep0" align="left">7 ± 4</td><td class="colsep0 rowsep0" align="left">16 ± 2</td><td class="colsep0 rowsep0" align="left">8 ± 8</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">4.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">9 ± 1</td><td class="colsep0 rowsep0" align="left">21 ± 2</td><td class="colsep0 rowsep0" align="left">9 ± 1</td><td class="colsep0 rowsep0" align="left">13 ± 7</td><td class="colsep0 rowsep0" align="left"><2</td><td class="colsep0 rowsep0" align="left">4.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">30 ± 1</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">37 ± 2</td><td class="colsep0 rowsep0" align="left">>56</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">3.97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-CH<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">95 ± 4</td><td class="colsep0 rowsep0" align="left">>98</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">3.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">97 ± 2</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">91 ± 5</td><td class="colsep0 rowsep0" align="left">>96</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">3.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">22 ± 1</td><td class="colsep0 rowsep0" align="left">26 ± 3</td><td class="colsep0 rowsep0" align="left">26 ± 3</td><td class="colsep0 rowsep0" align="left">25 ± 2</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">4.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="left">10 ± 1</td><td class="colsep0 rowsep0" align="left">26 ± 1</td><td class="colsep0 rowsep0" align="left">18 ± 2</td><td class="colsep0 rowsep0" align="left">18 ± 8</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">3.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">24 ± 1</td><td class="colsep0 rowsep0" align="left">26 ± 1</td><td class="colsep0 rowsep0" align="left">20 ± 1</td><td class="colsep0 rowsep0" align="left">23 ± 3</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">4.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">10 ± 1</td><td class="colsep0 rowsep0" align="left">15 ± 2</td><td class="colsep0 rowsep0" align="left">11 ± 1</td><td class="colsep0 rowsep0" align="left">12 ± 3</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">4.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">33 ± 1</td><td class="colsep0 rowsep0" align="left">49 ± 2</td><td class="colsep0 rowsep0" align="left">62 ± 9</td><td class="colsep0 rowsep0" align="left">48 ± 15</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">3.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="left">19 ± 3</td><td class="colsep0 rowsep0" align="left">10 ± 2</td><td class="colsep0 rowsep0" align="left">26 ± 2</td><td class="colsep0 rowsep0" align="left">18 ± 8</td><td class="colsep0 rowsep0" align="left"><2</td><td class="colsep0 rowsep0" align="left">4.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="left">7 ± 1</td><td class="colsep0 rowsep0" align="left">7 ± 1</td><td class="colsep0 rowsep0" align="left">7 ± 1</td><td class="colsep0 rowsep0" align="left">7 ± 1</td><td class="colsep0 rowsep0" align="left">-</td><td class="colsep0 rowsep0" align="left">4.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cisplatin</td><td class="colsep0 rowsep0" align="left">NA<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">NA<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">4 ± 1</td><td class="colsep0 rowsep0" align="left">12 ± 4</td><td class="colsep0 rowsep0" align="left">4 ± 1</td><td class="colsep0 rowsep0" align="left">7 ± 3</td><td class="colsep0 rowsep0" align="left">NA<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">NA<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values: concentration of drug responsible for the inhibition of 50% of the growth of the specified cell line after 72 h [mean ± SEM (<i>n</i> = 6 replicates)].</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">“Sel” means the level of selectivity, i.e., IC<sub>50</sub> values obtained on murine normal astrocytes (<i>n</i> = 3)/IC<sub>50</sub> values obtained on human tumor astrocytes (<i>n</i> = 3).</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">AclogP: calculated log <i>P</i> values according to the ALOGPS 2.1 software [VCCLAB, Virtual Computational Chemistry Laboratory, <a href="http://www.vcclab.org" class="extLink">http://www.vcclab.org</a>, 2005].</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">“-” = not determined.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">Published compounds in refs <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a> and <a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">56</a>.</p></div><div class="footnote" id="t1fn6"><sup>f</sup><p class="last">NA: not applicable.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Growth Inhibitory Activity against Three Human Glioma Cell Lines (Modulation of the 6-Position)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0019.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">in vitro IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">U373</th><th class="colsep0 rowsep0" align="center">T98G</th><th class="colsep0 rowsep0" align="center">Hs683</th><th class="colsep0 rowsep0" align="center">mean</th><th class="colsep0 rowsep0" align="center">AclogP<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">38 ± 2</td><td class="colsep0 rowsep0" align="left">32 ± 5</td><td class="colsep0 rowsep0" align="left">31 ± 5</td><td class="colsep0 rowsep0" align="left">34 ± 3</td><td class="colsep0 rowsep0" align="left">2.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">2.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">NHCHO</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">2.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">NHCOOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">45 ± 10</td><td class="colsep0 rowsep0" align="left">56 ± 7</td><td class="colsep0 rowsep0" align="left">84 ± 8</td><td class="colsep0 rowsep0" align="left">60 ± 20</td><td class="colsep0 rowsep0" align="left">2.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">NHCOOC<sub>2</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="left">38 ± 2</td><td class="colsep0 rowsep0" align="left">46 ± 4</td><td class="colsep0 rowsep0" align="left">15 ± 2</td><td class="colsep0 rowsep0" align="left">33 ± 16</td><td class="colsep0 rowsep0" align="left">3.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">NHCOOCH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8 ± 1</td><td class="colsep0 rowsep0" align="left">40 ± 5</td><td class="colsep0 rowsep0" align="left">45 ± 6</td><td class="colsep0 rowsep0" align="left">31 ± 20</td><td class="colsep0 rowsep0" align="left">3.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">NHCOOC(CH<sub>3</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">6 ± 1</td><td class="colsep0 rowsep0" align="left">14 ± 1</td><td class="colsep0 rowsep0" align="left">4 ± 1</td><td class="colsep0 rowsep0" align="left">8 ± 5</td><td class="colsep0 rowsep0" align="left">3.85</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values: concentration of drug responsible for the inhibition of 50% of the growth of the specified cell line after 72 h [mean ± SEM (<i>n</i> = 6 replicates)].</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">AclogP: calculated log <i>P</i> values according to the ALOGPS 2.1 software [VCCLAB, Virtual Computational Chemistry Laboratory, <a href="http://www.vcclab.org" class="extLink">http://www.vcclab.org</a>, 2005].</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Published compounds in ref <a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">56</a>.</p></div></div></div><div class="NLM_p">The 2,2-dimethylchroman compounds tested on glioma cells were characterized by the presence of a variety of substituents at the ortho, meta, or para position of the phenyl ring in the arylurea or arylthiourea moiety located at the 4-position of the benzopyran ring. The monosubstitution was investigated in these three positions with moderate to strong electron withdrawing (halogen, CN, NO<sub>2</sub>, CF<sub>3</sub>) or electron donating (OCH<sub>3</sub>, NH<sub>2</sub>) groups (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). With a second set of compounds, the nature of the substituent in the 6-position was also examined (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Particular attention was paid to the progressive increase of the steric hindrance of the “carbamate” moiety in this position.</div><div class="NLM_p">From the data reported in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, it was observed that for the compounds bearing the same substituent on the phenyl ring, the ortho position was generally found to be less favorable for growth inhibitory activity on glioma cells than the meta and the para positions (compare <b>10</b> versus <b>16</b> and <b>24</b>; compare <b>11</b> versus <b>18</b> and <b>25</b>; compare <b>13</b> versus <b>20</b> and <b>27</b>). However, no general trend can be formally deduced. The nitro group, for example, was better tolerated in the ortho position than in the para position, while the meta position remains the best choice for improved activity against all tumor cell lines (see <b>12</b>, <b>19</b>, and <b>26</b>).</div><div class="NLM_p">It also appears that for growth inhibitory activity on glioma cells, an electron withdrawing group was preferred to an electron donating group (i.e., positive mesomeric effect of OCH<sub>3</sub> and NH<sub>2</sub>), in particular in the meta and the para positions (compare <b>21</b> and <b>23</b> versus <b>15</b>–<b>20</b>; compare <b>28</b> versus <b>24</b>–<b>27</b>).</div><div class="NLM_p">Taken as a whole, the two best compounds from <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> were the 3-cyano and the 3-nitro-substituted arylurea compounds <b>18</b> and <b>19</b>, with an equal potency compared to cisplatin in these three tumor cell lines models, and 4-cyano-substituted arylthiourea compound <b>30</b>, previously described as an inhibitor of insulin release.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Interestingly, the reduction of the cyano group of <b>18</b>, which provides the corresponding aminomethyl-substituted derivative <b>22</b>, gave rise to a complete loss of biological activity.</div><div class="NLM_p">Results reported in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> clearly indicated that the presence of a bulky <i>tert</i>-butoxycarbonylamino group (see <b>18</b>) was preferred to less bulky “carbamate” moieties (see <b>35</b>, <b>36</b>, <b>37</b>) or the absence of a substituent (see <b>32</b>). The introduction of an amino (<b>33</b>) or a formamido group (<b>34</b>) was responsible for a complete loss of growth inhibitory activity against the three tumor cell lines.</div><div class="NLM_p last">Finally, looking at the selectivity index defined as the ratio between the GI<sub>50</sub> values on normal and tumor astrocytes, <b>18</b> (with a selectivity index of >10) was identified as one of the most promising compounds.</div></div><div id="sec2_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Biology. Therapeutic Potential of SIRT1 and -2 Targeting in Glioblastoma</h3><div class="NLM_p">Since the simultaneous inhibition of SIRT1 and -2 has been shown to display promising anticancer properties,<a onclick="showRef(event, 'ref8 ref18'); return false;" href="javascript:void(0);" class="ref ref8 ref18">(8, 18)</a> we aimed to assess the therapeutic potential of the pharmacological targeting of SIRT1 and -2 in glioblastoma. First, we investigated basal SIRT1 and -2 protein expression levels in U373 and Hs683 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). Results showed that Hs683 cells expressed a high constitutive level of SIRT1 compared to U373 cell, whereas SIRT2 was expressed at higher levels in U373 cells. Accordingly, we then knocked down SIRT1 in HS683 and SIRT1 and SIRT2 in U373 using siRNAs (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B) and followed their effects on cell growth (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C) by videomicroscopy over 72 h. Results suggested that a depletion of SIRT1 or -2 strongly reduced the proliferation of glioblastoma cells, thus further validating SIRT1 and -2 as interesting pharmacological targets.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. SIRT1/2 silencing decreases glioblastoma cell proliferation. (A) Constitutive SIRT1 and SIRT2 protein expression levels in U373 and Hs683 cell lines analyzed by Western blot. α-Tubulin was used as a loading control. (B, C) U373 and Hs683 cell lines were transfected with the indicated siRNA. (B) SIRT1 and SIRT2 protein expression levels were analyzed 24 h post-transfection. β-Actin was used as loading control. (C) 24 h post-transfection cell proliferation was monitored by time-lapse videomicroscopy. Graphs are representative of three independent experiments and correspond to the mean ± SD of 16 pictures per well acquired in triplicate. Blots are representative of three independent experiments, and quantifications are indicated under the blots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Predicting SIRT1/2 Binding Affinity of 2,2-Dimethylchroman Derivatives</h3><div class="NLM_p">To combine the differential cytotoxicity of our 2,2-dimethylchromans to their potential to inhibit SIRT1/2 activities, we compared the binding affinity of selected 2,2-dimethylchroman derivatives to known SIRTi including <b>2</b> as a dual SIRT1/2 inhibitor, <b>3</b> (SIRT1 inhibitor), and <b>4</b> (SIRT2 inhibitor). First, derivatives were analyzed against the human SIRT1 complex [Protein Data Bank (PDB) code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5I">4I5I</a>] and SIRT2 complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RMG">4RMG</a>) using AutoDock Vina<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> as described in “<a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>”. Briefly, the SIRT1 and -2 complexes were divided into ligand and protein and then the ligands were docked into the protein complexes. In silico docking results are represented in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf" class="ext-link">Figure SI-1 in Supporting Information</a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Silico Docking Scores of Selected Compounds against Human SIRT1 and SIRT2<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">SIRT1, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5I">4I5I</a></th><th class="colsep0 rowsep0" align="center" char=".">SIRT2, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RMG">4RMG</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">–7.0</td><td class="colsep0 rowsep0" align="char" char=".">–8.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">–9.4</td><td class="colsep0 rowsep0" align="char" char=".">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">–11.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">–8.3</td><td class="colsep0 rowsep0" align="char" char=".">–8.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">–9.2</td><td class="colsep0 rowsep0" align="char" char=".">–10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">–8.4</td><td class="colsep0 rowsep0" align="char" char=".">–9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">–7.5</td><td class="colsep0 rowsep0" align="char" char=".">–8.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">–7.6</td><td class="colsep0 rowsep0" align="char" char=".">–9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">–11.1</td><td class="colsep0 rowsep0" align="char" char=".">–10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">–7.2</td><td class="colsep0 rowsep0" align="char" char=".">–8.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">–7.2</td><td class="colsep0 rowsep0" align="char" char=".">–9.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">–7.7</td><td class="colsep0 rowsep0" align="char" char=".">–9.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">–7.6</td><td class="colsep0 rowsep0" align="char" char=".">–9.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">–7.8</td><td class="colsep0 rowsep0" align="char" char=".">–9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">–9.0</td><td class="colsep0 rowsep0" align="char" char=".">–9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char=".">–8.2</td><td class="colsep0 rowsep0" align="char" char=".">–9.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">–10.7</td><td class="colsep0 rowsep0" align="char" char=".">–10.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Binding affinity energy values (kcal/mol) for the indicated PDB codes were calculated using AutoDock Vina (for more details see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). <b>2</b>, <b>3</b>, and <b>4</b> were used as reference inhibitors of SIRT1/2, SIRT1, and SIRT2, respectively. “-” = not determined.</p></div></div></div><div class="NLM_p">Since compound <b>18</b> with the <i>N</i>-alkyl<i>-N</i>′-arylurea group in its cis, trans low-energy conformation demonstrated best docking affinity against SIRT1/2 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), a qualitative molecular docking was then performed with compound <b>18</b> in comparison to the SIRTi <b>4</b> and <b>2</b> against seven available experimental cocrystallized human SIRT2 complexes. The resulting lowest binding affinities were compared (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>A).<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20-23)</a> Overall, compound <b>18</b> exhibited a similar affinity to <b>2</b> but less than <b>4</b>. In <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A, the lowest affinity pose of compound <b>18</b> was selected as the likely binding modes in the binding pocket of SIRT2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RMG">4RMG</a>) where compound <b>18</b> formed a hydrogen bond with the backbone carbonyl oxygen of Val233. In addition, similar docking experiments were performed using compound <b>18</b> in comparison with the SIRTi <b>3</b> and <b>2</b> against six available experimental cocrystallized human SIRT1 complexes (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>B).<a onclick="showRef(event, 'ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27">(24-27)</a> Compound <b>18</b> exhibited better binding affinities than <b>3</b> and <b>2</b>. The lowest binding affinity pose of compound <b>18</b> was selected as the likely binding mode in the binding pocket of SIRT1 protein (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5I">4I5I</a>) where compound <b>18</b> formed two hydrogen bonds with the backbone nitrogen of Ala262 and the Nδ atom of His363 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>18</b> docked into human SIRT1 and SIRT2. (A) Docking pose of compound <b>18</b> on the crystal structure of SIRT1 (light pink; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5I">4I5I</a>). Close-up view on the right shows that compound <b>18</b> (lime) binds to the active site of SIRT1 structure. Hydrogen bonds are shown as dashed black lines. The residues forming hydrophobic interactions are represented as gray colored sticks. (B) Docking pose of compound <b>18</b> on the crystal structure of SIRT2 (wheat; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RMG">4RMG</a>). Close-up view on the right shows that compound <b>18</b> (lime) binds to the active site of SIRT2 structure. The hydrogen bond is shown as dashed black lines. The residues forming hydrophobic interactions are represented as gray colored sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Qualitative Molecular Docking of Compound <b>18</b> against Human SIRT1 (A) and SIRT2 (B)<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="4" align="center">(A)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">SIRT1 PDB code</th><th class="colsep0 rowsep0" align="center"><b>18</b></th><th class="colsep0 rowsep0" align="center"><b>2</b></th><th class="colsep0 rowsep0" align="center"><b>3</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5I">4I5I</a></td><td class="colsep0 rowsep0" align="left">–11.1</td><td class="colsep0 rowsep0" align="left">–7.0</td><td class="colsep0 rowsep0" align="left">–9.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IG9">4IG9</a></td><td class="colsep0 rowsep0" align="left">–8.5</td><td class="colsep0 rowsep0" align="left">–8.8</td><td class="colsep0 rowsep0" align="left">–7.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZZH">4ZZH</a></td><td class="colsep0 rowsep0" align="left">–8.5</td><td class="colsep0 rowsep0" align="left">–8.4</td><td class="colsep0 rowsep0" align="left">–7.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZZI">4ZZI</a></td><td class="colsep0 rowsep0" align="left">–9.9</td><td class="colsep0 rowsep0" align="left">–9.9</td><td class="colsep0 rowsep0" align="left">–8.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZZJ">4ZZJ</a></td><td class="colsep0 rowsep0" align="left">–7.4</td><td class="colsep0 rowsep0" align="left">–9.8</td><td class="colsep0 rowsep0" align="left">–8.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BTR">5BTR</a></td><td class="colsep0 rowsep0" align="left">–8.4</td><td class="colsep0 rowsep0" align="left">–7.9</td><td class="colsep0 rowsep0" align="left">–6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">average</td><td class="colsep0 rowsep0" align="left">–9.0</td><td class="colsep0 rowsep0" align="left">–8.6</td><td class="colsep0 rowsep0" align="left">–8.1</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="4" align="center">(B)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">SIRT2 PDB code</th><th class="colsep0 rowsep0" align="center"><b>18</b></th><th class="colsep0 rowsep0" align="center"><b>2</b></th><th class="colsep0 rowsep0" align="center"><b>4</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RMG">4RMG</a></td><td class="colsep0 rowsep0" align="left">–10.0</td><td class="colsep0 rowsep0" align="left">–8.7</td><td class="colsep0 rowsep0" align="left">–11.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RMH">4RMH</a></td><td class="colsep0 rowsep0" align="left">–10.6</td><td class="colsep0 rowsep0" align="left">–8.8</td><td class="colsep0 rowsep0" align="left">–11.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J8F">1J8F</a></td><td class="colsep0 rowsep0" align="left">–7.5</td><td class="colsep0 rowsep0" align="left">–9.8</td><td class="colsep0 rowsep0" align="left">–9.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZGO">3ZGO</a></td><td class="colsep0 rowsep0" align="left">–8.1</td><td class="colsep0 rowsep0" align="left">–10.3</td><td class="colsep0 rowsep0" align="left">–9.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZGV">3ZGV</a></td><td class="colsep0 rowsep0" align="left">–9.1</td><td class="colsep0 rowsep0" align="left">–9.8</td><td class="colsep0 rowsep0" align="left">–8.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DY4">5DY4</a></td><td class="colsep0 rowsep0" align="left">–9.4</td><td class="colsep0 rowsep0" align="left">–11.0</td><td class="colsep0 rowsep0" align="left">–10.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DY5">5DY5</a></td><td class="colsep0 rowsep0" align="left">–9.5</td><td class="colsep0 rowsep0" align="left">–7.5</td><td class="colsep0 rowsep0" align="left">–9.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">average</td><td class="colsep0 rowsep0" align="left">–9.2</td><td class="colsep0 rowsep0" align="left">–9.4</td><td class="colsep0 rowsep0" align="left">–10.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Binding affinity energy values (kcal/mol) for the indicated PDB codes were calculated using AutoDock Vina program (for more details see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). <b>2</b>, <b>3</b>, and <b>4</b> were used as reference inhibitors of SIRT1/2, SIRT1, and SIRT2, respectively.</p></div></div></div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Compound <b>18</b> Acts as a SIRT1/2 Inhibitor</h3><div class="NLM_p">Considering the proficiency of various HDAC inhibitors to impair glioblastoma cell proliferation<a onclick="showRef(event, 'ref3 ref28'); return false;" href="javascript:void(0);" class="ref ref3 ref28">(3, 28)</a> and the strong effect of the depletion of SIRT1 and -2 on glioblastoma cell growth, we then validated the potential of various 2,2-dimethylchromans selected based on our computational docking results to inhibit SIRT activities in vitro (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). In agreement with our docking data, compound <b>18</b> markedly inhibited both SIRT1 (IC<sub>50</sub> = 6.2 ± 1.7 μM) and SIRT2 (IC<sub>50</sub> = 4.2 ± 1.6 μM) activities within a concentration range comparable to <b>1</b> used as a positive control, even though <b>1</b> showed higher selectivity for SIRT1 (2.8 ± 0.3 μM) versus SIRT2 (13 ± 1 μM), whereas other derivatives performed less well or not at all.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Inhibitory Activity of Selected SIRT Inhibitors and Compound <b>18</b> on SIRT1, -2, and -3 Activities</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">SIRT1</th><th class="colsep0 rowsep0" align="center">SIRT2</th><th class="colsep0 rowsep0" align="center">SIRT3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">2.8 ± 0.3</td><td class="colsep0 rowsep0" align="left">13 ± 1</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">82.5 ± 7.1</td><td class="colsep0 rowsep0" align="left">47.1 ± 4.0</td><td class="colsep0 rowsep0" align="left">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">0.10 ± 0.06</td><td class="colsep0 rowsep0" align="left">20.1 ± 4.2</td><td class="colsep0 rowsep0" align="left">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">98.1 ± 2.4</td><td class="colsep0 rowsep0" align="left">2.8 ± 1.0</td><td class="colsep0 rowsep0" align="left">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">32.1 ± 6.5</td><td class="colsep0 rowsep0" align="left">18.5 ± 3.6</td><td class="colsep0 rowsep0" align="left">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">6.2 ± 1.7</td><td class="colsep0 rowsep0" align="left">4.2 ± 1.6</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">99.8 ± 11.0</td><td class="colsep0 rowsep0" align="left">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">121.2 ± 18.3</td><td class="colsep0 rowsep0" align="left">110.2 ± 18.9</td><td class="colsep0 rowsep0" align="left">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">109.9 ± 6.1</td><td class="colsep0 rowsep0" align="left">49.4 ± 7.6</td><td class="colsep0 rowsep0" align="left">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">108.7 ± 5.9</td><td class="colsep0 rowsep0" align="left">51.1 ± 11.1</td><td class="colsep0 rowsep0" align="left">-</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">54.8 ± 8.3</td><td class="colsep0 rowsep0" align="left">22.7 ± 3.5</td><td class="colsep0 rowsep0" align="left">-</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values: concentration of drug required for the inhibition of 50% of the specified sirtuin activity [mean ± SD (<i>n</i> = 3 independent experiments)]. <b>1</b> and <b>2</b>, <b>3</b>, and <b>4</b> were used as in vitro reference inhibitors of SIRT1/2, SIRT1, and SIRT2, respectively. “-”: not determined.</p></div></div></div><div class="NLM_p">Collectively, these data pointed out compound <b>18</b> as a good drug candidate for further investigation. First, we evaluated the selectivity of <b>18</b> by testing its activity against total in vitro HDAC activities (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A) as well as against the in vitro activity of various nonsirtuin HDAC isoenzymes (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). Results showed only residual inhibition of total HDAC activity, whereas increasing concentrations (0.1–100 μM) of <b>18</b> did not significantly impact HDAC 1, 2, 3, 8, 6, 10, and 11 activities. Therefore, compound <b>18</b> appeared essentially as a potent inhibitor of SIRT1/2 but not of SIRT3. Presently, we cannot exclude that <b>18</b> also targets other SIRT isoforms insofar expressed by glioblastoma.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro HDAC inhibition potential of compound <b>18</b>. (A) Residual inhibition of total HDAC activity. (B) Effect of <b>18</b> on activity of selected HDAC isoenzymes. Data are the mean ± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To validate in vitro results, <b>18</b> was then investigated on human U373 and Hs683 glioblastoma to assess in cellulo effects of SIRT inhibition on acetylation levels of histone and non-histone proteins. Cells were treated for 24 h at concentrations of 1–10 μM <b>18</b> compared to the pan-HDAC inhibitor suberoylanilide hydroxamic acid (SAHA, <b>38</b>; 2 μM) used as a positive control (<a class="ref internalNav" href="#fig1" aria-label="Figures 1">Figures 1</a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). We observed a concentration-dependent increase of α-tubulin, a well-known protein substrate for SIRT2,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and histone H4 acetylation starting at 5 μM in U373 cells and 1–2.5 μM in Hs683 cells, respectively. The differential dose–response of protein acetylation observed in those two cell lines after <b>18</b> exposure depending on the analyzed sirtuin substrate could be explained by the constitutive SIRT1 and -2 protein expression levels observed in glioblastoma cell lines (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). Furthermore, <b>18</b> increased acetylation levels in both lines for acetylated H4 and H3K56, reported to serve as substrates for SIRT1 (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf" class="ext-link">Figure SI-2</a>).</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In cellulo assessment of HDAC inhibition by compound <b>18</b> through the study of histone and α-tubulin acetylation levels. Cells were treated for 8 h at the indicated concentrations of compound <b>18</b>. The acetylation (Ac) of histone H4 (H4) and α-tubulin was analyzed by Western blot. Histone H1 (H1) and β-actin were used as loading controls for the analysis of acid (top panel) and total (bottom panel) extracts, respectively. <b>38</b> (2 μM) was used as a reference HDAC inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, we compared the growth inhibitory activity of <b>18</b> to reference SIRTi against U373 and Hs683 cell lines (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). MTT results highlighted <b>18</b> as a promising anticancer drug as it had the most pronounced growth inhibitory potency against glioblastoma cells, about 6 times compared to the SIRT1/2 inhibitor <b>2</b> and about 20 and 6–14 times for the SIRT1 and SIRT2 inhibitors <b>3</b> and <b>4</b>, respectively.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Growth Inhibitory Activities of Selected SIRT Inhibitors and Compound <b>18</b> in Glioma Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">U373</th><th class="colsep0 rowsep0" align="center">Hs683</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">39.3 ± 5.4</td><td class="colsep0 rowsep0" align="left">33.9 ± 4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">157.4 ± 23.0</td><td class="colsep0 rowsep0" align="left">115.9 ± 23.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">47.6 ± 4.4</td><td class="colsep0 rowsep0" align="left">80.2 ± 9.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">7.5 ± 1.1</td><td class="colsep0 rowsep0" align="left">5.8 ± 0.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values: concentration of drug responsible for the inhibition of 50% of the growth of the specified cell line after 72 h [mean ± SEM of three independent experiments (<i>n</i> = 4 replicates)].</p></div></div></div><div class="NLM_p">Finally, we investigated the effect of the depletion of SIRT1 or SIRT2 on the anticancer effects of compound <b>18</b> in glioblastoma cells. Results demonstrated that the downregulation of either one of these two HDAC enhanced the growth inhibitory properties of compound <b>18</b> on U373 and Hs683 cells (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. SIRT1 or SIRT2 knock-down enhances the growth inhibitory effects of <b>18</b> in glioblastoma cells. U373 and Hs683 cell lines were transfected with the indicated siRNA. 24 h post-transfection cells were treated with compound <b>18</b> at the respective IC<sub>50</sub> values calculated from MTT assays (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>), and proliferation was monitored by time-lapse videomicroscopy. Graphs are representative of three independent experiments and correspond to the mean ± SD of 16 pictures per well acquired in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Compound <b>18</b> Does Not Exert Its Growth Inhibitory Activity through Proapoptotic Effects in Human Glioblastoma Cells</h3><div class="NLM_p">We then assessed the biological effect of compound <b>18</b> by using computer-assisted phase contrast microscopy (quantitative videomicroscopy) to grossly analyze the way by which compound <b>18</b> inhibits the growth of human U373 and Hs683 glioma cell lines (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>A shows that 10 μM (i.e., approximately the GI<sub>50</sub> value revealed by the MTT colorimetric assay, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) compound <b>18</b> decreased by ∼70% the growth of the Hs683 cell line after 72 h of culture. While the growth inhibitory effects of <b>18</b> were pronounced on Hs683 cell line growth, the <b>18</b>-related growth inhibitory activity rather corresponded to cytostatic than to cytotoxic effects on these Hs683 tumor cells as morphologically illustrated in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>. The definitions of the global growth and the global growth ratio are provided in the legend of <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>. The same features were observed on the U373 glioblastoma cells (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>B). Remarkably, while U373 glioblastoma cells display certain levels of resistance to proapoptotic stimuli,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> these U373 cells appear as sensitive as Hs683 oligodendroglioma cells to the growth inhibitory effects of compound <b>18</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) with the fact that Hs683 cells are sensitive to proapoptotic stimuli.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a></div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Digitized images of Hs683 oligodendroglial (A) and U373 glioblastoma (B) cells were obtained using computer-assisted phase-contrast microscopy (quantitative videomicroscopy). A global growth ratio (the GGR index) was calculated, resulting in a value that can be directly compared to the IC<sub>50</sub> value determined by the MTT colorimetric assay (the hatched horizontal line in the bottom chart, i.e., ∼10 μM (see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>)). First, the global growth (GG) is calculated for each control and each treated condition at 24, 48, and 72 h by dividing the number of cells on the last image by the number of cells on the first image. The GGR index is obtained by dividing the GG values calculated for Hs683 tumor cells treated with <b>18</b> by the GG values calculated for the control. The experiment was performed once in triplicate, and the data represent the mean ± SEM values. White, gray, and black bars represent the data obtained at 24, 48 and 72 h, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The quantitative videomicroscopy-related analyses suggested that compound <b>18</b> is cytostatic rather than cytotoxic in both Hs683 and U373 glioma cell lines. We thus made use of flow cytometry analyses to investigate whether compound <b>18</b> induced, or not, significant proapoptotic effects in these two glioma cell lines. The data obtained with 10 μM compound <b>18</b> indicated modest proapoptotic effects in Hs683 and weak, if any, effects in U373 glioma cells (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf" class="ext-link">Figure SI-3</a>). It is thus unlikely that the growth inhibitory effects observed at 10 μM for compound <b>18</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) could relate to cytotoxic proapoptotic effects, even if, as expected,<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> Hs683 oligodendroglioma cells are more prone to enter apoptosis than U373 glioblastoma cells. Indeed, while both the MTT colorimetric assay and the quantitative videomicroscopy approach revealed that 10 μM compound <b>18</b> inhibited by ≥50% the growth of both Hs683 and U373 glioma cell lines (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>), flow cytometry analyses revealed that 10 μM compound <b>14</b> induced ∼25% and <10% apoptosis in Hs683 and U373 glioma cells, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf" class="ext-link">Figure SI-3</a>). These results were confirmed and generalized by the absence of a significant accumulation of cells in the sub G1 population (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf" class="ext-link">Figure SI-4</a>) when cells were treated with various SIRTi at the IC<sub>50</sub> calculated from MTT assays (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). Only <b>4</b> induced a modest increase of sub G1 population in both cell lines as observed with the pan-non-sirtuin HDAC inhibitor <b>38</b> in U373 cells.</div></div><div id="sec2_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Effect of Compound <b>18</b> on Cell Cycle and Senescence</h3><div class="NLM_p">Considering the strong effect of <b>18</b> on glioblastoma cell growth, we then investigated the effect of various SIRTi compounds on cell cycle distribution. As shown in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>A, compound <b>18</b> induced an accumulation in G1 in both cell lines comparable to the one observed with the SIRT1 inhibitor <b>3</b> as well as with the SIRT1/2 inhibitor <b>2</b> and the pan-non-sirtuin inhibitor <b>38</b> in Hs683 cells. In contrast, the SIRT2 inhibitor <b>4</b> triggered G2/M accumulation in both cell lines as observed with <b>2</b> and <b>38</b> in U373 cells.</div><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0009.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Compound <b>18</b> induces G1 cell cycle arrest in glioblastoma cell lines and promotes the accumulation of senescent U373 cells. (A) Cells were treated, or not, with <b>18</b>, <b>2</b>, <b>3</b>, <b>4</b> (at the respective IC<sub>50</sub> values for each cell lines reported in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>) and 2 μM <b>38</b>. After 24 and 48 h of exposure, cell cycle distribution was analyzed. Histograms correspond to the mean ± SD of the quantification of three independent experiments. ∗, ∗∗ indicate <i>p</i> < 0.05, <i>p</i> < 0.01 compared to control cells, respectively. (B) Cells were incubated in a medium containing DMSO as a vehicle control or 5 μM <b>18</b> for 6 days and were stained for β-galactosidase activity. Representative pictures of two independent experiments are depicted where SA-β-gal-positive cells are revealed by blue staining. The percentage of senescent cells, expressed as a percentage of the total number of cells counted, is indicated for each picture. Data represent the mean ± SD of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Irreversible cell cycle arrest may result in senescence induction.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Therefore, we investigated whether sustained exposure to subtoxic concentrations of compound <b>18</b> may promote senescence-associated β-galactosidase (SA-β-gal) activity. As shown in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>B, the number of senescent cells, identified as blue-stained cells, was markedly increased in <b>18</b>-treated U373 cells (≅20%), whereas no blue-stained cells were detected in untreated cells.</div></div><div id="sec2_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Compound <b>18</b> Inhibits Glioblastoma Cell Growth in Vivo</h3><div class="NLM_p">Considering the drastic antiproliferative properties of <b>18</b> in vitro, we next investigated whether this compound could also hamper the spheroid-forming capacity of glioblastoma cells. Our results show that 5 and 10 μM compound <b>18</b> significantly reduced the surface area and volume of multicellular tumor spheroids from glioma Hs683 (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>A) and U373 (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf" class="ext-link">Figure SI-5</a>) cell lines. The propensity of compound <b>18</b> to reduce the 3D tumor-like growth of glioblastoma cells was also confirmed by decreased ATP levels in <b>18</b>-treated tumor spheroid glioblastoma cultures (<a class="ref internalNav" href="#fig10" aria-label="Figures 10">Figures 10</a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf" class="ext-link">SI-5</a>).</div><figure id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0010.jpeg" id="gr14" class="inline-fig internalNav" /></img><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0023.jpeg" id="gr14.5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Antitumor potential of compound <b>18</b>. (A) Representative bright field images and 3D plots of spheroids generated from Hs683 cells (top panels). Cells were pretreated for 24 h with the indicated concentrations of <b>18</b> and then left untreated for 96 h (4-day incubation, upper left panel), or untreated cells were cultured for 96 h in the presence of the indicated concentrations of <b>18</b> (24 h pretreated cells, upper right panel). The surface, volume, and ATP levels of spheroids were measured as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> (bottom panels). Data are the mean ± SD of three independent experiments. (B) Fluorescent Hs683 and U373 cells were treated, or not, in vitro at 5 or 10 μM compound <b>18</b> for 30 or 36 h and then injected in the zebrafish yolk sac. The figure represents results obtained with a pretreatment of 36 h at 10 μM; for the other conditions of treatment we refer to <a href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf" class="ext-link">Figure SI-5</a>. After 72 h, fluorescence was quantified and representative images from a total of eight fish per condition are shown. For each fish, the upper panel represents the bright field, the middle panel the red fluorescence, and the bottom panel the merged picture. Fluorescence intensity quantification graphs are shown. PBS injection was used as a control for injection side effects. ∗, ∗∗, ∗∗∗ indicate <i>p</i> < 0.05, <i>p</i> < 0.01, <i>p</i> < 0.05 compared to control cells, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0010.jpeg jm-2017-005335_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To further extend our evaluation of the growth inhibitory capacities of <b>18</b> toward in vivo settings, we examined the ability of <b>18</b> to abrogate tumor development in a zebrafish xenotransplantation model. Fluorescently labeled tumor cells were pretreated for 30 (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf" class="ext-link">Figure SI-5</a>) or 36 h (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>B) with compound <b>18</b> and then injected into the yolk sacs of zebrafish embryos. Results revealed that the tumor-associated fluorescence intensity signal was drastically lowered in the <b>18</b>-treated zebrafish group compared to the untreated control group for both glioblastoma Hs683 and U373 cell lines. The capacity of <b>18</b> to impede tumor formation in vivo validated our in vitro results and sustained the potential anticancer activity of <b>18</b>.</div></div><div id="sec2_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Compound <b>18</b> Is Active against a Broad Range of Tumor Cell Lines Including Drug-Resistant Cancer Cells Harboring Different Resistance Mechanisms</h3><div class="NLM_p">Next, to extend the anticancer potential of <b>18</b>, <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a> (revealed with the permission of the NCI) shows that the mean GI<sub>50</sub> value of compound <b>18</b> in the NCI-60 cell line panel is log<sub>10</sub><sup>GI50</sup> = −5.52, i.e., ∼3 μM, a concentration very close to the one we obtained on the three Hs683, U373, and T98G glioma cell lines, i.e., 8 ±5 μM (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a> further shows that compound <b>18</b> displays similar growth inhibitory activity against a broad majority of the NCI cell lines.</div><figure id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0011.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Characterization of the growth inhibitory effects exerted by compound <b>18</b> in the NCI 60-cell-line panel (National Cancer Institute Developmental Therapeutics Program, mean graphs).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Successful cancer therapy by chemotherapeutic agents but also targeted small molecule inhibitors is frequently limited by drug resistance mechanisms leading to treatment failure and recurrence. Resistance might be mediated by mutations in sensor genes of DNA damage, like the tumor suppressor p53<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> or overexpression of pleiotropic efflux pumps for multiple drugs causing a broad-scale multidrug resistance (MDR) phenotype.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Hence we tested whether mutation of p53 or overexpression of the major MDR proteins ABCB1 (P-glycoprotein) and ABCC1 (multidrug resistance protein 1, MRP1) significantly reduces the anticancer activity of <b>18</b> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>). Neither loss of p53 nor overexpression of these ABC transporters resulted in a significant loss of activity against the investigated drug resistance models (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf" class="ext-link">Table SI-1</a>). In contrast, ABCB1 overexpression in SW1573 2R160 and KB-C-1 lines even resulted in a slight hypersensitivity to <b>18</b> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>B and <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>D, respectively, and <a href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf" class="ext-link">Table SI-1</a>). Additionally, an ovarian cancer cell model with acquired cisplatin resistance (A2780cis) and a hydroxyurea-resistant HeLa derivative overexpressing ribonucleotide reductase model (KB-HU)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> were compared to their respective parental cell lines (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>C and <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>D, respectively). Also in these two cases, no significant impact of the resistance phenotype on the cytotoxic activity of <b>18</b> was detectable. Collectively these data demonstrate that <b>18</b> is not susceptible to several important chemotherapy resistance mechanisms.</div><figure id="fig12" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0012.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Impact of clinically significant drug resistance mechanisms on the anticancer activity of <b>18</b>. (A) HCT-116 p53wt and HCT-116 p53ko (p53 knockout), (B) SW1573, SW1573 2R120 (ABCC1- and LRP-overexpressing) and 2R160 (ABCB1-overexpressing), (C) A2780 and A2780cis (cisplatin resistant), and (D) KB-3-1, KB-C-1 (ABCB1-overexpressing) and KB-HU (ribonucleotide reductase subunit 2-overexpressing) were treated with the indicated concentrations of compound <b>18</b>. After 72 h of continuous drug exposure, cell viability was determined by MTT assay. The experiments were performed in quintuplicate, and results are shown as the mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Finally, the effect of <b>18</b> was tested after 24 and 48 h of treatment on the viability of peripheral blood mononuclear cells (PBMCs) from healthy donors (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>). Compound <b>18</b> does not exhibit any major acute toxicity on this normal cell model.</div><figure id="fig13" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0013.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Effect of compound <b>18</b> on the viability of healthy peripheral blood mononuclear cells. Histograms correspond to the mean ± SD of three independent experiments. ∗, ∗∗ indicate <i>p</i> < 0.05, <i>p</i> < 0.01 compared to control cells, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32861" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32861" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We prepared new series of <i>N</i>-aryl-<i>N</i>′-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)ureas and thioureas bearing an alkoxycarbonylamino group (“carbamate” group) at the 6-position of the chroman nucleus. These compounds, structurally related to previously described 2,2-dimethylchroman derivatives acting on glioma cells, were examined as putative anticancer agents. Growth inhibitory activity was measured in three glioma cell lines (U373, T98G, and Hs683), as well as on normal astrocytes. Those data revealed that the compound bearing a cyano group at the meta position of the phenyl ring of the 4-arylurea moiety, as well as a bulky <i>tert</i>-butoxycarbonylamino group at the 6-position (compound <b>18</b>), exhibited a potent antiproliferative activity against the tumor glial cells while having lower impact on normal glial cells (selectivity index of >10). From the computational docking analysis, compound <b>18</b> also showed a potent binding affinity when compared with other derivatives as observed with our antiproliferative activity assay. This compound was therefore selected for further investigations to better understand its mechanism of action. Compound <b>18</b> was assayed in the NCI-60 cell line panel screening demonstrating interesting inhibitory potential in various cell types. <b>18</b> was also submitted to a COMPARE analysis (results not presented) to further decipher the mode of action of compound <b>18</b> as successfully done previously with respect to other compounds but without providing further clues. The screening confirmed the antiproliferative activity of <b>18</b> on a variety of cancer cell lines (mean GI<sub>50</sub> value of 3 μM), while the COMPARE tool did not allow obtaining a clear hypothesis about its potential mechanism of action. Quantitative videomicroscopy analysis revealed that <b>18</b> was a cytostatic rather than a cytotoxic agent.</div><div class="NLM_p">Furthermore, neither mutation of p53 nor overexpression of MDR efflux pumps including ABCB1 and ABCC1 significantly reduced the anticancer activity of <b>18</b>. The same holds true for acquired cisplatin and hydroxyurea resistance. These data suggest that several major drug resistance mechanisms limiting the success of current systemic cancer therapy are not affecting the activity of <b>18</b>. Hence this substance might be especially attractive for targeting treatment-resistant recurrences.</div><div class="NLM_p">Then, <b>18</b> was tested against a panel of HDAC activities and a potent inhibitory activity was observed in vitro on HDAC SIRT1/2 and IC<sub>50</sub> values in the low micromolar range (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Presently, we cannot exclude that inhibition of other SIRT isoforms led to growth arrest if expressed by the targeted cancer type. This observation was validated in cellulo when <b>18</b> was investigated on human U373 and Hs683 glioblastoma cell lines to assess effects of deacetylase inhibition on acetylation levels of histone and non-histone proteins. Interestingly, compound <b>18</b> acted as an in vitro SIRTi with activities commonly reported in the literature. Importantly we demonstrated associated biological activities (i.e., increased protein acetylation levels and important antiproliferative properties) at concentrations in the low micromolar range, which is usually not the case of SIRTi published over the past years (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf" class="ext-link">Table SI-4</a>).</div><div class="NLM_p">Finally, the anticancer potential of <b>18</b> was further highlighted through the growth inhibition of multicellular glioblastoma tumor spheroids as well as the reduction of tumor formation in vivo using zebrafish xenografts.</div><div class="NLM_p last">In conclusion, compound <b>18</b> is new anticancer agent active on glioma cells and expressing a cytostatic rather than a cytotoxic activity. Moreover, this compound is a potent inhibitor of SIRT1 and -2 and constitutes a model of chemical structure opening new perspectives in the medicinal chemistry of HDAC inhibitors against class III.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63738" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63738" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry</h3><div class="NLM_p last">Melting points were determined on a Stuart SMP3 capillary apparatus and are uncorrected. The <sup>1</sup>H NMR spectra were recorded on a Bruker Avance (500 MHz) instrument using DMSO-<i>d</i><sub>6</sub> as the solvent with TMS as an internal standard; chemical shifts are reported in δ values (ppm) relative to that of internal TMS. The abbreviations s = singlet, d = doublet, t = triplet, q = quadruplet, m = multiplet, b = broad are used throughout. Elemental analyses (C, H, N, S) were realized on a Thermo Scientific FlashEA 1112 elemental analyzer and were within ±0.4% of the theoretical values. This analytical method certified a purity of ≥95% for each tested compound. All reactions were routinely checked by TLC on silica gel Merck 60 F<sub>254</sub>.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>R</i>/<i>S</i>-<i>N</i>-2-Chlorophenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>10</b>)</h3><div class="NLM_p last">3-Chlorophenyl isocyanate (0.13 g, 0.82 mmol) was added to a solution of <b>9</b> (0.2 g, 0.68 mmol) in methylene chloride (5 mL). After 1 h, the solvent was removed under vacuum; the title product was obtained from the crude product by DCVC purification: mp 192–194 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.25 (s, 3H, C<i>H</i><sub>3</sub>), 1.36 (s, 3H, C<i>H</i><sub>3</sub>), 1.43 (s, 9H, NHCOOC(C<i>H</i><sub>3</sub>)<sub>3</sub>), 1.66 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.13 (dd, <i>J</i> = 13 Hz/6 Hz, 3-<i>H</i>), 4.91 (dd, <i>J</i> = 16 Hz/9 Hz, 1H, 4-<i>H</i>), 6,65 (d, <i>J</i> = 8.8 Hz, 1H, 8-<i>H</i>), 6.97 (td, <i>J</i> = 7.9 Hz/1.5 Hz, 1H, 4′-<i>H</i>), 7.19 (d, <i>J</i> = 7.1 Hz, 1H, 7-<i>H</i>), 7.27 (td, <i>J</i> = 7.9 Hz/1.5 Hz, 1H, 5′-<i>H</i>), 7.38 (d, <i>J</i> = 8.4 Hz, 1H, CHN<i>H</i>CONHAr), 7.41–7.42 (m, 2H, 5-<i>H</i>/3′-<i>H</i>), 8.07 (s, 1H, CHNHCON<i>H</i>Ar), 8.26 (dd, <i>J</i> = 8.3 Hz/1.2 Hz, 1H, 6′-<i>H</i>), 9.10 (s, 1H, N<i>H</i>COOC(CH<sub>3</sub>)<sub>3</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.6 (CH<sub>3</sub>), 28.1 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 28.9 (CH<sub>3</sub>), 40.0 (C-3), 42.4 (C-4), 74.7 (C-2), 78.6 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 116.7 (C-8), 117.7 (C-5), 119.7 (C-7), 120.7 (C-6′), 121.1 (C-2′), 122.5 (C-4′), 122.6 (C-4a), 127.5 (C-5′), 129.1 (C-3′), 132.1 (C-6), 136.6 (C-1′), 148.6 (C-8a), 153.0 (NH<i>C</i>OOC(CH<sub>3</sub>)<sub>3</sub>), 154.7 (CHNH<i>C</i>ONHAr). Anal. (C<sub>23</sub>H<sub>28</sub>ClN<sub>3</sub>O<sub>4</sub>) theoretical: C, 61.95; H, 6.33; N, 9.42. Found: C, 61.71; H, 6.33; N, 9.44.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>R</i>/<i>S</i>-<i>N</i>-2-Cyanophenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>11</b>)</h3><div class="NLM_p last">The title compound was obtained as described for <b>10</b>, starting from <b>9</b> (0.2 g, 0.68 mmol) and 2-cyanophenyl isocyanate (0.12 g, 0.82 mmol): mp 206–208 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.25 (s, 3H, C<i>H</i><sub>3</sub>), 1.36 (s, 3H, C<i>H</i><sub>3</sub>), 1.43 (s, 9H, NHCOOC(C<i>H</i><sub>3</sub>)<sub>3</sub>), 1.69 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.14 (dd, <i>J</i> = 13 Hz/6 Hz, 3-<i>H</i>), 4.91 (dd, <i>J</i> = 16 Hz/9 Hz, 1H, 4-<i>H</i>), 6,65 (d, <i>J</i> = 8.8 Hz, 1H, 8-<i>H</i>), 7.12 (t, <i>J</i> = 8 Hz, 1H, 4′-<i>H</i>), 7.20 (d, <i>J</i> = 7.3 Hz, 1H, 7-<i>H</i>), 7.42 (d, <i>J</i> = 8.8 Hz, 1H, CHN<i>H</i>CONHAr), 7.43 (s, 1H, 5-<i>H</i>), 7.61 (m, 1H, 5′-<i>H</i>), 7.71 (dd, <i>J</i> = 7.8 Hz/1.4 Hz, 3′-<i>H</i>), 8.22 (d, <i>J</i> = 8.5 Hz, 1H, 6′-<i>H</i>), 8.54 (s, 1H, CHNHCON<i>H</i>Ar), 9.11 (s, 1H, N<i>H</i>COOC(CH<sub>3</sub>)<sub>3</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.6 (CH<sub>3</sub>), 28.1 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 28.8 (CH<sub>3</sub>), 40.0 (C-3), 42.6 (C-4), 74.7 (C-2), 78.6 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 100.5 (C-2′), 116.8 (C-8), 117.0 (CN), 117.6 (C-5), 119.7 (C-7), 120.4 (C-6′), 122.2 (C-4′), 122.4 (C-4a), 132.1 (C-6), 133.0 (C-3′), 133.9 (C-5′), 142.7 (C-1′), 148.5 (C-8a), 153.0 (NH<i>C</i>OOC(CH<sub>3</sub>)<sub>3</sub>), 154.4 (CHNH<i>C</i>ONHAr). Anal. (C<sub>24</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub>) theoretical: C, 66.04; H, 6.47; N, 12.84. Found: C, 66.12; H, 6.11; N, 13.26.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>R</i>/<i>S</i>-<i>N</i>-2-Nitrophenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>12</b>)</h3><div class="NLM_p last">The title compound was obtained as described for <b>10</b>, starting from <b>9</b> (0.2 g, 0.68 mmol) and 2-nitrophenyl isocyanate (0.13 g, 0.82 mmol): mp 218–219 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.25 (s, 3H, C<i>H</i><sub>3</sub>), 1.37 (s, 3H, C<i>H</i><sub>3</sub>), 1.42 (s, 9H, NHCOOC(C<i>H</i><sub>3</sub>)<sub>3</sub>), 1.69 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.11 (dd, <i>J</i> = 13 Hz/6 Hz, 3-<i>H</i>), 4.92 (dd, <i>J</i> = 16 Hz/9 Hz, 1H, 4-<i>H</i>), 6,65 (d, <i>J</i> = 8.8 Hz, 1H, 8-<i>H</i>), 7.16 (m, 1H, 4′-<i>H</i>), 7.20 (d, <i>J</i> = 6.4 Hz, 1H, 7-<i>H</i>), 7.40 (s, 1H, 5-<i>H</i>), 7.68 (m, 1H, 5′-<i>H</i>), 7.98 (d, <i>J</i> = 8.1 Hz, 1H, CHN<i>H</i>CONHAr), 8.09 (dd, <i>J</i> = 8.4 Hz/1.5 Hz, 1H, 6′-<i>H</i>), 8.45 (d, <i>J</i> = 8.5 Hz, 1H, 3′-<i>H</i>), 9.09 (s, 1H, N<i>H</i>COOC(CH<sub>3</sub>)<sub>3</sub>), 9.45 (s, 1H, CHNHCON<i>H</i>Ar). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.4 (CH<sub>3</sub>), 28.1 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 29.0 (CH<sub>3</sub>), 40.0 (C-3), 42.7 (C-4), 74.7 (C-2), 78.6 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 116.7 (C-8), 117.7 (C-5), 119.6 (C-7), 121.5 (C-4′), 122.1 (C-3′), 122.4 (C-4a), 125.4 (C-6′), 132.0 (C-6), 135.0 (C-5′), 135.8 (C-1′), 136.7 (C-2′), 148.5 (C-8a), 152.9 (NH<i>C</i>OOC(CH<sub>3</sub>)<sub>3</sub>), 154.2 (CHNH<i>C</i>ONHAr). Anal. (C<sub>23</sub>H<sub>28</sub>N<sub>4</sub>O<sub>6</sub>) theoretical: C, 60.52; H, 6.18; N, 12.27. Found: C, 60.18; H, 6.17; N, 11.86.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>R</i>/<i>S</i>-<i>N</i>-2-Trifluoromethylphenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>13</b>)</h3><div class="NLM_p last">The title compound was obtained as described for <b>10</b>, starting from <b>9</b> (0.2 g, 0.68 mmol) and 2-trifluoromethylphenyl isocyanate (0.15 g, 0.82 mmol): mp 239–239.5 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.25 (s, 3H, C<i>H</i><sub>3</sub>), 1.36 (s, 3H, C<i>H</i><sub>3</sub>), 1.44 (s, 9H, NHCOOC(C<i>H</i><sub>3</sub>)<sub>3</sub>), 1.67 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.12 (dd, <i>J</i> = 13 Hz/6 Hz, 3-<i>H</i>), 4.90 (dd, <i>J</i> = 16 Hz/9 Hz, 1H, 4-<i>H</i>), 6.64 (d, <i>J</i> = 8.8 Hz, 8-<i>H</i>), 7.15 (d, <i>J</i> = 7.6 Hz, 1H, 7-<i>H</i>), 7.21 (t, <i>J</i> = 7.6 Hz, 1H, 4′-<i>H</i>), 7.38 (d, <i>J</i> = 8.3 Hz, 1H, CHN<i>H</i>CONHAr), 7.48 (s, 1H, 5-<i>H</i>), 7.60 (t, <i>J</i> = 7.8 Hz, 1H, 5′-<i>H</i>), 7.63 (d, <i>J</i> = 7.9 Hz, 1H, 3′-<i>H</i>), 7.83 (s, 1H, CHNHCON<i>H</i>Ar), 8.09 (d, <i>J</i> = 8.3 Hz, 1H, 6′-<i>H</i>), 9.12 (s, 1H, N<i>H</i>COOC(CH<sub>3</sub>)<sub>3</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.6 (CH<sub>3</sub>), 28.1 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 28.9 (CH<sub>3</sub>), 40.0 (C-3), 42.6 (C-4), 74.7 (C-2), 78.6 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 116.7 (C-8), 117.8 (C-5), 119.6 (C-7), 122.7 (C-4a), 122.8 (C-4′), 123.0–125.1 (d, <i>J</i> = 273 Hz, CF<sub>3</sub>), 124.8 (C-6′), 125.7 (C-3′), 127.3 (C-2′), 132.0 (C-6), 132.7 (C-5′), 137.2 (C-1′), 148.5 (C-8a), 152.9 (NH<i>C</i>OOC(CH<sub>3</sub>)<sub>3</sub>), 154.9 (CHNH<i>C</i>ONHAr). Anal. (C<sub>24</sub>H<sub>28</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub>) theoretical: C, 60.12; H, 5.89; N, 8.76. Found: C, 60.12; H, 5.95; N, 8.73.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>R</i>/<i>S</i>-<i>N</i>-2-Methoxyphenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>14</b>)</h3><div class="NLM_p last">The title compound was obtained as described for <b>10</b>, starting from <b>9</b> (0.2 g, 0.68 mmol) and 2-methoxyphenyl isocyanate (0.12 g, 0.82 mmol): mp 204–205 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.25 (s, 3H, C<i>H</i><sub>3</sub>), 1.35 (s, 3H, C<i>H</i><sub>3</sub>), 1.42 (s, 9H, NHCOOC(C<i>H</i><sub>3</sub>)<sub>3</sub>), 1.62 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.10 (dd, <i>J</i> = 13 Hz/6 Hz, 3-<i>H</i>), 3.83 (s, 3H, OC<i>H</i><sub>3</sub>), 4.90 (dd, <i>J</i> = 16 Hz/9 Hz, 1H, 4-<i>H</i>), 6,63 (d, <i>J</i> = 8.8 Hz, 1H, 8-<i>H</i>), 6.88 (pd, <i>J</i> = 7.4 Hz/1.6 Hz, 2H, 4′-<i>H</i>/5′-<i>H</i>), 6.98 (dd, <i>J</i> = 7.7 Hz/1.6 Hz, 1H, 3′-<i>H</i>), 7.19 (bs, 1H, CHN<i>H</i>CONHAr), 7.20 (d, <i>J</i> = 8.5 Hz, 1H, 7-<i>H</i>), 7.40 (s, 1H, 5-<i>H</i>), 8.01 (s, 1H, CHNHCON<i>H</i>Ar), 8.18 (dd, <i>J</i> = 7.5 Hz/1.9 Hz, 1H, 6′-<i>H</i>), 9.10 (s, 1H, N<i>H</i>COOC(CH<sub>3</sub>)<sub>3</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.6 (CH<sub>3</sub>), 28.1 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 28.9 (CH<sub>3</sub>), 40.0 (C-3), 42.2 (C-4), 55.6 (OCH<sub>3</sub>), 74.7 (C-2), 78.5 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 110.5 (C-3′), 116.6 (C-8), 117.8 (C-5/C-6′), 119.6 (C-7), 120.5 (C-5′), 121.0 (C-4′), 122.9 (C-4a), 129.4 (C-1′), 132.0 (C-6), 147.2 (C-2′), 148.6 (C-8a), 153.0 (NH<i>C</i>OOC(CH<sub>3</sub>)<sub>3</sub>), 155.0 (CHNH<i>C</i>ONHAr). Anal. (C<sub>24</sub>H<sub>31</sub>N<sub>3</sub>O<sub>5</sub>) theoretical: C, 65.29; H, 7.08; N, 9.52. Found: C, 65.20; H, 7.09; N, 9.51.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>R</i>/<i>S</i>-<i>N</i>-3-Fluorophenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>15</b>)</h3><div class="NLM_p last">The title compound was obtained as described for <b>10</b>, starting from <b>9</b> (0.2 g, 0.68 mmol) and 3-fluorophenyl isocyanate (0.11 g, 0.82 mmol): mp 115–125 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.24 (s, 3H, C<i>H</i><sub>3</sub>), 1.35 (s, 3H, C<i>H</i><sub>3</sub>), 1.42 (s, 9H, NHCOOC(C<i>H</i><sub>3</sub>)<sub>3</sub>), 1.70 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.08 (dd, <i>J</i> = 13 Hz/6 Hz, 3-<i>H</i>), 4.92 (dd, <i>J</i> = 16 Hz/10 Hz, 1H, 4-<i>H</i>), 6.55 (d, <i>J</i> = 8.6 Hz, 1H, CHN<i>H</i>CONHAr), 6,64 (d, <i>J</i> = 8.7 Hz, 1H, 8-<i>H</i>), 6.73 (t, <i>J</i> = 7.6 Hz, 1H, 4′-<i>H</i>), 7.06 (d, <i>J</i> = 7.8 Hz, 1H, 6′-<i>H</i>), 7.17 (d, <i>J</i> = 7.1 Hz, 1H, 7-<i>H</i>), 7.26 (dd, <i>J</i> = 15.2 Hz/7.7 Hz, 1H, 5′-<i>H</i>), 7.41 (s, 1H, 5-<i>H</i>), 7.53 (d, <i>J</i> = 12 Hz, 1H, 2′-<i>H</i>), 8.73 (s, 1H, CHNHCON<i>H</i>Ar), 9.11 (s, 1H, N<i>H</i>COOC(CH<sub>3</sub>)<sub>3</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.4 (CH<sub>3</sub>), 28.1 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 29.0 (CH<sub>3</sub>), 40.0 (C-3), 42.3 (C-4), 74.8 (C-2), 78.5 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 104.4 (d, <i>J</i> = 27 Hz, C-2′), 107.4 (d, <i>J</i> = 21 Hz, C-4′), 113.5 (d, <i>J</i> = 2 Hz, C-6′), 116.7 (C-8), 117.6 (C-5), 119.6 (C-7), 122.9 (C-4a), 130.1 (d, <i>J</i> = 10 Hz, C-5′), 132.0 (C-6), 142.2 (d, <i>J</i> = 12 Hz, C-1′), 148.5 (C-8a), 152.9 (NH<i>C</i>OOC(CH<sub>3</sub>)<sub>3</sub>), 154.9 (CHNH<i>C</i>ONHAr), 161.5–163.4 (d, <i>J</i> = 240 Hz, C-3′). Anal. (C<sub>23</sub>H<sub>28</sub>FN<sub>3</sub>O<sub>4</sub>) theoretical: C, 64.32; H, 6.57; N, 9.78. Found: C, 64.68; H, 6.26; N, 10.09.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>R</i>/<i>S</i>-<i>N</i>-3-Bromophenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>17</b>)</h3><div class="NLM_p last">The title compound was obtained as described for <b>10</b>, starting from <b>9</b> (0.2 g, 0.68 mmol) and 3-bromophenyl isocyanate (0.16 g, 0.82 mmol): mp 209.5–210.5 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.24 (s, 3H, C<i>H</i><sub>3</sub>), 1.35 (s, 3H, C<i>H</i><sub>3</sub>), 1.42 (s, 9H, NHCOOC(C<i>H</i><sub>3</sub>)<sub>3</sub>), 1.71 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.08 (dd, <i>J</i> = 13 Hz/6 Hz, 3-<i>H</i>), 4.92 (dd, <i>J</i> = 16 Hz/10 Hz, 1H, 4-<i>H</i>), 6.57 (d, <i>J</i> = 8.6 Hz, 1H, CHN<i>H</i>CONHAr), 6,63 (d, <i>J</i> = 8.7 Hz, 1H, 8-<i>H</i>), 7.09 (d, <i>J</i> = 8.5 Hz, 1H, 4′-<i>H</i>), 7.16 (d, <i>J</i> = 7.1 Hz, 1H, 7-<i>H</i>), 7.20 (t, <i>J</i> = 8 Hz, 1H, 5′-<i>H</i>), 7.26 (d, <i>J</i> = 8.7 Hz, 1H, 6′-<i>H</i>), 7.40 (s, 1H, 5-<i>H</i>), 7.90 (t, <i>J</i> = 1.9 Hz, 1H, 2′-<i>H</i>), 8.71 (s, 1H, CHNHCON<i>H</i>Ar), 9.09 (s, 1H, N<i>H</i>COOC(CH<sub>3</sub>)<sub>3</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.4 (CH<sub>3</sub>), 28.1 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 29.0 (CH<sub>3</sub>), 40.0 (C-3), 42.4 (C-4), 74.8 (C-2), 78.5 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 116.6 (C-8/C-6′), 117.5 (C-5), 119.6 (C-7), 120.1 (C-2′), 121.7 (C-3′), 122.9 (C-4a), 123.7 (C-4′), 130.6 (C-5′), 132.0 (C-6), 142.0 (C-1′), 148.5 (C-8a), 152.9 (NH<i>C</i>OOC(CH<sub>3</sub>)<sub>3</sub>), 154.9 (CHNH<i>C</i>ONHAr). Anal. (C<sub>23</sub>H<sub>28</sub>BrN<sub>3</sub>O<sub>4</sub>) theoretical: C, 56.33; H, 5.76; N, 8.57. Found: C, 56.40; H, 5.83; N, 8.44.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>R</i>/<i>S</i>-<i>N</i>-3-Nitrophenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>19</b>)</h3><div class="NLM_p last">The title compound was obtained as described for <b>10</b>, starting from <b>9</b> (0.2 g, 0.68 mmol) and 3-nitrophenyl isocyanate (0.13 g, 0.82 mmol): mp 120–155 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.25 (s, 3H, C<i>H</i><sub>3</sub>), 1.36 (s, 3H, C<i>H</i><sub>3</sub>), 1.41 (s, 9H, NHCOOC(C<i>H</i><sub>3</sub>)<sub>3</sub>), 1.76 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.09 (dd, <i>J</i> = 13 Hz/6 Hz, 3-<i>H</i>), 4.95 (dd, <i>J</i> = 16 Hz/10 Hz, 1H, 4-<i>H</i>), 6.64 (d, <i>J</i> = 8.8 Hz, 1H, 8-<i>H</i>), 6.71 (d, <i>J</i> = 8.7 Hz, 1H, CHN<i>H</i>CONHAr), 7.17 (bs, 1H, 7-<i>H</i>), 7.41 (s, 1H, 5-<i>H</i>), 7.53 (t, <i>J</i> = 8.2 Hz, 1H, 5′-<i>H</i>), 7.69 (d, <i>J</i> = 7.8 Hz, 1H, 4′-<i>H</i>), 7.78 (d, <i>J</i> = 8.1 Hz, 1H, 6′-<i>H</i>), 8.61 (t, <i>J</i> = 2 Hz, 1H, 2′-<i>H</i>), 9.09 (s, 2H, CHNHCON<i>H</i>Ar/N<i>H</i>COOC(CH<sub>3</sub>)<sub>3</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.4 (CH<sub>3</sub>), 28.1 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 29.1 (CH<sub>3</sub>), 40.0 (C-3), 42.5 (C-4), 74.8 (C-2), 78.5 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 111.7 (C-2′), 115.7 (C-6′), 116.7 (C-8), 117.5 (C-5), 119.6 (C-7), 122.8 (C-4a), 123.9 (C-4′), 129.9 (C-5′), 132.0 (C-6), 141.7 (C-1′), 148.1 (C-3′), 148.5 (C-8a), 152.9 (NH<i>C</i>OOC(CH<sub>3</sub>)<sub>3</sub>), 154.9 (CHNH<i>C</i>ONHAr). Anal. (C<sub>23</sub>H<sub>28</sub>N<sub>4</sub>O<sub>6</sub>) theoretical: C, 60.52; H, 6.18; N, 12.27. Found: C, 61.01; H, 6.13; N, 12.18.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>R</i>/<i>S</i>-<i>N</i>-3-Trifluoromethylphenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>20</b>)</h3><div class="NLM_p last">The title compound was obtained as described for <b>10</b>, starting from <b>9</b> (0.2 g, 0.68 mmol) and 3-trifluoromethylphenyl isocyanate (0.15 g, 0.82 mmol): mp 140–155 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.25 (s, 3H, C<i>H</i><sub>3</sub>), 1.36 (s, 3H, C<i>H</i><sub>3</sub>), 1.42 (s, 9H, NHCOOC(C<i>H</i><sub>3</sub>)<sub>3</sub>), 1.74 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.09 (dd, <i>J</i> = 13 Hz/6 Hz, 3-<i>H</i>), 4.94 (dd, <i>J</i> = 16 Hz/10 Hz, 1H, 4-<i>H</i>), 6.62 (d, <i>J</i> = 8.6 Hz, 1H, CHN<i>H</i>CONHAr), 6.64 (d, <i>J</i> = 8.8 Hz, 1H, 8-<i>H</i>), 7.17 (bd, <i>J</i> = 6.7 Hz, 1H, 7-<i>H</i>), 7.26 (d, <i>J</i> = 7.5 Hz, 1H, 4′-<i>H</i>), 7.41 (s, 1H, 5-<i>H</i>), 7.47 (t, <i>J</i> = 7.9 Hz, 1H, 5′-<i>H</i>), 7.53 (d, <i>J</i> = 8.2 Hz, 1H, 6′-<i>H</i>), 8.07 (s, 1H, 2′-<i>H</i>), 8.89 (s, 1H, CHNHCON<i>H</i>Ar), 9.08 (s, 1H, N<i>H</i>COOC(CH<sub>3</sub>)<sub>3</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.4 (CH<sub>3</sub>), 28.1 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 29.1 (CH<sub>3</sub>), 40.0 (C-3), 42.4 (C-4), 74.8 (C-2), 78.5 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 113.8 (C-2′), 116.6 (C-8), 117.4 (C-5/C-4′), 119.6 (C-7), 121.3 (C-6′), 122.9 (C-4a), 123.2–125.4 (d, <i>J</i> = 272 Hz, CF<sub>3</sub>), 129.3–129.6 (d, <i>J</i> = 31 Hz, C-3′), 129.7 (C-5′), 132.0 (C-6), 141.2 (C-1′), 148.5 (C-8a), 153.0 (NH<i>C</i>OOC(CH<sub>3</sub>)<sub>3</sub>), 155.0 (CHNH<i>C</i>ONHAr). Anal. (C<sub>24</sub>H<sub>28</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub>) theoretical: C, 60.12; H, 5.89; N, 8.76. Found: C, 60.19; H, 6.03; N, 8.59.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>R</i>/<i>S</i>-<i>N</i>-3-Methoxyphenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>21</b>)</h3><div class="NLM_p last">The title compound was obtained as described for <b>10</b>, starting from <b>9</b> (0.2 g, 0.68 mmol) and 3-methoxyphenyl isocyanate (0.12 g, 0.82 mmol): mp 189–191 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.24 (s, 3H, C<i>H</i><sub>3</sub>), 1.35 (s, 3H, C<i>H</i><sub>3</sub>), 1.42 (s, 9H, NHCOOC(C<i>H</i><sub>3</sub>)<sub>3</sub>), 1.68 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.08 (dd, <i>J</i> = 13 Hz/6 Hz, 3-<i>H</i>), 3.72 (s, 1H, OC<i>H</i><sub>3</sub>), 4.91 (dd, <i>J</i> = 16 Hz/10 Hz, 1H, 4-<i>H</i>), 6.46 (d, <i>J</i> = 8.7 Hz, 1H, CHN<i>H</i>CONHAr), 6.50 (dd, <i>J</i> = 8.2 Hz/1.9 Hz, 1H, 4′-<i>H</i>), 6.63 (d, <i>J</i> = 8.8 Hz, 1H, 8-<i>H</i>), 6.89 (dd, <i>J</i> = 8.1 Hz/1 Hz, 1H, 6′-<i>H</i>), 7.13 (t, <i>J</i> = 8 Hz, 1H, 5′-<i>H</i>), 7.17 (d, <i>J</i> = 7.8 Hz, 1H, 7-<i>H</i>), 7.22 (t, <i>J</i> = 2 Hz, 1H, 2′-<i>H</i>), 7.40 (s, 1H, 5-<i>H</i>), 8.52 (s, 1H, CHNHCON<i>H</i>Ar), 9.08 (s, 1H, N<i>H</i>COOC(CH<sub>3</sub>)<sub>3</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.5 (CH<sub>3</sub>), 28.1 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 29.0 (CH<sub>3</sub>), 40.0 (C-3), 42.3 (C-4), 54.8 (OCH<sub>3</sub>), 74.8 (C-2), 78.5 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 103.4 (C-2′), 106.7 (C-4′), 110.1 (C-6′), 116.6 (C-8), 117.6 (C-5), 119.6 (C-7), 123.0 (C-4a), 129.4 (C-5′), 132.0 (C-6), 141.6 (C-1′), 148.6 (C-8a), 153.0 (NH<i>C</i>OOC(CH<sub>3</sub>)<sub>3</sub>), 155.0 (CHNH<i>C</i>ONHAr), 159.7 (C-3′). Anal. (C<sub>24</sub>H<sub>31</sub>N<sub>3</sub>O<sub>5</sub>) theoretical: C, 65.29; H, 7.08; N, 9.52. Found: C, 65.25; H, 7.13; N, 9.43.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>R</i>/<i>S</i>-<i>N</i>-3-Aminomethylphenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>22</b>)</h3><div class="NLM_p last">Raney nickel was added to a solution of <b>18</b> (0.3 g, 0.69 mmol) and ammonia (0.3 mL) in ethanol (10 mL). The solution was stirred in a sealed hydrogenator under a hydrogen pressure of 7 bar. When the reaction was ended (3 h), the catalyst was filtered off and the filtrate was evaporated under pressure. The title compound was obtained after purification on a DCVC system: mp 120–170 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.24 (s, 3H, C<i>H</i><sub>3</sub>), 1.35 (s, 3H, C<i>H</i><sub>3</sub>), 1.42 (s, 9H, NHCOOC(C<i>H</i><sub>3</sub>)<sub>3</sub>), 1.68 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.09 (dd, <i>J</i> = 13 Hz/6 Hz, 3-<i>H</i>), 3.3 (bs, 2H, CH<sub>2</sub>N<i>H</i><sub>2</sub>), 3.67 (s, 2H, C<i>H</i><sub>2</sub>NH<sub>2</sub>), 4.91 (dd, <i>J</i> = 16 Hz/10 Hz, 1H, 4-<i>H</i>), 6.47 (d, <i>J</i> = 8.7 Hz, 1H, CHN<i>H</i>CONHAr), 6.63 (d, <i>J</i> = 8.8 Hz, 1H, 8-<i>H</i>), 6.89 (d, <i>J</i> = 7.5 Hz, 1H, 4′-<i>H</i>), 7.17 (m, 2H, 7-<i>H</i>/5′-<i>H</i>), 7.31 (d, <i>J</i> = 8.2 Hz, 1H, 6′-<i>H</i>), 7.37 (s, 1H, 2′-<i>H</i>), 7.41 (s, 1H, 5-<i>H</i>), 8.46 (s, 1H, CHNHCON<i>H</i>Ar), 9.08 (s, 1H, N<i>H</i>COOC(CH<sub>3</sub>)<sub>3</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.5 (CH<sub>3</sub>), 28.1 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 29.0 (CH<sub>3</sub>), 40.0 (C-3), 42.3 (C-4), 45.7 (CH<sub>2</sub>NH<sub>2</sub>), 74.8 (C-2), 78.5 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 115.8 (C-6′), 116.5 (C-2′), 116.7 (C-8), 117.5 (C-5), 119.6 (C-7), 120.0 (C-4′), 123.0 (C-4a), 128.4 (C-5′), 132.0 (C-6), 140.2 (C-1′), 144.5 (C-3′), 148.6 (C-8a), 153.0 (NH<i>C</i>OOC(CH<sub>3</sub>)<sub>3</sub>), 155.1 (CHNH<i>C</i>ONHAr). Anal. (C<sub>24</sub>H<sub>32</sub>N<sub>4</sub>O<sub>4</sub>) theoretical: C, 65.43; H, 7.32; N, 12.72. Found: C, 64.96; H, 7.31; N, 12.70.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>R</i>/<i>S</i>-<i>N</i>-3-Aminophenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>23</b>)</h3><div class="NLM_p last">Ammonium chloride (0.15 g, 2.83 mmol) and iron (0.6 g, 10,7 mmol) were added to a solution of <b>19</b> (0.3 g, 0.66 mmol) in ethanol/water 3:1 (10 mL). The solution was heated at 80 °C for 15 min. After filtration (without cooling), the filtrate was treated with charcoal, filtered, and evaporated under vacuum. The title compound was obtained after purification on a DCVC system: mp 130–140 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.24 (s, 3H, C<i>H</i><sub>3</sub>), 1.35 (s, 3H, C<i>H</i><sub>3</sub>), 1.43 (s, 9H, NHCOOC(C<i>H</i><sub>3</sub>)<sub>3</sub>), 1.65 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.08 (dd, <i>J</i> = 13 Hz/6 Hz, 3-<i>H</i>), 4.89 (dd, <i>J</i> = 16 Hz/10 Hz, 1H, 4-<i>H</i>), 4.95 (s, 1H, N<i>H</i><sub>2</sub>), 6.14 (dd, <i>J</i> = 7.9 Hz/1.3 Hz, 1H, 4′-<i>H</i>), 6.35 (d, <i>J</i> = 8.7 Hz, 1H, CHN<i>H</i>CONHAr), 6.57 (dd, <i>J</i> = 8.1 Hz/1 Hz, 1H, 6′-<i>H</i>), 6.63 (d, <i>J</i> = 8.8 Hz, 1H, 8-<i>H</i>), 6.72 (t, <i>J</i> = 1.9 Hz, 1H, 2′-<i>H</i>), 6.85 (t, <i>J</i> = 8 Hz, 1H, 5′-<i>H</i>), 7.17 (d, <i>J</i> = 6.6 Hz, 1H, 7-<i>H</i>), 7.39 (s, 1H, 5-<i>H</i>), 8.17 (s, 1H, CHNHCON<i>H</i>Ar), 9.10 (s, 1H, N<i>H</i>COOC(CH<sub>3</sub>)<sub>3</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.6 (CH<sub>3</sub>), 28.1 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 29.0 (CH<sub>3</sub>), 40.0 (C-3), 42.2 (C-4), 74.8 (C-2), 78.5 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 103.4 (C-2′), 105.8 (C-6′), 107.6 (C-4′), 116.6 (C-8), 117.7 (C-5), 119.6 (C-7), 123.1 (C-4a), 128.9 (C-5′), 132.0 (C-6), 140.9 (C-1′), 148.6 (C-8a), 149.0 (C-3′), 153.0 (NH<i>C</i>OOC(CH<sub>3</sub>)<sub>3</sub>), 154.9 (CHNH<i>C</i>ONHAr). Anal. (C<sub>23</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub>) theoretical: C, 64.77; H, 7.09; N, 13.14. Found: C, 64.32; H, 7.06; N, 12.95.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>R</i>/<i>S</i>-<i>N</i>-4-Nitrophenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>26</b>)</h3><div class="NLM_p last">The title compound was obtained as described for <b>10</b>, starting from <b>9</b> (0.2 g, 0.68 mmol) and 4-nitrophenyl isocyanate (0.13 g, 0.82 mmol): mp 233–233.5 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.25 (s, 3H, C<i>H</i><sub>3</sub>), 1.36 (s, 3H, C<i>H</i><sub>3</sub>), 1.42 (s, 9H, NHCOOC(C<i>H</i><sub>3</sub>)<sub>3</sub>), 1.75 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.10 (dd, <i>J</i> = 13 Hz/6 Hz, 3-<i>H</i>), 4.94 (dd, <i>J</i> = 16 Hz/9 Hz, 1H, 4-<i>H</i>), 6.64 (d, <i>J</i> = 8.8 Hz, 1H, 8-<i>H</i>), 6.82 (d, <i>J</i> = 8.6 Hz, 1H, CHN<i>H</i>CONHAr), 7.18 (d, <i>J</i> = 6.5 Hz, 1H, 7-<i>H</i>), 7.40 (s, 1H, 5-<i>H</i>), 7.69 (d, <i>J</i> = 7.7 Hz, 2H, 2′-<i>H</i>/6′-<i>H</i>), 8.17 (d, <i>J</i> = 9.3 Hz, 2H, 3′-<i>H</i>/5′-<i>H</i>), 9.09 (s, 1H, N<i>H</i>COOC(CH<sub>3</sub>)<sub>3</sub>), 9.32 (s, 1H, CHNHCON<i>H</i>Ar). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.4 (CH<sub>3</sub>), 28.1 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 29.0 (CH<sub>3</sub>), 40.4 (C-3), 42.5 (C-4), 74.8 (C-2), 78.6 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 116.7 (C-8), 117.0 (C-2′/C-6′), 117.5 (C-5), 119.6 (C-7), 122.5 (C-4a), 125.1 (C-3′/C-5′), 132.1 (C-6), 140.5 (C-1′), 147.0 (C-4′), 148.5 (C-8a), 152.9 (NH<i>C</i>OOC(CH<sub>3</sub>)<sub>3</sub>), 154.4 (CHNH<i>C</i>ONHAr). Anal. (C<sub>23</sub>H<sub>28</sub>N<sub>4</sub>O<sub>6</sub>) theoretical: C, 60.52; H, 6.18; N, 12.27. Found: C, 59.95; H, 6.16; N, 12.09.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>R</i>/<i>S</i>-<i>N</i>-4-Trifluoromethylphenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>27</b>)</h3><div class="NLM_p last">The title compound was obtained as described for <b>10</b>, starting from <b>9</b> (0.2 g, 0.68 mmol) and 4-trifluoromethylphenyl isocyanate (0.15 g, 0.82 mmol): mp 186–188 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.25 (s, 3H, C<i>H</i><sub>3</sub>), 1.36 (s, 3H, C<i>H</i><sub>3</sub>), 1.42 (s, 9H, NHCOOC(C<i>H</i><sub>3</sub>)<sub>3</sub>), 1.72 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.09 (dd, <i>J</i> = 13 Hz/6 Hz, 3-<i>H</i>), 4.94 (dd, <i>J</i> = 16 Hz/9 Hz, 1H, 4-<i>H</i>), 6.63–6.66 (m, 2H, CHN<i>H</i>CONHAr/8-<i>H</i>), 7.18 (d, <i>J</i> = 7 Hz, 1H, 7-<i>H</i>), 7.40 (s, 1H, 5-<i>H</i>), 7.59 (d, <i>J</i> = 8.8 Hz, 2H, 3′-<i>H</i>/5′-<i>H</i>), 7.65 (d, <i>J</i> = 8.8 Hz, 1H, 2′-<i>H</i>/6′-<i>H</i>), 8.95 (s, 1H, CHNHCON<i>H</i>Ar), 9.09 (s, 1H, N<i>H</i>COOC(CH<sub>3</sub>)<sub>3</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.4 (CH<sub>3</sub>), 28.1 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 29.0 (CH<sub>3</sub>), 40.4 (C-3), 42.4 (C-4), 74.8 (C-2), 78.5 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 116.7 (C-8), 117.4 (C-5/C-2′/C-6′), 119.6 (C-7), 121.0–121.2 (d, <i>J</i> = 32 Hz, C-4′), 122.8 (C-4a), 123.5–125.7 (d, <i>J</i> = 271 Hz, CF<sub>3</sub>), 126.0 (C-3′/C-5′), 132.0 (C-6), 144.1 (C-1′), 148.6 (C-8a), 153.0 (NH<i>C</i>OOC(CH<sub>3</sub>)<sub>3</sub>), 154.8 (CHNH<i>C</i>ONHAr). Anal. (C<sub>24</sub>H<sub>28</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub>) theoretical: C, 60.12; H, 5.89; N, 8.76. Found: C, 60.08; H, 5.97; N, 8.72.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>R</i>/<i>S</i>-<i>N</i>-4-Methoxyphenyl-<i>N</i>′-(6-<i>tert</i>-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>28</b>)</h3><div class="NLM_p last">The title compound was obtained as described for <b>10</b>, starting from <b>9</b> (0.2 g, 0.68 mmol) and 4-methoxyphenyl isocyanate (0.12 g, 0.82 mmol): mp 204–205 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.24 (s, 3H, C<i>H</i><sub>3</sub>), 1.35 (s, 3H, C<i>H</i><sub>3</sub>), 1.43 (s, 9H, NHCOOC(C<i>H</i><sub>3</sub>)<sub>3</sub>), 1.68 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.06 (dd, <i>J</i> = 13 Hz/6 Hz, 3-<i>H</i>), 3.70 (s, 3H, OC<i>H</i><sub>3</sub>), 4.91 (dd, <i>J</i> = 16 Hz/9 Hz, 1H, 4-<i>H</i>), 6.47 (d, <i>J</i> = 8.7 Hz, 1H, CHN<i>H</i>CONHAr), 6,62 (d, <i>J</i> = 8.8 Hz, 1H, 8-<i>H</i>), 6.83 (d, <i>J</i> = 9 Hz, 2H, 3′-<i>H</i>/5′-<i>H</i>), 7.16 (d, <i>J</i> = 7.2 Hz, 7-<i>H</i>), 7.35 (d, <i>J</i> = 9 Hz, 2H, 2′-<i>H</i>/6′-<i>H</i>), 7.40 (s, 1H, 5-<i>H</i>), 8.41 (s, 1H, CHNHCON<i>H</i>Ar), 9.08 (s, 1H, N<i>H</i>COOC(CH<sub>3</sub>)<sub>3</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.4 (CH<sub>3</sub>), 28.1 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 29.1 (CH<sub>3</sub>), 40.0 (C-3), 42.3 (C-4), 55.1 (OCH<sub>3</sub>), 74.8 (C-2), 78.5 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 113.8 (C-3′/C-5′), 116.6 (C-8), 117.7 (C-5), 119.5 (C-2′/C-6′), 119.6 (C-7), 123.3 (C-4a), 132.0 (C-6), 133.6 (C-1′), 148.6 (C-8a), 153.0 (NH<i>C</i>OOC(CH<sub>3</sub>)<sub>3</sub>), 154.0 (CHNH<i>C</i>ONHAr), 155.4 (C-4′). Anal. (C<sub>24</sub>H<sub>31</sub>N<sub>3</sub>O<sub>5</sub>) theoretical: C, 65.29; H, 7.08; N, 9.52. Found: C, 64.88; H, 7.20; N, 9.13.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>R</i>/<i>S</i>-<i>N</i>-3-Cyanophenyl-<i>N</i>′-(3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>32</b>)</h3><div class="NLM_p last">The title compound was obtained as described for <b>10</b>, starting from <b>31</b> (0.2 g, 1.13 mmol) and 3-cyanophenyl isocyanate (0.18 g, 1.25 mmol): mp 217–219 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.28 (s, 3H, C<i>H</i><sub>3</sub>), 1.39 (s, 3H, C<i>H</i><sub>3</sub>), 1.77 (t, <i>J</i> = 12 Hz, 1H, 3-<i>H</i>), 2.12 (dd, <i>J</i> = 13 Hz/6.2 Hz, 3-<i>H</i>), 4.98 (dd, <i>J</i> = 16.3 Hz/9.2 Hz, 1H, 4-<i>H</i>), 6.74 (d, <i>J</i> = 8.7 Hz, 1H, 8-<i>H</i>), 6.76 (d, <i>J</i> = 10 Hz, 1H, CHN<i>H</i>CONHAr), 6.88 (t, <i>J</i> = 7.4 Hz, 1H, 6-<i>H</i>), 7.14 (t, <i>J</i> = 7.6 Hz, 1H, 7-H), 7.26 (d, <i>J</i> = 7.6 Hz, 1H, 5-<i>H</i>), 7.37 (d, <i>J</i> = 7.5 Hz, 1H, 4′-<i>H</i>), 7.46 (t, <i>J</i> = 8 Hz, 1H, 5′-<i>H</i>), 7.64 (d, <i>J</i> = 8.3 Hz, 1H, 6′-<i>H</i>), 8.00 (s, 1H, 2′-<i>H</i>), 8.92 (s, 1H, CHNHCON<i>H</i>Ar). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 25.0 (CH<sub>3</sub>), 29.6 (CH<sub>3</sub>), 40.0 (C-3), 42.8 (C-4), 75.6 (C-2), 117.2 (C-8), 119.4 (CN), 120.4 (C-6), 120.8 (C-2′), 122.9 (C-6′), 123.7 (C-4a), 125.1 (C-4′), 128.0 (C-5), 129.0 (C-7), 130.6 (C-5′), 141.8 (C-1′), 153.8 (C-8a), 155.5 (CHNH<i>C</i>ONHAr). Anal. (C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub>) theoretical: C, 71.01; H, 5.96; N, 13.08. Found: C, 70.90; H, 5.97; N, 12.83.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>R</i>/<i>S</i>-<i>N</i>-3-Cyanophenyl-<i>N</i>′-(6-amino-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>33</b>)</h3><div class="NLM_p last">A suspension of <b>18</b> (2.85 g, 6.5 mmol) in a 5 N hydrochloric acid ethanolic solution (100 mL) was heated for 5 min. The mixture was then poured into water (200 mL). The title compound was precipitated by addition of a 20% aqueous solution of sodium hydroxide until pH = 10, filtered, washed with water, and dried: mp 176–178 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.21 (s, 3H, C<i>H</i><sub>3</sub>), 1.32 (s, 3H, C<i>H</i><sub>3</sub>), 1.67 (dd, <i>J</i> = 13 Hz/11 Hz, 1H, 3-<i>H</i>), 2.03 (dd, <i>J</i> = 13 Hz/6.3 Hz, 3-<i>H</i>), 4.57 (s, 2H, N<i>H</i><sub>2</sub>), 4.87 (dd, <i>J</i> = 15.9 Hz/9.7 Hz, 1H, 4-<i>H</i>), 6.40 (dd, <i>J</i> = 8.5 Hz/2.5 Hz, 1H, 7-<i>H</i>), 6.45 (d, <i>J</i> = 8.5 Hz, 1H, 8-<i>H</i>), 6.51 (d, <i>J</i> = 2.2 Hz, 1H, 5-<i>H</i>), 6.63 (d, <i>J</i> = 8.7 Hz, 1H, CHN<i>H</i>CONHAr), 7.36 (d, <i>J</i> = 7.7 Hz, 1H, 4′-<i>H</i>), 7.45 (t, <i>J</i> = 8 Hz, 1H, 5′-<i>H</i>), 7.63 (d, <i>J</i> = 8.3 Hz, 1H, 6′-<i>H</i>), 8.00 (s, 1H, 2′-<i>H</i>), 8.86 (s, 1H, CHNHCON<i>H</i>Ar). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.8 (CH<sub>3</sub>), 29.6 (CH<sub>3</sub>), 40.8 (C-3), 42.9 (C-4), 74.4 (C-2), 112.0 (C-3′), 112.7 (C-5), 115.7 (C-7), 117.4 (C-8), 119.5 (CN), 120.7 (C-2′), 122.8 (C-6′), 123.4 (C-4a), 125.1 (C-4′), 130.6 (C-5′), 141.8 (C-6), 142.2 (C-1′), 144.8 (C-8a), 155.4 (CHNH<i>C</i>ONHAr). Anal. (C<sub>19</sub>H<sub>20</sub>N<sub>4</sub>O<sub>2</sub>) theoretical: C, 67.84; H, 5.99; N, 16.66. Found: C, 67.47; H, 6.03; N, 16.53.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>R</i>/<i>S</i>-<i>N</i>-3-Cyanophenyl-<i>N</i>′-(6-formamido-3,4-dihydro-2,2-dimethyl-2<i>H</i>-1-benzopyran-4-yl)urea (<b>34</b>)</h3><div class="NLM_p last">A mixture of acetic anhydride (2 mL, 21.2 mmol) and formic acid (1 mL, 26.5 mmol) was heated at 55 °C for 2 h. The mixture was then cooled to 0 °C, and anhydrous THF (2 mL) was added. A solution of <b>33</b> (0.3 g, 0.89 mmol) in anhydrous THF was added dropwise. When the reaction was complete, water was added and the resulting precipitate was filtered, washed with water, and dried. The title product was obtained from the crude product by DCVC purification: mp 200–202 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.26 (s, 3H, C<i>H</i><sub>3</sub>), 1.37 (s, 3H, C<i>H</i><sub>3</sub>), 1.76 (t, <i>J</i> = 12 Hz, 1H, 3-<i>H</i>), 2.09 (dd, <i>J</i> = 13 Hz/6.2 Hz, 3-<i>H</i>), 4.96 (dd, <i>J</i> = 15.3 Hz/10.3 Hz, 1H, 4-<i>H</i>), 6.70 (d, <i>J</i> = 8.7 Hz, 1H, 8-<i>H</i>), 6.80 (d, <i>J</i> = 8.7 Hz, 1H, CHN<i>H</i>CONHAr), 7.37 (d, <i>J</i> = 7.7 Hz, 1H, 4′-<i>H</i>), 7.42–7.48 (m, 3H, 5-<i>H</i>/7-<i>H</i>/5′-<i>H</i>), 7.66 (m, 1H, 6′-<i>H</i>), 8.01 (s, 1H, 2′-<i>H</i>), 8.15 (d, <i>J</i> = 2 Hz, 1H, N<i>H</i>CHO), 8.96 (s, 1H, CHNHCON<i>H</i>Ar), 10.00 (s, 1H, NHC<i>H</i>O). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 24.4 (CH<sub>3</sub>), 29.1 (CH<sub>3</sub>), 40.0 (C-3), 42.3 (C-4), 75.1 (C-2), 111.5 (C-3′), 116.8 (C-8), 118.3 (C-5), 119.0 (CN), 120.2 (C-7), 120.3 (C-2′), 122.4 (C-6′), 123.2 (C-4a), 124.0 (), 124.7 (C-4′), 130.1 (C-5′), 131.0 (C-6), 141.2 (C-1′), 149.5 (C-8a), 154.9 (CHNH<i>C</i>ONHAr), 158.9 (NHCHO). Anal. (C<sub>19</sub>H<sub>20</sub>N<sub>4</sub>OS) theoretical: C, 65.92; H, 5.53; N, 15.38. Found: C, 65.43; H, 5.55; N, 15.37.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Docking Studies</h3><div class="NLM_p last">AutoDock Vina software (The Scripps Research Institute, CA, USA)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> was used in the docking studies. Initial structures of SIRT1 and SIRT2 were obtained from the Protein Data Bank (PDB), and coordinates for the compounds were generated using the GlycoBioChem PRODRG2 server.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> To prepare the structure for docking, the ligand and all water molecules were removed. The size of the docking grid was 40 Å × 40 Å × 40 Å, which encompassed most of the entire structures of SIRT1 and -2. AutoDock Vina program was run with four-way multithreading, and the other parameters were default settings in AutoDock Vina program. Figures were generated using PyMol (<contrib-group person-group-type="allauthors">DeLano, W. L.</contrib-group> <cite>The PyMol Molecular Graphics System</cite>; DeLano Scientific: Palo Alto, CA, USA, <span class="NLM_year">2002</span>) and LigPlot+.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Pharmacology. Cell Cultures and Media</h3><div class="NLM_p">Three human glioma cell lines were used (the Hs683 oligodendroglial and the U373 and T98G glioblastoma models). The biological and histopathological characteristics demonstrating the oligodendroglial nature of the Hs683 model were provided by Le Mercier et al.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> A controversy exists today about the origin of the U373 cells, which are in fact U251 glioblastoma cells.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> A new U373 cell line has been established and deposited at the European Collection of Cell Cultures (Salisbury, U.K.; code ECACC 08061901). We used this U373 model in the current study. The T98G glioma cell line was obtained from the American Type Culture Collection (Manassas, VA, USA; code ATCC CRL-1690) and was initially described by Stein.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The Hs683 model was also obtained from the ATCC (code HTB-138). The uterine cervix carcinoma-derived cell line KB-3-1 and its ABCB1-overexpressing MDR subline KB-C-1 were provided by Dr. Shen (Bethesda, MD, USA).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The KB-3-1 derivative KB-HU selected against hydroxyurea was generously donated by Dr. Y. C. Cheng (Yale University, New Haven, CT, USA).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The ovarian cancer cell line A2780 and its cisplatin resistant subline A2780/cis were purchased from Sigma (Bornem, Belgium). The human colon cancer cell line HCT116 p53 wild-type and its p53/ko clone with deleted p53 were generously donated by Dr. B. Vogelstein (Johns Hopkins University, Baltimore, MD, USA).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The non-small-cell lung cancer cell model SW1573 with its ABCC1- and LRP-overexpressing subline 2R120 and its ABCB1-overexpressing subline 2R160 is from H. Broxterman (Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p">PBMCs from healthy donors were isolated as previously reported.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Normal astrocytes from murine origin were established and cultured as previously described.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p">Cells were grown in RPMI 1640 (BioWhittaker, Lonza, Verviers, Belgium) supplemented with 10% heat-inactivated fetal calf serum (BioWhittaker) and 1% antibiotic–antimycotic (BioWhittaker) at 37 °C in humid atmosphere and 5% CO<sub>2</sub>. PBMC viability was evaluated as previously described.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p last"><b>1</b> (Sigma), <b>2</b> (Santa Cruz Biotechnology, Heidelberg, Germany), <b>3</b> (Sigma), <b>4</b> (Enzo Life Sciences, Antwerpen, Belgium), <b>38</b> (Cayman, Bio-connect, Huissen, The Netherlands), and all 2,2-dimethylchromans-related compounds were dissolved in DMSO.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Quantitative Videomicroscopy</h3><div class="NLM_p last">For videomicroscopic evaluation of the in vitro anticancer effects of <b>18</b>, cells were cultured in 25 cm<sup>2</sup> flasks. Time-lapse acquisition of phase contrast microscopy pictures was automatically recorded every 4 min over a 72 h period in triplicate.<a onclick="showRef(event, 'ref30 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref30 ref46 ref47 ref48">(30, 46-48)</a> Quantitative data have been obtained by the counting of the number of cells on the pictures over time as previously described<a onclick="showRef(event, 'ref30 ref46 ref48'); return false;" href="javascript:void(0);" class="ref ref30 ref46 ref48">(30, 46, 48)</a> and detailed in the legends of the figures.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> MTT Colorimetric Assay</h3><div class="NLM_p last">The MTT colorimetric assay was performed as previously described after 72 h of exposure to the compounds.<a onclick="showRef(event, 'ref30 ref46 ref48'); return false;" href="javascript:void(0);" class="ref ref30 ref46 ref48">(30, 46, 48)</a> Briefly, cells were seeded in 96-well plates 24 h before treatments. Concentrations of the compounds tested range from 0.01 to 100 μM for 72 h. The growth inhibitory concentration, i.e., the GI<sub>50</sub> is the concentration of a compound that decreased by 50% the optical density in comparison to the untreated control condition. Experiments on Hs683, T98G, and U373 cells were conducted once in sextuplicate.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Cell Cycle Analysis</h3><div class="NLM_p last">Cell cycle distribution was analyzed as previously described.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> SA-β-gal Assay</h3><div class="NLM_p last">The assessment of senescence was performed using an SA-β-gal assay described elsewhere.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Monitoring Cell Proliferation in SIRT1- or SIRT2-Depleted Cells</h3><div class="NLM_p last">Cells in 12-well plates were transfected with small interfering RNAs [siRNAs; Qiagen, Venlo, The Netherlands: SiSIRT1_1 (SI00098434), SiHDAC1_2 (SI00098448), siSIRT2_1 (SI00098406), siSIRT2_2 (SI02655471), control siRNA (AllStars Negative Control siRNA)] as described elsewhere.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Gene silencing effects on glioblastoma cell proliferation were recorded and quantified by time-lapse phase contrast videomicroscopy using IncuCyte live-cell imaging system (Essen Bioscience Inc., Hertfordshire, U.K.).</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Generation of U373 and Hs683 Spheroids</h3><div class="NLM_p last">Spheroids were generated as previously described elsewhere<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> using a starting cell suspension of 1 × 10<sup>3</sup> cells in 25 μL. The volume of multicellular spheroids expressed in voxels (3D pixels) was determined through the generation of 3D plots using the ReViSP software after an initial segmentation with ImageJ software (U.S. National Institutes of Health, Bethesda, MD, USA) as described elsewhere.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> ATP Measurement in 3D Spheroid Culture</h3><div class="NLM_p last">ATP levels were measured using the CellTiter-Glo 3D cell viability assay (Promega, Leiden, The Netherlands) according to the manufacturer’s instructions. Briefly, spheroids were harvested and then mixed with CellTiter-Glo 3D reagent. After shaking for 5 min and stabilizing for 25 min, luminescence signal was measured with a luminometer (Centro LB 960, Berthold Technologies, Korea).</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Zebrafish Assay</h3><div class="NLM_p last">Wild type zebrafish (<i>Danio rerio</i>) were obtained from the Zebrafish International Resource Center (ZIRC, University of Oregon, OR), maintained according to SNU guidelines at 28.5 °C with 10 h dark/14 h light cycles. Zebrafish experiments were carried out as previously described<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> except that cells were fluorescently labeled with CM-Dil (Invitrogen, Korea) 2 h prior to injection. For CM-Dil labeled cancer cell injection, micropipettes for injection and anesthesia were generated from a 1.0 mm glass capillary (World Precision Instruments, Sarasota, FL, USA) by using a micropipette puller (Shutter Instrument, Novato, CA, USA). 48 h after fertilization, zebrafish were anesthetized in 0.02% tricaine (Sigma) and immobilized on an agar plate. 100–200 of CM-Dil labeled cancer cells are also stained with 0.05% of phenol red solution (Sigma) for better visualization during injection into the yolk sac. After injection, zebrafish were incubated in 24-well plates containing Danieau solution with 0.003% phenylthiourea (Sigma, USA) at 28.5 °C for 72 h. Pictures were taken by fixing zebrafish embryos onto a glass slide with 3% methylcellulose (Sigma).</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> In Vitro HDAC Activity Assay</h3><div class="NLM_p last">Assays were carried out as previously described.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> IC<sub>50</sub> values were determined using the GraphPad Prism 6.0 software.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Western Blot Analysis</h3><div class="NLM_p">For the preparation of total proteins, cells were harvested, washed in cold 1× PBS, and lysed in MPER (Thermo-Scientific, Erembodegem-Aalst, Belgium) supplemented with 1× protease inhibitor cocktail (Complete EDTA-free, Roche, Prophac, Luxembourg, Luxembourg) according to the manufacturer’s instructions. Histones were isolated as previously reported.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_p last">Western blots were carried out as previously described.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Antibodies were from the following: from Sigma, anti-β-actin (A5441); from Santa Cruz Biotechnology (Heidelberg, Germany), antiacetylated α-tubulin (sc-23950), anti-SIRT1 (sc-15404), anti-SIRT2 (sc-20966); from Merck Millipore (Brussels, Belgium), anti-histone H1 (05-457), anti-histone H4 (05-858), anti-acetylated histone H4 (06-866), anti-acetylated histone H3 lysine 56 (04-1135); from Calbiochem, anti-tubulin (CP06); and the corresponding secondary antibody (all from Santa Cruz Biotechnology). β-Actin or α-tubulin and histone H1 or Coomassie blue staining (LKB, Villeneuve-la-Garenne, France) were used as loading controls for non-histone and histone proteins, respectively. Western blot membranes and Coomassie blue gels were quantified using ImageQuant TL (GE Healthcare, Roosendaal, The Netherlands) and ImageJ (U.S. National Institutes of Health, Bethesda, MD, USA) software, respectively, and data were reported to the control.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Statistical Analyses</h3><div class="NLM_p last">Statistical analyses were carried out using the GraphPad Prism 6.0 software. One-way ANOVA and the Holm–Sidak multiple comparison tests were used for statistical comparisons. <i>p</i> values below 0.05 were considered as statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00533">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71357" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71357" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00533" class="ext-link">10.1021/acs.jmedchem.7b00533</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional experimental details; docking model of selected compounds in SIRT1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5I">4I5I</a>) and SIRT2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RMG">4RMG</a>); in cellulo assessment of HDAC inhibition by compound <b>18</b> through the study of histone and α-tubulin acetylation levels; analysis of apoptosis induced by <b>18</b> in glioma cells; analysis of sub G1 population in glioblastoma cells treated with SIRTi; antitumor potential of compound <b>18</b>; summary of the IC<sub>50</sub> values obtained for compound <b>18</b> on various human cancer cell lines with acquired drug resistance; IC<sub>50</sub> values and biological data of newly described SIRT1 and/or SIRT2 inhibitors; supplementary references (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES representations and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf">jm7b00533_si_001.pdf (2.12 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_002.csv">jm7b00533_si_002.csv (3.85 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00533" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bernard Pirotte</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Center for Interdisciplinary Research on Medicines
(CIRM), University of Liège, 4000 Liège, Belgium</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#482a6638213a273c3c2d083d242f66292b662a2d"><span class="__cf_email__" data-cfemail="3a58144a5348554e4e5f7a4f565d145b5914585f">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Diederich</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacy, Research Institute
of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0115-4725" title="Orcid link">http://orcid.org/0000-0003-0115-4725</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#87eae6f5e4e3eee2e3e2f5eee4efc7f4e9f2a9e6e4a9ecf5"><span class="__cf_email__" data-cfemail="5e333f2c3d3a373b3a3b2c373d361e2d302b703f3d70352c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Schnekenburger</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Biologie
Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg, 9, Rue Edward Steichen, L-2540 Luxembourg, Luxembourg</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Goffin</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Center for Interdisciplinary Research on Medicines
(CIRM), University of Liège, 4000 Liège, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jin-Young Lee</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacy, Research Institute
of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Young Jang</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacy, Research Institute
of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aloran Mazumder</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacy, Research Institute
of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seungwon Ji</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacy, Research Institute
of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bernard Rogister</span> - <span class="hlFld-Affiliation affiliation">Nervous System Diseases and Treatment, GIGA-Neurosciences, University of Liège, 4000 Liège, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nafila Bouider</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Center for Interdisciplinary Research on Medicines
(CIRM), University of Liège, 4000 Liège, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florence Lefranc</span> - <span class="hlFld-Affiliation affiliation">Service de Neurochirurgie, Hôpital Erasme, Université
Libre de Bruxelles, 1070 Brussels, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Walter Miklos</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine
I, Comprehensive Cancer Center and Institute of Cancer Research, Medical University of Vienna, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Véronique Mathieu</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Cancérologie et de Toxicologie
Expérimentale, Faculté de Pharmacie, Université Libre de Bruxelles, 1050 Brussels, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascal de Tullio</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Center for Interdisciplinary Research on Medicines
(CIRM), University of Liège, 4000 Liège, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyu-Won Kim</span> - <span class="hlFld-Affiliation affiliation">SNU-Harvard Neurovascular Protection Center,
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mario Dicato</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Biologie
Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg, 9, Rue Edward Steichen, L-2540 Luxembourg, Luxembourg</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Walter Berger</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine
I, Comprehensive Cancer Center and Institute of Cancer Research, Medical University of Vienna, 1090 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Byung Woo Han</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacy, Research Institute
of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Kiss</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Cancérologie et de Toxicologie
Expérimentale, Faculté de Pharmacie, Université Libre de Bruxelles, 1050 Brussels, Belgium</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">M.S. and E.G. equally contributed to the work.</p><br /></br><p class="inlineNote">B.P. and M.D. equally supervised the work.</p></div></li></ul></div><div class="ack" id="ACK-d236e7290-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87038" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87038" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully thank Thierry Gras and Delphine Lamoral-Theys for their technical assistance. R.K. is a director of research with the Fonds National de la Recherche Scientifique (FRS-FNRS, Belgium). M.S. was supported by a “Waxweiler Grant for Cancer Prevention Research” from the Action Lions “Vaincre le Cancer”. LBMCC was supported by the “Recherche Cancer et Sang” foundation, by the “Recherches Scientifiques Luxembourg” association, by the “Een Häerz fir kriibskrank Kanner” association, by the Action LIONS “Vaincre le Cancer” association, and by Télévie Luxembourg. College of Pharmacy, SNU is supported by the NRF by the MEST of Korea for Tumor Microenvironment GCRC Grant 2012-0001184 and by Brain Korea (BK21) PLUS program.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i56" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i56"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i57" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i57"> Abbreviations Used</h2><tr><td class="NLM_term">GG</td><td class="NLM_def"><p class="first last">global growth</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">MRP1</td><td class="NLM_def"><p class="first last">multidrug resistance protein 1</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cell</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">SA-β-gal</td><td class="NLM_def"><p class="first last">senescence-associated β-galactosidase</p></td></tr><tr><td class="NLM_term">SAHA</td><td class="NLM_def"><p class="first last">suberoylanilide hydroxamic acid</p></td></tr><tr><td class="NLM_term">SIRT</td><td class="NLM_def"><p class="first last">sirtuin</p></td></tr><tr><td class="NLM_term">SIRTi</td><td class="NLM_def"><p class="first last">sirtuin inhibitor</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 56 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2411</span><span class="NLM_x">–</span> <span class="NLM_lpage">2422</span><span class="refDoi"> DOI: 10.1200/JCO.2005.03.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1200%2FJCO.2005.03.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=15800333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsVyhsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=2411-2422&author=F.+Lefrancauthor=J.+Brotchiauthor=R.+Kiss&title=Possible+future+issues+in+the+treatment+of+glioblastomas%3A+Special+emphasis+on+cell+migration+and+the+resistance+of+migrating+glioblastoma+cells+to+apoptosis&doi=10.1200%2FJCO.2005.03.089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis</span></div><div class="casAuthors">Lefranc, Florence; Brotchi, Jacques; Kiss, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2411-2422</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The present review aims to emphasize that malignant gliomas are characterized by the diffuse invasion of distant brain tissue by a myriad of single migrating cells that exhibit decreased levels of apoptosis (programmed cell death type I), thus a resistance to cytotoxic insult.  The present review surveys the mol. mechanisms of migration in malignant gliomas and potential issues arising from treatments, in addn. to relationships between glioma cell migration and resistance to apoptosis in terms of the mol. signaling pathways.  Clin. and exptl. data demonstrate that glioma cell migration is a complex combination of multiple mol. processes, including the alteration of tumor cell adhesion to a modified extracellular matrix, the secretion of proteases by the cells, and modifications to the actin cytoskeleton.  Intracellular signaling pathways involved in the acquisition of resistance to apoptosis by migrating glioma cells concern Pl3K, Akt, mTOR, NF-κB, and autophagy (programmed cell death type II).  A no. of signaling pathways can be constitutively activated in migrating glioma cells, thus rendering these cells resistant to cytotoxic insults.  However, these pathways are not all constitutively activated at the same time in any one glioma.  Particular inhibitors should therefore only be chosen if the target is present in the tumor tissue, but this is only possible if individual patients are submitted to the mol. profiling of their tumors before undergoing any treatment to combat their migratory glioma cells.  Specific antimigratory compds. should be added to conventional radio- and/or chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRxPKR4Wm5vbVg90H21EOLACvtfcHk0lhPXRF0KuwByw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsVyhsrY%253D&md5=9195f4ac3a7cccda1ca747dbb35f3023</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.089%26sid%3Dliteratum%253Aachs%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DPossible%2520future%2520issues%2520in%2520the%2520treatment%2520of%2520glioblastomas%253A%2520Special%2520emphasis%2520on%2520cell%2520migration%2520and%2520the%2520resistance%2520of%2520migrating%2520glioblastoma%2520cells%2520to%2520apoptosis%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D2411%26epage%3D2422%26doi%3D10.1200%2FJCO.2005.03.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Stupp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegi, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Bent, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taphoorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzer, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allgeier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandes, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijtenbeek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marosi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecht, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokhtari, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesseling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhauer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorlia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairncross, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirimanoff, R. O.</span><span> </span><span class="NLM_article-title">Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase iii study: 5-year analysis of the eortc-ncic trial</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span><span class="refDoi"> DOI: 10.1016/S1470-2045(09)70025-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2FS1470-2045%2809%2970025-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=19269895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVKhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=459-466&author=R.+Stuppauthor=M.+E.+Hegiauthor=W.+P.+Masonauthor=M.+J.+van+den+Bentauthor=M.+J.+Taphoornauthor=R.+C.+Janzerauthor=S.+K.+Ludwinauthor=A.+Allgeierauthor=B.+Fisherauthor=K.+Belangerauthor=P.+Hauauthor=A.+A.+Brandesauthor=J.+Gijtenbeekauthor=C.+Marosiauthor=C.+J.+Vechtauthor=K.+Mokhtariauthor=P.+Wesselingauthor=S.+Villaauthor=E.+Eisenhauerauthor=T.+Gorliaauthor=M.+Wellerauthor=D.+Lacombeauthor=J.+G.+Cairncrossauthor=R.+O.+Mirimanoff&title=Effects+of+radiotherapy+with+concomitant+and+adjuvant+temozolomide+versus+radiotherapy+alone+on+survival+in+glioblastoma+in+a+randomised+phase+iii+study%3A+5-year+analysis+of+the+eortc-ncic+trial&doi=10.1016%2FS1470-2045%2809%2970025-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial</span></div><div class="casAuthors">Stupp, Roger; Hegi, Monika E.; Mason, Warren P.; van den Bent, Martin J.; Taphoorn, Martin J. B.; Janzer, Robert C.; Ludwin, Samuel K.; Allgeier, Anouk; Fisher, Barbara; Belanger, Karl; Hau, Peter; Brandes, Alba A.; Gijtenbeek, Johanna; Marosi, Christine; Vecht, Charles J.; Mokhtari, Karima; Wesseling, Pieter; Villa, Salvador; Eisenhauer, Elizabeth; Gorlia, Thierry; Weller, Michael; Lacombe, Denis; Cairncross, J. Gregory; Mirimanoff, Rene-Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">459-466</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In 2004, a randomized phase III trial by the European Organization for Research and Treatment of Cancer (EORTC) and National Cancer Institute of Canada Clin. Trials Group (NCIC) reported improved median and 2-yr survival for patients with glioblastoma treated with concomitant and adjuvant temozolomide and radiotherapy.  We report the final results with a median follow-up of more than 5 years.  Adult patients with newly diagnosed glioblastoma were randomly assigned to receive either std. radiotherapy or identical radiotherapy with concomitant temozolomide followed by up to six cycles of adjuvant temozolomide.  The methylation status of the methyl-guanine Me transferase gene, MGMT, was detd. retrospectively from the tumor tissue of 206 patients.  The primary endpoint was overall survival.  Analyses were by intention to treat.  This trial is registered with, no.  Between Aug 17, 2000, and March 22, 2002, 573 patients were assigned to treatment. 278 (97%) of 286 patients in the radiotherapy alone group and 254 (89%) of 287 in the combined-treatment group died during 5 years of follow-up.  Overall survival was 27.2% (95% CI 22.2-32.5) at 2 years, 16.0% (12.0-20.6) at 3 years, 12.1% (8.5-16.4) at 4 years, and 9.8% (6.4-14.0) at 5 years with temozolomide, vs. 10.9% (7.6-14.8), 4.4% (2.4-7.2), 3.0% (1.4-5.7), and 1.9% (0.6-4.4) with radiotherapy alone (hazard ratio 0.6, 95% CI 0.5-0.7; p<0.0001).  A benefit of combined therapy was recorded in all clin. prognostic subgroups, including patients aged 60-70 years.  Methylation of the MGMT promoter was the strongest predictor for outcome and benefit from temozolomide chemotherapy.  Benefits of adjuvant temozolomide with radiotherapy lasted throughout 5 years of follow-up.  A few patients in favorable prognostic categories survive longer than 5 years.  MGMT methylation status identifies patients most likely to benefit from the addn. of temozolomide.  Funding: EORTC, NCIC, Nelia and Amadeo Barletta Foundation, Schering-Plough.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodXEfj7tq5LLVg90H21EOLACvtfcHk0lh2HY5DYr9OGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVKhs74%253D&md5=5cc84038ab5ca34ce0f18049c053483b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2809%2970025-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252809%252970025-7%26sid%3Dliteratum%253Aachs%26aulast%3DStupp%26aufirst%3DR.%26aulast%3DHegi%26aufirst%3DM.%2BE.%26aulast%3DMason%26aufirst%3DW.%2BP.%26aulast%3Dvan%2Bden%2BBent%26aufirst%3DM.%2BJ.%26aulast%3DTaphoorn%26aufirst%3DM.%2BJ.%26aulast%3DJanzer%26aufirst%3DR.%2BC.%26aulast%3DLudwin%26aufirst%3DS.%2BK.%26aulast%3DAllgeier%26aufirst%3DA.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DBelanger%26aufirst%3DK.%26aulast%3DHau%26aufirst%3DP.%26aulast%3DBrandes%26aufirst%3DA.%2BA.%26aulast%3DGijtenbeek%26aufirst%3DJ.%26aulast%3DMarosi%26aufirst%3DC.%26aulast%3DVecht%26aufirst%3DC.%2BJ.%26aulast%3DMokhtari%26aufirst%3DK.%26aulast%3DWesseling%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DS.%26aulast%3DEisenhauer%26aufirst%3DE.%26aulast%3DGorlia%26aufirst%3DT.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DLacombe%26aufirst%3DD.%26aulast%3DCairncross%26aufirst%3DJ.%2BG.%26aulast%3DMirimanoff%26aufirst%3DR.%2BO.%26atitle%3DEffects%2520of%2520radiotherapy%2520with%2520concomitant%2520and%2520adjuvant%2520temozolomide%2520versus%2520radiotherapy%2520alone%2520on%2520survival%2520in%2520glioblastoma%2520in%2520a%2520randomised%2520phase%2520iii%2520study%253A%25205-year%2520analysis%2520of%2520the%2520eortc-ncic%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2009%26volume%3D10%26spage%3D459%26epage%3D466%26doi%3D10.1016%2FS1470-2045%2809%2970025-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Cuperlovic-Culf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Touaibia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Coeur, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poitras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culf, A. S.</span><span> </span><span class="NLM_article-title">Metabolic effects of known and novel hdac and sirt inhibitors in glioblastomas independently or combined with temozolomide</span> <span class="citation_source-journal">Metabolites</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span><span class="refDoi"> DOI: 10.3390/metabo4030807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.3390%2Fmetabo4030807" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=807-830&author=M.+Cuperlovic-Culfauthor=M.+Touaibiaauthor=P.+D.+St-Coeurauthor=J.+Poitrasauthor=P.+Morinauthor=A.+S.+Culf&title=Metabolic+effects+of+known+and+novel+hdac+and+sirt+inhibitors+in+glioblastomas+independently+or+combined+with+temozolomide&doi=10.3390%2Fmetabo4030807"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fmetabo4030807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmetabo4030807%26sid%3Dliteratum%253Aachs%26aulast%3DCuperlovic-Culf%26aufirst%3DM.%26aulast%3DTouaibia%26aufirst%3DM.%26aulast%3DSt-Coeur%26aufirst%3DP.%2BD.%26aulast%3DPoitras%26aufirst%3DJ.%26aulast%3DMorin%26aufirst%3DP.%26aulast%3DCulf%26aufirst%3DA.%2BS.%26atitle%3DMetabolic%2520effects%2520of%2520known%2520and%2520novel%2520hdac%2520and%2520sirt%2520inhibitors%2520in%2520glioblastomas%2520independently%2520or%2520combined%2520with%2520temozolomide%26jtitle%3DMetabolites%26date%3D2014%26volume%3D4%26spage%3D807%26epage%3D830%26doi%3D10.3390%2Fmetabo4030807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Folmer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlikova, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Naturally occurring regulators of histone acetylation/deacetylation</span> <span class="citation_source-journal">Curr. Nutr. Food Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.2174/157340110790909581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.2174%2F157340110790909581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXms1ansL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=78-99&author=F.+Folmerauthor=B.+Orlikovaauthor=M.+Schnekenburgerauthor=M.+Dicatoauthor=M.+Diederich&title=Naturally+occurring+regulators+of+histone+acetylation%2Fdeacetylation&doi=10.2174%2F157340110790909581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Naturally occurring regulators of histone acetylation/deacetylation</span></div><div class="casAuthors">Folmer, Florence; Orlikova, Barbora; Schnekenburger, Michael; Dicato, Mario; Diederich, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Current Nutrition & Food Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-99</span>CODEN:
                <span class="NLM_cas:coden">CNFSCQ</span>;
        ISSN:<span class="NLM_cas:issn">1573-4013</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Acetylation and deacetylation of lysine residues on histones, which are catalyzed by histone acetyltransferases (HATs) and histone deacetylases (HDACs), are epigenetic modifications that play a very important role in the regulation of gene transcription.  Perturbation of the balance between histone acetylation and deacetylation leads to a myriad of diseases, including cancer, AIDS, malaria, neurodegenerative diseases, and diabetes.  HATs and HDACs have recently been recognized as key targets for chemoprevention and drug discovery, and numerous natural and synthetic compds. have been screened in order to identify promising regulators of subtle balance between histone acetylation and deacetylation.  Here, we present dietary compds. and other natural products that have emerged as potent HAT or HDAC activity modulators, and we discuss their current and future applications as chemopreventive or therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsTjMuCy_GY7Vg90H21EOLACvtfcHk0lj0fcY4KImdWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXms1ansL4%253D&md5=fc66f2ee7dea84979bdf5c8d4303f5c1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F157340110790909581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157340110790909581%26sid%3Dliteratum%253Aachs%26aulast%3DFolmer%26aufirst%3DF.%26aulast%3DOrlikova%26aufirst%3DB.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DNaturally%2520occurring%2520regulators%2520of%2520histone%2520acetylation%252Fdeacetylation%26jtitle%3DCurr.%2520Nutr.%2520Food%2520Sci.%26date%3D2010%26volume%3D6%26spage%3D78%26epage%3D99%26doi%3D10.2174%2F157340110790909581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Seidel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Histone deacetylase modulators provided by mother nature</span> <span class="citation_source-journal">Genes Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1007/s12263-012-0283-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1007%2Fs12263-012-0283-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=22328271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFWgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=357-367&author=C.+Seidelauthor=M.+Schnekenburgerauthor=M.+Dicatoauthor=M.+Diederich&title=Histone+deacetylase+modulators+provided+by+mother+nature&doi=10.1007%2Fs12263-012-0283-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase modulators provided by Mother Nature</span></div><div class="casAuthors">Seidel, Carole; Schnekenburger, Michael; Dicato, Mario; Diederich, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Genes and Nutrition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-367</span>CODEN:
                <span class="NLM_cas:coden">GNEUAZ</span>;
        ISSN:<span class="NLM_cas:issn">1555-8932</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Protein acetylation status results from a balance between histone acetyltransferase and histone deacetylase (HDAC) activities.  Alteration of this balance leads to a disruption of cellular integrity and participates in the development of numerous diseases, including cancer.  Therefore, modulation of these activities appears to be a promising approach for anticancer therapy.  Histone deacetylase inhibitors (HDACi) are epigenetically active drugs that induce the hyperacetylation of lysine residues within histone and non-histone proteins, thus affecting gene expression and cellular processes such as protein-protein interactions, protein stability, DNA binding and protein sub-cellular localization.  Therefore, HDACi are promising anti-tumor agents as they may affect the cell cycle, inhibit proliferation, stimulate differentiation and induce apoptotic cell death.  Over the last 30 years, numerous synthetic and natural products, including a broad range of dietary compds., have been identified as HDACi.  This review focuses on mols. from natural origins modulating HDAC activities and presenting promising anticancer activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT709dfz24zbVg90H21EOLACvtfcHk0lj0fcY4KImdWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFWgu7w%253D&md5=9b6a9f9dce5e59164f16d7e9dc105a77</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs12263-012-0283-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12263-012-0283-9%26sid%3Dliteratum%253Aachs%26aulast%3DSeidel%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DHistone%2520deacetylase%2520modulators%2520provided%2520by%2520mother%2520nature%26jtitle%3DGenes%2520Nutr.%26date%3D2012%26volume%3D7%26spage%3D357%26epage%3D367%26doi%3D10.1007%2Fs12263-012-0283-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florean, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span><span class="refDoi"> DOI: 10.2174/1568026615666150825141330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.2174%2F1568026615666150825141330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=26303418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVGnsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=745-776&author=M.+Schnekenburgerauthor=C.+Floreanauthor=M.+Dicatoauthor=M.+Diederich&title=Epigenetic+alterations+as+a+universal+feature+of+cancer+hallmarks+and+a+promising+target+for+personalized+treatments&doi=10.2174%2F1568026615666150825141330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments</span></div><div class="casAuthors">Schnekenburger, Michael; Florean, Cristina; Dicato, Mario; Diederich, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">745-776</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Despite considerable scientific progress, the burden of cancer in our society remains a major public health problem.  Tumorigenesis is recognized as a complex and multistep process that involves the accumulation of successive transformational events with multi-factorial etiol.  Nevertheless, such events result in the acquisition of key hallmark characteristics that are shared by all cancer cells.  Accumulating evidence indicates that, besides genetic alterations, epigenetic mechanisms (heritable changes in gene expression caused by modifications in chromatin structure without alterations of DNA sequence) are implicated in the acquisition of malignant phenotype.  The potential reversibility of epigenetic alterations linked to tumorigenesis offers a promising avenue for therapeutic intervention.  This review focuses on the epigenetic regulation of the cancer hallmarks and the foreseeable use of epigenetic drugs to target these features as a promising strategy for anti-cancer therapy.  Based on this body of evidence, we believe that epigenetic deregulations can affect virtually all cell functions and therefore therapeutic approaches with epigenetic drugs could allow multi-target approach against the hallmarks of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3l2qKFb0VhbVg90H21EOLACvtfcHk0lj0fcY4KImdWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVGnsLnN&md5=0a0e44b061720bd1baff96e6e7365fa9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150825141330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150825141330%26sid%3Dliteratum%253Aachs%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DFlorean%26aufirst%3DC.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DEpigenetic%2520alterations%2520as%2520a%2520universal%2520feature%2520of%2520cancer%2520hallmarks%2520and%2520a%2520promising%2520target%2520for%2520personalized%2520treatments%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D745%26epage%3D776%26doi%3D10.2174%2F1568026615666150825141330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Seidel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florean, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Chromatin-modifying agents in anti-cancer therapy</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">2264</span><span class="NLM_x">–</span> <span class="NLM_lpage">2279</span><span class="refDoi"> DOI: 10.1016/j.biochi.2012.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.biochi.2012.05.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2012&pages=2264-2279&author=C.+Seidelauthor=C.+Floreanauthor=M.+Schnekenburgerauthor=M.+Dicatoauthor=M.+Diederich&title=Chromatin-modifying+agents+in+anti-cancer+therapy&doi=10.1016%2Fj.biochi.2012.05.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2012.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2012.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DSeidel%26aufirst%3DC.%26aulast%3DFlorean%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DChromatin-modifying%2520agents%2520in%2520anti-cancer%2520therapy%26jtitle%3DBiochimie%26date%3D2012%26volume%3D94%26spage%3D2264%26epage%3D2279%26doi%3D10.1016%2Fj.biochi.2012.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Mei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Y.</span><span> </span><span class="NLM_article-title">Sirtuins in metabolism, DNA repair and cancer</span> <span class="citation_source-journal">J. Exp. Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="refDoi"> DOI: 10.1186/s13046-016-0461-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1186%2Fs13046-016-0461-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=27916001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A280%3ADC%252BC2sjjtlSlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=182&author=Z.+Meiauthor=X.+Zhangauthor=J.+Yiauthor=J.+Huangauthor=J.+Heauthor=Y.+Tao&title=Sirtuins+in+metabolism%2C+DNA+repair+and+cancer&doi=10.1186%2Fs13046-016-0461-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuins in metabolism, DNA repair and cancer</span></div><div class="casAuthors">Mei Zhen; Zhang Xian; Yi Jiarong; Huang Junjie; He Jian; Tao Yongguang; Mei Zhen; Zhang Xian; Yi Jiarong; Huang Junjie; He Jian; Tao Yongguang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of experimental & clinical cancer research : CR</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The mammalian sirtuin family has attracted tremendous attention over the past few years as stress adaptors and post-translational modifier.  They have involved in diverse cellular processes including DNA repair, energy metabolism, and tumorigenesis.  Notably, genomic instability and metabolic reprogramming are two of characteristic hallmarks in cancer.  In this review, we summarize current knowledge on the functions of sirtuins mainly regarding DNA repair and energy metabolism, and further discuss the implication of sirtuins in cancer specifically by regulating genome integrity and cancer-related metabolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYJnknlDW2rny-c-E1v-fmfW6udTcc2eZ1WJlHZ5ahQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sjjtlSlsg%253D%253D&md5=86aa35b880235a56dacabc455d57cada</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1186%2Fs13046-016-0461-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-016-0461-5%26sid%3Dliteratum%253Aachs%26aulast%3DMei%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYi%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DTao%26aufirst%3DY.%26atitle%3DSirtuins%2520in%2520metabolism%252C%2520DNA%2520repair%2520and%2520cancer%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D35%26spage%3D182%26doi%3D10.1186%2Fs13046-016-0461-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Carafa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotili, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgione, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuomo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serretiello, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hailu, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarho, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahtela-Kakkonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altucci, L.</span><span> </span><span class="NLM_article-title">Sirtuin functions and modulation: From chemistry to the clinic</span> <span class="citation_source-journal">Clin. Epigenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="refDoi"> DOI: 10.1186/s13148-016-0224-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1186%2Fs13148-016-0224-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=27226812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFKlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=61&author=V.+Carafaauthor=D.+Rotiliauthor=M.+Forgioneauthor=F.+Cuomoauthor=E.+Serretielloauthor=G.+S.+Hailuauthor=E.+Jarhoauthor=M.+Lahtela-Kakkonenauthor=A.+Maiauthor=L.+Altucci&title=Sirtuin+functions+and+modulation%3A+From+chemistry+to+the+clinic&doi=10.1186%2Fs13148-016-0224-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin functions and modulation: from chemistry to the clinic</span></div><div class="casAuthors">Carafa, Vincenzo; Rotili, Dante; Forgione, Mariantonietta; Cuomo, Francesca; Serretiello, Enrica; Hailu, Gebremedhin Solomon; Jarho, Elina; Lahtela-Kakkonen, Maija; Mai, Antonello; Altucci, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Epigenetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61/1-61/21</span>CODEN:
                <span class="NLM_cas:coden">CELPCI</span>;
        ISSN:<span class="NLM_cas:issn">1868-7083</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Sirtuins are NAD+-dependent histone deacetylases regulating important metabolic pathways in prokaryotes and eukaryotes and are involved in many biol. processes such as cell survival, senescence, proliferation, apoptosis, DNA repair, cell metab., and caloric restriction.  The seven members of this family of enzymes are considered potential targets for the treatment of human pathologies including neurodegenerative diseases, cardiovascular diseases, and cancer.  Furthermore, recent interest focusing on sirtuin modulators as epigenetic players in the regulation of fundamental biol. pathways has prompted increased efforts to discover new small mols. able to modify sirtuin activity.  Here, we review the role, mechanism of action, and biol. function of the seven sirtuins, as well as their inhibitors and activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIH3R2LEVdxLVg90H21EOLACvtfcHk0lidpGX11THPnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFKlsbY%253D&md5=67fd293f52235a36c45acdbcdca540bf</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1186%2Fs13148-016-0224-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13148-016-0224-3%26sid%3Dliteratum%253Aachs%26aulast%3DCarafa%26aufirst%3DV.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DForgione%26aufirst%3DM.%26aulast%3DCuomo%26aufirst%3DF.%26aulast%3DSerretiello%26aufirst%3DE.%26aulast%3DHailu%26aufirst%3DG.%2BS.%26aulast%3DJarho%26aufirst%3DE.%26aulast%3DLahtela-Kakkonen%26aufirst%3DM.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DAltucci%26aufirst%3DL.%26atitle%3DSirtuin%2520functions%2520and%2520modulation%253A%2520From%2520chemistry%2520to%2520the%2520clinic%26jtitle%3DClin.%2520Epigenet.%26date%3D2016%26volume%3D8%26spage%3D61%26doi%3D10.1186%2Fs13148-016-0224-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Peck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fruscia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myatt, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, E. W.</span><span> </span><span class="NLM_article-title">Sirt inhibitors induce cell death and p53 acetylation through targeting both sirt1 and sirt2</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1158%2F1535-7163.MCT-09-0971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=20371709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlCqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=844-855&author=B.+Peckauthor=C.+Y.+Chenauthor=K.+K.+Hoauthor=P.+Di+Frusciaauthor=S.+S.+Myattauthor=R.+C.+Coombesauthor=M.+J.+Fuchterauthor=C.+D.+Hsiaoauthor=E.+W.+Lam&title=Sirt+inhibitors+induce+cell+death+and+p53+acetylation+through+targeting+both+sirt1+and+sirt2&doi=10.1158%2F1535-7163.MCT-09-0971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2</span></div><div class="casAuthors">Peck, Barrie; Chen, Chun-Yuan; Ho, Ka-Kei; Di Fruscia, Paolo; Myatt, Stephen S.; Coombes, R. Charles; Fuchter, Matthew J.; Hsiao, Chwan-Deng; Lam, Eric W.-F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">844-855</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">SIRT proteins play an important role in the survival and drug resistance of tumor cells, esp. during chemotherapy.  In this study, we investigated the potency, specificity, and cellular targets of three SIRT inhibitors, Sirtinol, Salermide, and EX527.  Cell proliferative and cell cycle analyses showed that Sirtinol and Salermide, but not EX527, were effective in inducing cell death at concns. of 50 μmol/L or over in MCF-7 cells.  Instead, EX527 caused cell cycle arrest at G1 at comparable concns.  In vitro SIRT assays using a p53 peptide substrate showed that all three compds. are potent SIRT1/2 inhibitors, with EX527 having the highest inhibitory activity for SIRT1.  Computational docking anal. showed that Sirtinol and Salermide have high degrees of selectivity for SIRT1/2, whereas EX527 has high specificity for SIRT1 but not SIRT2.  Consistently, Sirtinol and Salermide, but not EX527, treatment resulted in the in vivo acetylation of the SIRT1/2 target p53 and SIRT2 target tubulin in MCF-7 cells, suggesting that EX527 is ineffective in inhibiting SIRT2 and that p53 mediates the cytotoxic function of Sirtinol and Salermide.  Studies using breast carcinoma cell lines and p53-deficient mouse fibroblasts confirmed that p53 is essential for the Sirtinol and Salermide-induced apoptosis.  Further, we showed using small interfering RNA that silencing both SIRTs, but not SIRT1 and SIRT2 individually, can induce cell death in MCF-7 cells.  Together, our results identify the specificity and cellular targets of these novel inhibitors and suggest that SIRT inhibitors require combined targeting of both SIRT1 and SIRT2 to induce p53 acetylation and cell death.  Mol Cancer Ther; 9(4); 844-55.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruOOb1TBGW47Vg90H21EOLACvtfcHk0lidpGX11THPnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlCqt74%253D&md5=d2cf2c3adb9d6218c94ad143011082bd</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0971%26sid%3Dliteratum%253Aachs%26aulast%3DPeck%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DHo%26aufirst%3DK.%2BK.%26aulast%3DDi%2BFruscia%26aufirst%3DP.%26aulast%3DMyatt%26aufirst%3DS.%2BS.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26aulast%3DFuchter%26aufirst%3DM.%2BJ.%26aulast%3DHsiao%26aufirst%3DC.%2BD.%26aulast%3DLam%26aufirst%3DE.%2BW.%26atitle%3DSirt%2520inhibitors%2520induce%2520cell%2520death%2520and%2520p53%2520acetylation%2520through%2520targeting%2520both%2520sirt1%2520and%2520sirt2%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D844%26epage%3D855%26doi%3D10.1158%2F1535-7163.MCT-09-0971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sakkiah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arooj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eom, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. W.</span><span> </span><span class="NLM_article-title">Identification of inhibitor binding site in human sirtuin 2 using molecular docking and dynamics simulations</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e51429</span><span class="refDoi"> DOI: 10.1371/journal.pone.0051429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1371%2Fjournal.pone.0051429" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e51429&author=S.+Sakkiahauthor=M.+Aroojauthor=M.+R.+Kumarauthor=S.+H.+Eomauthor=K.+W.+Lee&title=Identification+of+inhibitor+binding+site+in+human+sirtuin+2+using+molecular+docking+and+dynamics+simulations&doi=10.1371%2Fjournal.pone.0051429"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0051429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0051429%26sid%3Dliteratum%253Aachs%26aulast%3DSakkiah%26aufirst%3DS.%26aulast%3DArooj%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DM.%2BR.%26aulast%3DEom%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DK.%2BW.%26atitle%3DIdentification%2520of%2520inhibitor%2520binding%2520site%2520in%2520human%2520sirtuin%25202%2520using%2520molecular%2520docking%2520and%2520dynamics%2520simulations%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De51429%26doi%3D10.1371%2Fjournal.pone.0051429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Trapp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jochum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goekjian, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Adenosine mimetics as inhibitors of nad+-dependent histone deacetylases, from kinase to sirtuin inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7307</span><span class="NLM_x">–</span> <span class="NLM_lpage">7316</span><span class="refDoi"> DOI: 10.1021/jm060118b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060118b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2it7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7307-7316&author=J.+Trappauthor=A.+Jochumauthor=R.+Meierauthor=L.+Saundersauthor=B.+Marshallauthor=C.+Kunickauthor=E.+Verdinauthor=P.+Goekjianauthor=W.+Sipplauthor=M.+Jung&title=Adenosine+mimetics+as+inhibitors+of+nad%2B-dependent+histone+deacetylases%2C+from+kinase+to+sirtuin+inhibition&doi=10.1021%2Fjm060118b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine Mimetics as Inhibitors of NAD+-Dependent Histone Deacetylases, from Kinase to Sirtuin Inhibition</span></div><div class="casAuthors">Trapp, Johannes; Jochum, Anne; Meier, Rene; Saunders, Laura; Marshall, Brett; Kunick, Conrad; Verdin, Eric; Goekjian, Peter; Sippl, Wolfgang; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7307-7316</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">NAD+-dependent histone deacetylases, sirtuins, cleave acetyl groups from lysines of histones and other proteins to regulate their activity.  Identification of potent selective inhibitors would help to elucidate sirtuin biol. and could lead to useful therapeutic agents.  NAD+ has an adenosine moiety that is also present in the kinase cofactor ATP.  Kinase inhibitors based upon adenosine mimesis may thus also target NAD+-dependent enzymes.  We present a systematic approach using adenosine mimics from one cofactor class (kinase inhibitors) as a viable method to generate new lead structures in another cofactor class (sirtuin inhibitors).  Our findings have broad implications for medicinal chem. and specifically for sirtuin inhibitor design.  Our results also raise a question as to whether selectivity profiling for kinase inhibitors should be limited to ATP-dependent targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsPuIQW02_4bVg90H21EOLACvtfcHk0liN621BiVITlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2it7fL&md5=ed26cd66275abf4366d650a2d30e2f4f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm060118b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060118b%26sid%3Dliteratum%253Aachs%26aulast%3DTrapp%26aufirst%3DJ.%26aulast%3DJochum%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DR.%26aulast%3DSaunders%26aufirst%3DL.%26aulast%3DMarshall%26aufirst%3DB.%26aulast%3DKunick%26aufirst%3DC.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DGoekjian%26aufirst%3DP.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DAdenosine%2520mimetics%2520as%2520inhibitors%2520of%2520nad%252B-dependent%2520histone%2520deacetylases%252C%2520from%2520kinase%2520to%2520sirtuin%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7307%26epage%3D7316%26doi%3D10.1021%2Fjm060118b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Medda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slawin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, N. J.</span><span> </span><span class="NLM_article-title">Novel cambinol analogs as sirtuin inhibitors: Synthesis, biological evaluation, and rationalization of activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2673</span><span class="NLM_x">–</span> <span class="NLM_lpage">2682</span><span class="refDoi"> DOI: 10.1021/jm8014298</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8014298" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFKltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2673-2682&author=F.+Meddaauthor=R.+J.+Russellauthor=M.+Higginsauthor=A.+R.+McCarthyauthor=J.+Campbellauthor=A.+M.+Slawinauthor=D.+P.+Laneauthor=S.+Lainauthor=N.+J.+Westwood&title=Novel+cambinol+analogs+as+sirtuin+inhibitors%3A+Synthesis%2C+biological+evaluation%2C+and+rationalization+of+activity&doi=10.1021%2Fjm8014298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Cambinol Analogs as Sirtuin Inhibitors: Synthesis, Biological Evaluation, and Rationalization of Activity</span></div><div class="casAuthors">Medda, Federico; Russell, Rupert J. M.; Higgins, Maureen; McCarthy, Anna R.; Campbell, Johanna; Slawin, Alexandra M. Z.; Lane, David P.; Lain, Sonia; Westwood, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2673-2682</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The tenovins and cambinol are two classes of sirtuin inhibitor that exhibit antitumor activity in preclin. models.  This report describes modifications to the core structure of cambinol, in particular by incorporation of substituents at the N1-position, which lead to increased potency and modified selectivity.  These improvements have been rationalized using mol. modeling techniques.  The expected functional selectivity in cells was also obsd. for both a SIRT1 and a SIRT2 selective analog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEkyITsDCBvbVg90H21EOLACvtfcHk0lhKoT1pymFTwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFKltbo%253D&md5=9080cf969afe9433ad20514c281298af</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm8014298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014298%26sid%3Dliteratum%253Aachs%26aulast%3DMedda%26aufirst%3DF.%26aulast%3DRussell%26aufirst%3DR.%2BJ.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DMcCarthy%26aufirst%3DA.%2BR.%26aulast%3DCampbell%26aufirst%3DJ.%26aulast%3DSlawin%26aufirst%3DA.%2BM.%26aulast%3DLane%26aufirst%3DD.%2BP.%26aulast%3DLain%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DN.%2BJ.%26atitle%3DNovel%2520cambinol%2520analogs%2520as%2520sirtuin%2520inhibitors%253A%2520Synthesis%252C%2520biological%2520evaluation%252C%2520and%2520rationalization%2520of%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2673%26epage%3D2682%26doi%3D10.1021%2Fjm8014298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Outeiro, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontopoulos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmann, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strathearn, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amore, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feany, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span><span class="refDoi"> DOI: 10.1126/science.1143780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1126%2Fscience.1143780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=17588900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFylurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=516-519&author=T.+F.+Outeiroauthor=E.+Kontopoulosauthor=S.+M.+Altmannauthor=I.+Kufarevaauthor=K.+E.+Strathearnauthor=A.+M.+Amoreauthor=C.+B.+Volkauthor=M.+M.+Maxwellauthor=J.+C.+Rochetauthor=P.+J.+McLeanauthor=A.+B.+Youngauthor=R.+Abagyanauthor=M.+B.+Feanyauthor=B.+T.+Hymanauthor=A.+G.+Kazantsev&title=Sirtuin+2+inhibitors+rescue+alpha-synuclein-mediated+toxicity+in+models+of+Parkinson%E2%80%99s+disease&doi=10.1126%2Fscience.1143780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease</span></div><div class="casAuthors">Outeiro, Tiago Fleming; Kontopoulos, Eirene; Altmann, Stephen M.; Kufareva, Irina; Strathearn, Katherine E.; Amore, Allison M.; Volk, Catherine B.; Maxwell, Michele M.; Rochet, Jean-Christophe; McLean, Pamela J.; Young, Anne B.; Abagyan, Ruben; Feany, Mel B.; Hyman, Bradley T.; Kazantsev, Aleksey G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5837</span>),
    <span class="NLM_cas:pages">516-519</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The sirtuins are members of the histone deacetylase family of proteins that participate in a variety of cellular functions and play a role in aging.  We identified a potent inhibitor of sirtuin 2 (SIRT2) and found that inhibition of SIRT2 rescued α-synuclein toxicity and modified inclusion morphol. in a cellular model of Parkinson's disease.  Genetic inhibition of SIRT2 via small interfering RNA similarly rescued α-synuclein toxicity.  Furthermore, the inhibitors protected against dopaminergic cell death both in vitro and in a Drosophila model of Parkinson's disease.  The results suggest a link between neurodegeneration and aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm5psHCGzkkLVg90H21EOLACvtfcHk0lhKoT1pymFTwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFylurs%253D&md5=4b8914c34ad0f45fb51b94701609bfa6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.1143780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1143780%26sid%3Dliteratum%253Aachs%26aulast%3DOuteiro%26aufirst%3DT.%2BF.%26aulast%3DKontopoulos%26aufirst%3DE.%26aulast%3DAltmann%26aufirst%3DS.%2BM.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DStrathearn%26aufirst%3DK.%2BE.%26aulast%3DAmore%26aufirst%3DA.%2BM.%26aulast%3DVolk%26aufirst%3DC.%2BB.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DRochet%26aufirst%3DJ.%2BC.%26aulast%3DMcLean%26aufirst%3DP.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BB.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DFeany%26aufirst%3DM.%2BB.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DSirtuin%25202%2520inhibitors%2520rescue%2520alpha-synuclein-mediated%2520toxicity%2520in%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D516%26epage%3D519%26doi%3D10.1126%2Fscience.1143780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kim, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, S. G.</span><span> </span><span class="NLM_article-title">Sirtuin inhibitors, ex527 and agk2, suppress cell migration by inhibiting hsf1 protein stability</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.3892/or.2015.4381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.3892%2For.2015.4381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=26530275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=235-242&author=H.+W.+Kimauthor=S.+A.+Kimauthor=S.+G.+Ahn&title=Sirtuin+inhibitors%2C+ex527+and+agk2%2C+suppress+cell+migration+by+inhibiting+hsf1+protein+stability&doi=10.3892%2For.2015.4381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin inhibitors, EX527 and AGK2, suppress cell migration by inhibiting HSF1 protein stability</span></div><div class="casAuthors">Kim, Hyun-Woo; Kim, Soo-A.; Ahn, Sang-Gun</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The histone deacetylases (HDACs), Sirtuin 1 (Sirt1) and Sirt2, play crucial roles in many biol. processes, including cell proliferation, differentiation and apoptosis.  HDAC inhibitors have been considered as a potential therapeutic approach for various types of cancers.  Here, we demonstrated that the Sirt1 and Sirt2 inhibitors EX527 and AGK2 suppressed cell growth and caused G1 phase arrest by inhibiting the expression of Cdk6 and/or Cdk4.  An agar colony formation assay revealed that EX527 and AGK2 decreased colony formation in soft agar.  Furthermore, EX527 and AGK2 pretreatment inhibited the expression of HSF1 and HSP27 and induced HSF1 ubiquitination.  Sirt1 overexpression increased HSF1 expression and/or stabilization and induced cell migration in a scratch assay.  Overall, these results indicate that EX527 and AGK2 suppress cell growth and migration by inhibiting HSF1 protein stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS8CqhdC4wHbVg90H21EOLACvtfcHk0lhKoT1pymFTwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslCrsg%253D%253D&md5=6d9a62fb1129aeab09dca40f2f124412</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3892%2For.2015.4381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2015.4381%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BW.%26aulast%3DKim%26aufirst%3DS.%2BA.%26aulast%3DAhn%26aufirst%3DS.%2BG.%26atitle%3DSirtuin%2520inhibitors%252C%2520ex527%2520and%2520agk2%252C%2520suppress%2520cell%2520migration%2520by%2520inhibiting%2520hsf1%2520protein%2520stability%26jtitle%3DOncol.%2520Rep.%26date%3D2016%26volume%3D35%26spage%3D235%26epage%3D242%26doi%3D10.3892%2For.2015.4381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Florence, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dilly, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Tullio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirotte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebrun, P.</span><span> </span><span class="NLM_article-title">Modulation of the 6-position of benzopyran derivatives and inhibitory effects on the insulin releasing process</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3919</span><span class="NLM_x">–</span> <span class="NLM_lpage">3928</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.05.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.bmc.2011.05.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3919-3928&author=X.+Florenceauthor=S.+Dillyauthor=P.+de+Tullioauthor=B.+Pirotteauthor=P.+Lebrun&title=Modulation+of+the+6-position+of+benzopyran+derivatives+and+inhibitory+effects+on+the+insulin+releasing+process&doi=10.1016%2Fj.bmc.2011.05.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DFlorence%26aufirst%3DX.%26aulast%3DDilly%26aufirst%3DS.%26aulast%3Dde%2BTullio%26aufirst%3DP.%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DLebrun%26aufirst%3DP.%26atitle%3DModulation%2520of%2520the%25206-position%2520of%2520benzopyran%2520derivatives%2520and%2520inhibitory%2520effects%2520on%2520the%2520insulin%2520releasing%2520process%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3919%26epage%3D3928%26doi%3D10.1016%2Fj.bmc.2011.05.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Khelili, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florence, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhadja, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelaziz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechouch, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Tullio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebrun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirotte, B.</span><span> </span><span class="NLM_article-title">Synthesis and activity on rat aorta rings and rat pancreatic beta-cells of ring-opened analogues of benzopyran-type potassium channel activators</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6124</span><span class="NLM_x">–</span> <span class="NLM_lpage">6130</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.04.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.bmc.2008.04.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=6124-6130&author=S.+Kheliliauthor=X.+Florenceauthor=M.+Bouhadjaauthor=S.+Abdelazizauthor=N.+Mechouchauthor=Y.+Mohamedauthor=P.+de+Tullioauthor=P.+Lebrunauthor=B.+Pirotte&title=Synthesis+and+activity+on+rat+aorta+rings+and+rat+pancreatic+beta-cells+of+ring-opened+analogues+of+benzopyran-type+potassium+channel+activators&doi=10.1016%2Fj.bmc.2008.04.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.04.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.04.043%26sid%3Dliteratum%253Aachs%26aulast%3DKhelili%26aufirst%3DS.%26aulast%3DFlorence%26aufirst%3DX.%26aulast%3DBouhadja%26aufirst%3DM.%26aulast%3DAbdelaziz%26aufirst%3DS.%26aulast%3DMechouch%26aufirst%3DN.%26aulast%3DMohamed%26aufirst%3DY.%26aulast%3Dde%2BTullio%26aufirst%3DP.%26aulast%3DLebrun%26aufirst%3DP.%26aulast%3DPirotte%26aufirst%3DB.%26atitle%3DSynthesis%2520and%2520activity%2520on%2520rat%2520aorta%2520rings%2520and%2520rat%2520pancreatic%2520beta-cells%2520of%2520ring-opened%2520analogues%2520of%2520benzopyran-type%2520potassium%2520channel%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D6124%26epage%3D6130%26doi%3D10.1016%2Fj.bmc.2008.04.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruwge, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strambi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Milito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodin, B.</span><span> </span><span class="NLM_article-title">Sirt1 and sirt2 inhibition impairs pediatric soft tissue sarcoma growth</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1483</span><span class="refDoi"> DOI: 10.1038/cddis.2014.385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1038%2Fcddis.2014.385" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1483&author=L.+Maauthor=W.+Maruwgeauthor=A.+Strambiauthor=P.+D%E2%80%99Arcyauthor=P.+Pellegriniauthor=L.+Kisauthor=A.+de+Militoauthor=S.+Lainauthor=B.+Brodin&title=Sirt1+and+sirt2+inhibition+impairs+pediatric+soft+tissue+sarcoma+growth&doi=10.1038%2Fcddis.2014.385"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.385%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DMaruwge%26aufirst%3DW.%26aulast%3DStrambi%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DPellegrini%26aufirst%3DP.%26aulast%3DKis%26aufirst%3DL.%26aulast%3Dde%2BMilito%26aufirst%3DA.%26aulast%3DLain%26aufirst%3DS.%26aulast%3DBrodin%26aufirst%3DB.%26atitle%3DSirt1%2520and%2520sirt2%2520inhibition%2520impairs%2520pediatric%2520soft%2520tissue%2520sarcoma%2520growth%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1483%26doi%3D10.1038%2Fcddis.2014.385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Trott, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">Autodock vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span><span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=Autodock+vina%3A+Improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0lii-mgqwI5EnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutodock%2520vina%253A%2520Improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Rumpf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiedel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karaman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roessler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehotzky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladwein, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidtkunz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steegborn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovadi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einsle, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Selective sirt2 inhibition by ligand-induced rearrangement of the active site</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">6263</span><span class="refDoi"> DOI: 10.1038/ncomms7263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1038%2Fncomms7263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=25672491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFemsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6263&author=T.+Rumpfauthor=M.+Schiedelauthor=B.+Karamanauthor=C.+Roesslerauthor=B.+J.+Northauthor=A.+Lehotzkyauthor=J.+Olahauthor=K.+I.+Ladweinauthor=K.+Schmidtkunzauthor=M.+Gajerauthor=M.+Pannekauthor=C.+Steegbornauthor=D.+A.+Sinclairauthor=S.+Gerhardtauthor=J.+Ovadiauthor=M.+Schutkowskiauthor=W.+Sipplauthor=O.+Einsleauthor=M.+Jung&title=Selective+sirt2+inhibition+by+ligand-induced+rearrangement+of+the+active+site&doi=10.1038%2Fncomms7263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Sirt2 inhibition by ligand-induced rearrangement of the active site</span></div><div class="casAuthors">Rumpf, Tobias; Schiedel, Matthias; Karaman, Berin; Roessler, Claudia; North, Brian J.; Lehotzky, Attila; Olah, Judit; Ladwein, Kathrin I.; Schmidtkunz, Karin; Gajer, Markus; Pannek, Martin; Steegborn, Clemens; Sinclair, David A.; Gerhardt, Stefan; Ovadi, Judit; Schutkowski, Mike; Sippl, Wolfgang; Einsle, Oliver; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6263</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sirtuins are a highly conserved class of NAD-dependent lysine deacylases.  Human isotype Sirt2 has been implicated in the pathogenesis of cancer, inflammation, and neurodegeneration, which makes the modulation of Sirt2 activity a promising strategy for pharmaceutical intervention.  However, a rational basis for the development of optimized Sirt2 inhibitors is lacking so far.  Here, the authors present high-resoln. structures of human Sirt2 in complex with highly selective drug-like inhibitors that show a unique inhibitory mechanism.  The potency and the unprecedented Sirt2 selectivity were based on a ligand-induced structural rearrangement of the active site unveiling a yet-unexploited binding pocket.  The application of the most potent sirtuin-rearranging ligand, termed SirReal2, led to tubulin hyperacetylation in HeLa cells and induced destabilization of checkpoint protein BubR1, consistent with Sirt2 inhibition in vivo.  The structural insights into this unique mechanism of selective sirtuin inhibition provide the basis for further inhibitor development and selective tools for sirtuin biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN2LzipheDFLVg90H21EOLACvtfcHk0lhwVxrH_BB0UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFemsr4%253D&md5=bc3c61af5e456f4483746a588db91643</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fncomms7263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms7263%26sid%3Dliteratum%253Aachs%26aulast%3DRumpf%26aufirst%3DT.%26aulast%3DSchiedel%26aufirst%3DM.%26aulast%3DKaraman%26aufirst%3DB.%26aulast%3DRoessler%26aufirst%3DC.%26aulast%3DNorth%26aufirst%3DB.%2BJ.%26aulast%3DLehotzky%26aufirst%3DA.%26aulast%3DOlah%26aufirst%3DJ.%26aulast%3DLadwein%26aufirst%3DK.%2BI.%26aulast%3DSchmidtkunz%26aufirst%3DK.%26aulast%3DGajer%26aufirst%3DM.%26aulast%3DPannek%26aufirst%3DM.%26aulast%3DSteegborn%26aufirst%3DC.%26aulast%3DSinclair%26aufirst%3DD.%2BA.%26aulast%3DGerhardt%26aufirst%3DS.%26aulast%3DOvadi%26aufirst%3DJ.%26aulast%3DSchutkowski%26aufirst%3DM.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DEinsle%26aufirst%3DO.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DSelective%2520sirt2%2520inhibition%2520by%2520ligand-induced%2520rearrangement%2520of%2520the%2520active%2520site%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D6263%26doi%3D10.1038%2Fncomms7263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Moniot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steegborn, C.</span><span> </span><span class="NLM_article-title">Crystal structure analysis of human sirt2 and its adp-ribose complex</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span><span class="refDoi"> DOI: 10.1016/j.jsb.2013.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.jsb.2013.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=23454361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlGhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2013&pages=136-143&author=S.+Moniotauthor=M.+Schutkowskiauthor=C.+Steegborn&title=Crystal+structure+analysis+of+human+sirt2+and+its+adp-ribose+complex&doi=10.1016%2Fj.jsb.2013.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure analysis of human Sirt2 and its ADP-ribose complex</span></div><div class="casAuthors">Moniot, Sebastien; Schutkowski, Mike; Steegborn, Clemens</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Structural Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">136-143</span>CODEN:
                <span class="NLM_cas:coden">JSBIEM</span>;
        ISSN:<span class="NLM_cas:issn">1047-8477</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Sirtuins are NAD+-dependent protein deacetylases that regulate metab. and aging-related processes.  Sirt2 is the only cytoplasmic isoform among the seven mammalian Sirtuins (Sirt1-7) and structural information concerning this isoform is limited.  The authors crystd. Sirt2 in complex with a product analog, ADP-ribose, and solved this first crystal structure of a Sirt2 ligand complex at 2.3 Å resoln.  Addnl., the authors re-refined the structure of the Sirt2 apoform and analyzed the conformational changes assocd. with ligand binding to derive insights into the dynamics of the enzyme.  The authors' analyses also provide information on Sirt2 peptide substrate binding and structural states of a Sirt2-specific protein region, and the authors' insights and the novel Sirt2 crystal form provide helpful tools for the development of Sirt2 specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW7XI0QpfrLVg90H21EOLACvtfcHk0lhwVxrH_BB0UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlGhtLs%253D&md5=caae1bfc3feaf3766bf55e5dd84d2700</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.jsb.2013.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsb.2013.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DMoniot%26aufirst%3DS.%26aulast%3DSchutkowski%26aufirst%3DM.%26aulast%3DSteegborn%26aufirst%3DC.%26atitle%3DCrystal%2520structure%2520analysis%2520of%2520human%2520sirt2%2520and%2520its%2520adp-ribose%2520complex%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2013%26volume%3D182%26spage%3D136%26epage%3D143%26doi%3D10.1016%2Fj.jsb.2013.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Finnin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donigian, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of the histone deacetylase sirt2</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span><span class="refDoi"> DOI: 10.1038/89668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1038%2F89668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=11427894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvFCrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=621-625&author=M.+S.+Finninauthor=J.+R.+Donigianauthor=N.+P.+Pavletich&title=Structure+of+the+histone+deacetylase+sirt2&doi=10.1038%2F89668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the histone deacetylase SIRT2</span></div><div class="casAuthors">Finnin, Michael S.; Donigian, Jill R.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">621-625</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Sir2 is an NAD-dependent histone deacetylase that mediates transcriptional silencing at mating-type loci, telomeres, and ribosomal gene clusters, and plays a crit. role in the detn. of life span in yeast and Caenorhabditis elegans.  Here, the 1.7 Å crystal structure of the 323-amino-acid catalytic core of human SIRT2, a homolog of yeast Sir2, revealed an NAD-binding domain, which was a variant of the Rossmann fold, and a smaller domain composed of a helical module and a Zn-binding module.  A conserved large groove at the interface of the 2 domains was the likely site of catalysis based on mutagenesis.  Intersecting this large groove, there was a pocket formed by the helical module.  The pocket was lined with hydrophobic residues conserved within each of the 5 Sir2 classes, suggesting that it is a class-specific protein-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDNi1R8KPeQ7Vg90H21EOLACvtfcHk0lhwVxrH_BB0UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvFCrtLs%253D&md5=6d305c420bff2690da780fc23938c22f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2F89668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F89668%26sid%3Dliteratum%253Aachs%26aulast%3DFinnin%26aufirst%3DM.%2BS.%26aulast%3DDonigian%26aufirst%3DJ.%2BR.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520the%2520histone%2520deacetylase%2520sirt2%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D621%26epage%3D625%26doi%3D10.1038%2F89668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Schiedel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumpf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karaman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehotzky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovadi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einsle, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Aminothiazoles as potent and selective sirt2 inhibitors: A structure-activity relationship study</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1599</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01517</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01517" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrs73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1599-1612&author=M.+Schiedelauthor=T.+Rumpfauthor=B.+Karamanauthor=A.+Lehotzkyauthor=J.+Olahauthor=S.+Gerhardtauthor=J.+Ovadiauthor=W.+Sipplauthor=O.+Einsleauthor=M.+Jung&title=Aminothiazoles+as+potent+and+selective+sirt2+inhibitors%3A+A+structure-activity+relationship+study&doi=10.1021%2Facs.jmedchem.5b01517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study</span></div><div class="casAuthors">Schiedel, Matthias; Rumpf, Tobias; Karaman, Berin; Lehotzky, Attila; Olah, Judit; Gerhardt, Stefan; Ovadi, Judit; Sippl, Wolfgang; Einsle, Oliver; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1599-1612</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sirtuins are NAD+-dependent protein deacylases that cleave off acetyl but also other acyl groups from the ε-amino group of lysines in histones and other substrate proteins.  Dysregulation of human Sirt2 (hSirt2) activity has been assocd. with the pathogenesis of cancer, inflammation, and neurodegeneration, which makes the modulation of hSirt2 activity a promising strategy for pharmaceutical intervention.  The sirtuin rearranging ligands (SirReals) have recently been discovered by us as highly potent and isotype-selective hSirt2 inhibitors.  Here, we present a well-defined structure-activity relationship study, which rationalizes the unique features of the SirReals and probes the limits of modifications on this scaffold regarding inhibitor potency.  Moreover, we present a crystal structure of hSirt2 in complex with an optimized SirReal deriv. that exhibits an improved in vitro activity.  Lastly, we show cellular hyperacetylation of the hSirt2 targeted tubulin caused by our improved lead structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow3tFNLizRV7Vg90H21EOLACvtfcHk0lhuJtSlZ9e3Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrs73K&md5=4e912cc141b51655833799beaacb630b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01517%26sid%3Dliteratum%253Aachs%26aulast%3DSchiedel%26aufirst%3DM.%26aulast%3DRumpf%26aufirst%3DT.%26aulast%3DKaraman%26aufirst%3DB.%26aulast%3DLehotzky%26aufirst%3DA.%26aulast%3DOlah%26aufirst%3DJ.%26aulast%3DGerhardt%26aufirst%3DS.%26aulast%3DOvadi%26aufirst%3DJ.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DEinsle%26aufirst%3DO.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DAminothiazoles%2520as%2520potent%2520and%2520selective%2520sirt2%2520inhibitors%253A%2520A%2520structure-activity%2520relationship%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1599%26epage%3D1612%26doi%3D10.1021%2Facs.jmedchem.5b01517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Davenport, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelz, A.</span><span> </span><span class="NLM_article-title">Structural and functional analysis of human sirt1</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span><span class="refDoi"> DOI: 10.1016/j.jmb.2013.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.jmb.2013.10.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2014&pages=526-541&author=A.+M.+Davenportauthor=F.+M.+Huberauthor=A.+Hoelz&title=Structural+and+functional+analysis+of+human+sirt1&doi=10.1016%2Fj.jmb.2013.10.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2013.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2013.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DDavenport%26aufirst%3DA.%2BM.%26aulast%3DHuber%26aufirst%3DF.%2BM.%26aulast%3DHoelz%26aufirst%3DA.%26atitle%3DStructural%2520and%2520functional%2520analysis%2520of%2520human%2520sirt1%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D426%26spage%3D526%26epage%3D541%26doi%3D10.1016%2Fj.jmb.2013.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Dai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riera, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Considine, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamuro, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweitzer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disch, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczepankiewicz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oalmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee Ng, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casaubon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koppetsch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbonais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlasuk, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. L.</span><span> </span><span class="NLM_article-title">Crystallographic structure of a small molecule sirt1 activator-enzyme complex</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">7645</span><span class="refDoi"> DOI: 10.1038/ncomms8645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1038%2Fncomms8645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=26134520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A280%3ADC%252BC28%252Fgs1WqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=7645&author=H.+Daiauthor=A.+W.+Caseauthor=T.+V.+Rieraauthor=T.+Considineauthor=J.+E.+Leeauthor=Y.+Hamuroauthor=H.+Zhaoauthor=Y.+Jiangauthor=S.+M.+Sweitzerauthor=B.+Pietrakauthor=B.+Schwartzauthor=C.+A.+Blumauthor=J.+S.+Dischauthor=R.+Caldwellauthor=B.+Szczepankiewiczauthor=C.+Oalmannauthor=P.+Yee+Ngauthor=B.+H.+Whiteauthor=R.+Casaubonauthor=R.+Narayanauthor=K.+Koppetschauthor=F.+Bourbonaisauthor=B.+Wuauthor=J.+Wangauthor=D.+Qianauthor=F.+Jiangauthor=C.+Maoauthor=M.+Wangauthor=E.+Huauthor=J.+C.+Wuauthor=R.+B.+Perniauthor=G.+P.+Vlasukauthor=J.+L.+Ellis&title=Crystallographic+structure+of+a+small+molecule+sirt1+activator-enzyme+complex&doi=10.1038%2Fncomms8645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic structure of a small molecule SIRT1 activator-enzyme complex</span></div><div class="casAuthors">Dai Han; Ellis James L; Case April W; Riera Thomas V; Considine Thomas; Blum Charles A; Disch Jeremy S; Caldwell Richard; Szczepankiewicz Bruce; Oalmann Christopher; Yee Ng Pui; White Brian H; Casaubon Rebecca; Narayan Radha; Koppetsch Karsten; Bourbonais Francis; Wu Joe C; Perni Robert B; Vlasuk George P; Lee Jessica E; Hamuro Yoshitomo; Zhao Huizhen; Jiang Yong; Sweitzer Sharon M; Pietrak Beth; Schwartz Benjamin; Wang Minghui; Hu Erding; Wu Bo; Wang Junfeng; Qian Dongming; Jiang Fan; Mao Cheney</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7645</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">SIRT1, the founding member of the mammalian family of seven NAD(+)-dependent sirtuins, is composed of 747 amino acids forming a catalytic domain and extended N- and C-terminal regions.  We report the design and characterization of an engineered human SIRT1 construct (mini-hSIRT1) containing the minimal structural elements required for lysine deacetylation and catalytic activation by small molecule sirtuin-activating compounds (STACs).  Using this construct, we solved the crystal structure of a mini-hSIRT1-STAC complex, which revealed the STAC-binding site within the N-terminal domain of hSIRT1.  Together with hydrogen-deuterium exchange mass spectrometry (HDX-MS) and site-directed mutagenesis using full-length hSIRT1, these data establish a specific STAC-binding site and identify key intermolecular interactions with hSIRT1.  The determination of the interface governing the binding of STACs with human SIRT1 facilitates greater understanding of STAC activation of this enzyme, which holds significant promise as a therapeutic target for multiple human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUuRoXD3S0w9j_Vg2vObihfW6udTcc2eaOPit9rwX3Lrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252Fgs1WqsQ%253D%253D&md5=d29f8cc1296653bb4f6f3c97de921af0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fncomms8645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms8645%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DH.%26aulast%3DCase%26aufirst%3DA.%2BW.%26aulast%3DRiera%26aufirst%3DT.%2BV.%26aulast%3DConsidine%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DHamuro%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSweitzer%26aufirst%3DS.%2BM.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DBlum%26aufirst%3DC.%2BA.%26aulast%3DDisch%26aufirst%3DJ.%2BS.%26aulast%3DCaldwell%26aufirst%3DR.%26aulast%3DSzczepankiewicz%26aufirst%3DB.%26aulast%3DOalmann%26aufirst%3DC.%26aulast%3DYee%2BNg%26aufirst%3DP.%26aulast%3DWhite%26aufirst%3DB.%2BH.%26aulast%3DCasaubon%26aufirst%3DR.%26aulast%3DNarayan%26aufirst%3DR.%26aulast%3DKoppetsch%26aufirst%3DK.%26aulast%3DBourbonais%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DVlasuk%26aufirst%3DG.%2BP.%26aulast%3DEllis%26aufirst%3DJ.%2BL.%26atitle%3DCrystallographic%2520structure%2520of%2520a%2520small%2520molecule%2520sirt1%2520activator-enzyme%2520complex%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D7645%26doi%3D10.1038%2Fncomms8645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R. M.</span><span> </span><span class="NLM_article-title">Structural basis for allosteric, substrate-dependent stimulation of sirt1 activity by resveratrol</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1316</span><span class="NLM_x">–</span> <span class="NLM_lpage">1325</span><span class="refDoi"> DOI: 10.1101/gad.265462.115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1101%2Fgad.265462.115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=26109052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFynsbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=1316-1325&author=D.+Caoauthor=M.+Wangauthor=X.+Qiuauthor=D.+Liuauthor=H.+Jiangauthor=N.+Yangauthor=R.+M.+Xu&title=Structural+basis+for+allosteric%2C+substrate-dependent+stimulation+of+sirt1+activity+by+resveratrol&doi=10.1101%2Fgad.265462.115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol</span></div><div class="casAuthors">Cao, Duanfang; Wang, Mingzhu; Qiu, Xiayang; Liu, Dongxiang; Jiang, Hualiang; Yang, Na; Xu, Rui-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1316-1325</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Sirtuins with an extended N-terminal domain (NTD), represented by yeast Sir2 and human SIRT1, harbor intrinsic mechanisms for regulation of their NAD-dependent deacetylase activities.  Elucidation of the regulatory mechanisms is crucial for understanding the biol. functions of sirtuins and development of potential therapeutics.  In particular, SIRT1 has emerged as an attractive therapeutic target, and the search for SIRT1-activating compds. (STACs) has been actively pursued.  However, the effectiveness of a class of reported STACs (represented by resveratrol) as direct SIRT1 activators is under debate due to the complication involving the use of fluorogenic substrates in in vitro assays.  Future efforts of SIRT1-based therapeutics necessitate the dissection of the mol. mechanism of SIRT1 stimulation.  We solved the structure of SIRT1 in complex with resveratrol and a 7-amino-4-methylcoumarin (AMC)-contg. peptide.  The structure reveals the presence of three resveratrol mols., two of which mediate the interaction between the AMC peptide and the NTD of SIRT1.  The two NTD-bound resveratrol mols. are principally responsible for promoting tighter binding between SIRT1 and the peptide and the stimulation of SIRT1 activity.  The structural information provides valuable insights into regulation of SIRT1 activity and should benefit the development of authentic SIRT1 activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR12x9jJ-rzLVg90H21EOLACvtfcHk0lhuJtSlZ9e3Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFynsbzL&md5=3013c25b9a2ee804adfb6d143e1462cd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1101%2Fgad.265462.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.265462.115%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DR.%2BM.%26atitle%3DStructural%2520basis%2520for%2520allosteric%252C%2520substrate-dependent%2520stimulation%2520of%2520sirt1%2520activity%2520by%2520resveratrol%26jtitle%3DGenes%2520Dev.%26date%3D2015%26volume%3D29%26spage%3D1316%26epage%3D1325%26doi%3D10.1101%2Fgad.265462.115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacEwan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamison, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luz, J. G.</span><span> </span><span class="NLM_article-title">The 2.5 a crystal structure of the sirt1 catalytic domain bound to nicotinamide adenine dinucleotide (nad+) and an indole (ex527 analogue) reveals a novel mechanism of histone deacetylase inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span><span class="refDoi"> DOI: 10.1021/jm301431y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301431y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=963-969&author=X.+Zhaoauthor=D.+Allisonauthor=B.+Condonauthor=F.+Zhangauthor=T.+Gheyiauthor=A.+Zhangauthor=S.+Ashokauthor=M.+Russellauthor=I.+MacEwanauthor=Y.+Qianauthor=J.+A.+Jamisonauthor=J.+G.+Luz&title=The+2.5+a+crystal+structure+of+the+sirt1+catalytic+domain+bound+to+nicotinamide+adenine+dinucleotide+%28nad%2B%29+and+an+indole+%28ex527+analogue%29+reveals+a+novel+mechanism+of+histone+deacetylase+inhibition&doi=10.1021%2Fjm301431y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301431y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301431y%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DAllison%26aufirst%3DD.%26aulast%3DCondon%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DGheyi%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DAshok%26aufirst%3DS.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DMacEwan%26aufirst%3DI.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DJamison%26aufirst%3DJ.%2BA.%26aulast%3DLuz%26aufirst%3DJ.%2BG.%26atitle%3DThe%25202.5%2520a%2520crystal%2520structure%2520of%2520the%2520sirt1%2520catalytic%2520domain%2520bound%2520to%2520nicotinamide%2520adenine%2520dinucleotide%2520%2528nad%252B%2529%2520and%2520an%2520indole%2520%2528ex527%2520analogue%2529%2520reveals%2520a%2520novel%2520mechanism%2520of%2520histone%2520deacetylase%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D963%26epage%3D969%26doi%3D10.1021%2Fjm301431y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Sayd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thirant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Habr, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipecka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogeas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahiri-Jouti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chneiweiss, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junier, M. P.</span><span> </span><span class="NLM_article-title">Sirtuin-2 activity is required for glioma stem cell proliferation arrest but not necrosis induced by resveratrol</span> <span class="citation_source-journal">Stem Cell Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1007/s12015-013-9465-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1007%2Fs12015-013-9465-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=23955573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFCqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=103-113&author=S.+Saydauthor=C.+Thirantauthor=E.+A.+El-Habrauthor=J.+Lipeckaauthor=L.+G.+Duboisauthor=A.+Bogeasauthor=N.+Tahiri-Joutiauthor=H.+Chneiweissauthor=M.+P.+Junier&title=Sirtuin-2+activity+is+required+for+glioma+stem+cell+proliferation+arrest+but+not+necrosis+induced+by+resveratrol&doi=10.1007%2Fs12015-013-9465-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin-2 Activity is Required for Glioma Stem Cell Proliferation Arrest but not Necrosis Induced by Resveratrol</span></div><div class="casAuthors">Sayd, Salwa; Thirant, Cecile; El-Habr, Elias A.; Lipecka, Joanna; Dubois, Luiz Gustavo; Bogeas, Alexandra; Tahiri-Jouti, Nadia; Chneiweiss, Herve; Junier, Marie-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cell Reviews and Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-113</span>CODEN:
                <span class="NLM_cas:coden">SCRREE</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Glioblastomas, the most common form of primary brain tumors, are the fourth cause of death by cancer in adults.  Increasing evidences suggest that glioblastoma resistance to existing radio- and chemotherapies rely on glioblastoma stem cells (GSCs).  GSCs are endowed with a unique combination of stem-like properties alike to normal neural stem cells (NSCs), and of tumor initiating properties.  The natural polyphenol resveratrol is known to exert opposite actions on neural cells according to their normal or cancerous status.  Here, we used resveratrol to explore the mol. mechanisms differing between GSCs and NSCs.  We obsd. a dual action of resveratrol on GSCs: resveratrol blocked GSC proliferation up to 150 μM and induced their necrosis at higher doses.  On the opposite, resveratrol had no effect on NSC behavior.  To det. the mechanisms underlying resveratrol effects, we focused our attention on the family of NAD-dependent deacetylases sirtuins (SIRT).  A member of this family, SIRT1, has been repetitively shown to constitute a preferential resveratrol target, at least in normal cells.  Western blot anal. showed that SIRT1 and SIRT3 were expressed by both GSCs and NSCs whereas SIRT2 expression was restricted to GSCs.  Pharmacol. blockade of SIRT2 activity or down-regulation of SIRT2 expression with siRNAs counteracted the inhibitory effect of resveratrol on cell proliferation.  On the contrary, inhibition of SIRT2 activity or expression did not counteract GSC necrosis obsd. in presence of high doses of resveratrol.  Our results highlight SIRT2 as a novel target for altering GSC properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc7aPoQs9Pm7Vg90H21EOLACvtfcHk0liGmr1YP0nJjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFCqtb0%253D&md5=2453e12fa059a70396684297be0fe981</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs12015-013-9465-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12015-013-9465-0%26sid%3Dliteratum%253Aachs%26aulast%3DSayd%26aufirst%3DS.%26aulast%3DThirant%26aufirst%3DC.%26aulast%3DEl-Habr%26aufirst%3DE.%2BA.%26aulast%3DLipecka%26aufirst%3DJ.%26aulast%3DDubois%26aufirst%3DL.%2BG.%26aulast%3DBogeas%26aufirst%3DA.%26aulast%3DTahiri-Jouti%26aufirst%3DN.%26aulast%3DChneiweiss%26aufirst%3DH.%26aulast%3DJunier%26aufirst%3DM.%2BP.%26atitle%3DSirtuin-2%2520activity%2520is%2520required%2520for%2520glioma%2520stem%2520cell%2520proliferation%2520arrest%2520but%2520not%2520necrosis%2520induced%2520by%2520resveratrol%26jtitle%3DStem%2520Cell%2520Rev.%26date%3D2014%26volume%3D10%26spage%3D103%26epage%3D113%26doi%3D10.1007%2Fs12015-013-9465-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Seidel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Histone deacetylase 6 in health and disease</span> <span class="citation_source-journal">Epigenomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.2217/epi.14.69</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.2217%2Fepi.14.69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=25687470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=103-118&author=C.+Seidelauthor=M.+Schnekenburgerauthor=M.+Dicatoauthor=M.+Diederich&title=Histone+deacetylase+6+in+health+and+disease&doi=10.2217%2Fepi.14.69"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 in health and disease</span></div><div class="casAuthors">Seidel, Carole; Schnekenburger, Michael; Dicato, Mario; Diederich, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Epigenomics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-118</span>CODEN:
                <span class="NLM_cas:coden">EPIGC7</span>;
        ISSN:<span class="NLM_cas:issn">1750-192X</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase (HDAC)6 is a member of the class IIb HDAC family.  This enzyme is zinc-dependent and mainly localized in the cytoplasm.  HDAC6 is a unique isoenzyme with two functional catalytic domains and specific physiol. roles.  Indeed, HDAC6 deacetylates various substrates including α-tubulin and HSP90α, and is involved in protein trafficking and degrdn., cell shape and migration.  Consequently, deregulation of HDAC6 activity was assocd. to a variety of diseases including cancer, neurodegenerative diseases and pathol. autoimmune response.  Therefore, HDAC6 represents an interesting potential therapeutic target.  In this review, we discuss structural features of this histone deacetylase, regulation of its expression and activity, biol. functions, implication in human disease initiation and progression.  Finally will describe novel and selective HDAC6 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0ng4pDM6Ob7Vg90H21EOLACvtfcHk0liGmr1YP0nJjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGisbY%253D&md5=21a22233741335632ae499640d799f8d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2217%2Fepi.14.69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fepi.14.69%26sid%3Dliteratum%253Aachs%26aulast%3DSeidel%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DHistone%2520deacetylase%25206%2520in%2520health%2520and%2520disease%26jtitle%3DEpigenomics%26date%3D2015%26volume%3D7%26spage%3D103%26epage%3D118%26doi%3D10.2217%2Fepi.14.69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuzzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamdy, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fakhr, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno Y Banuls, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goietsenoven, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Soest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciavatta, M. L.</span><span> </span><span class="NLM_article-title">In vitro pharmacological and toxicological effects of norterpene peroxides isolated from the red sea sponge diacarnus erythraeanus on normal and cancer cells</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">1541</span><span class="NLM_x">–</span> <span class="NLM_lpage">1547</span><span class="refDoi"> DOI: 10.1021/np400107t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np400107t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2013&pages=1541-1547&author=F.+Lefrancauthor=G.+Nuzzoauthor=N.+A.+Hamdyauthor=I.+Fakhrauthor=L.+Moreno+Y+Banulsauthor=G.+Van+Goietsenovenauthor=G.+Villaniauthor=V.+Mathieuauthor=R.+van+Soestauthor=R.+Kissauthor=M.+L.+Ciavatta&title=In+vitro+pharmacological+and+toxicological+effects+of+norterpene+peroxides+isolated+from+the+red+sea+sponge+diacarnus+erythraeanus+on+normal+and+cancer+cells&doi=10.1021%2Fnp400107t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fnp400107t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp400107t%26sid%3Dliteratum%253Aachs%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DNuzzo%26aufirst%3DG.%26aulast%3DHamdy%26aufirst%3DN.%2BA.%26aulast%3DFakhr%26aufirst%3DI.%26aulast%3DMoreno%2BY%2BBanuls%26aufirst%3DL.%26aulast%3DVan%2BGoietsenoven%26aufirst%3DG.%26aulast%3DVillani%26aufirst%3DG.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3Dvan%2BSoest%26aufirst%3DR.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DCiavatta%26aufirst%3DM.%2BL.%26atitle%3DIn%2520vitro%2520pharmacological%2520and%2520toxicological%2520effects%2520of%2520norterpene%2520peroxides%2520isolated%2520from%2520the%2520red%2520sea%2520sponge%2520diacarnus%2520erythraeanus%2520on%2520normal%2520and%2520cancer%2520cells%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2013%26volume%3D76%26spage%3D1541%26epage%3D1547%26doi%3D10.1021%2Fnp400107t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Branle, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camby, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeuken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geurts-Moespot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprenger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweep, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, I.</span><span> </span><span class="NLM_article-title">Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in c6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span><span class="refDoi"> DOI: 10.1002/cncr.10710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1002%2Fcncr.10710" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2002&pages=641-655&author=F.+Branleauthor=F.+Lefrancauthor=I.+Cambyauthor=J.+Jeukenauthor=A.+Geurts-Moespotauthor=S.+Sprengerauthor=F.+Sweepauthor=R.+Kissauthor=I.+Salmon&title=Evaluation+of+the+efficiency+of+chemotherapy+in+in+vivo+orthotopic+models+of+human+glioma+cells+with+and+without+1p19q+deletions+and+in+c6+rat+orthotopic+allografts+serving+for+the+evaluation+of+surgery+combined+with+chemotherapy&doi=10.1002%2Fcncr.10710"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcncr.10710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcncr.10710%26sid%3Dliteratum%253Aachs%26aulast%3DBranle%26aufirst%3DF.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DCamby%26aufirst%3DI.%26aulast%3DJeuken%26aufirst%3DJ.%26aulast%3DGeurts-Moespot%26aufirst%3DA.%26aulast%3DSprenger%26aufirst%3DS.%26aulast%3DSweep%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DSalmon%26aufirst%3DI.%26atitle%3DEvaluation%2520of%2520the%2520efficiency%2520of%2520chemotherapy%2520in%2520in%2520vivo%2520orthotopic%2520models%2520of%2520human%2520glioma%2520cells%2520with%2520and%2520without%25201p19q%2520deletions%2520and%2520in%2520c6%2520rat%2520orthotopic%2520allografts%2520serving%2520for%2520the%2520evaluation%2520of%2520surgery%2520combined%2520with%2520chemotherapy%26jtitle%3DCancer%26date%3D2002%26volume%3D95%26spage%3D641%26epage%3D655%26doi%3D10.1002%2Fcncr.10710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Grandjenette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karius, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghelfi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaigneaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">5-aza-2′-deoxycytidine-mediated c-myc down-regulation triggers telomere-dependent senescence by regulating human telomerase reverse transcriptase in chronic myeloid leukemia</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span><span class="refDoi"> DOI: 10.1016/j.neo.2014.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.neo.2014.05.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=511-528&author=C.+Grandjenetteauthor=M.+Schnekenburgerauthor=T.+Kariusauthor=J.+Ghelfiauthor=A.+Gaigneauxauthor=E.+Henryauthor=M.+Dicatoauthor=M.+Diederich&title=5-aza-2%E2%80%B2-deoxycytidine-mediated+c-myc+down-regulation+triggers+telomere-dependent+senescence+by+regulating+human+telomerase+reverse+transcriptase+in+chronic+myeloid+leukemia&doi=10.1016%2Fj.neo.2014.05.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.neo.2014.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neo.2014.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DGrandjenette%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DKarius%26aufirst%3DT.%26aulast%3DGhelfi%26aufirst%3DJ.%26aulast%3DGaigneaux%26aufirst%3DA.%26aulast%3DHenry%26aufirst%3DE.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3D5-aza-2%25E2%2580%25B2-deoxycytidine-mediated%2520c-myc%2520down-regulation%2520triggers%2520telomere-dependent%2520senescence%2520by%2520regulating%2520human%2520telomerase%2520reverse%2520transcriptase%2520in%2520chronic%2520myeloid%2520leukemia%26jtitle%3DNeoplasia%26date%3D2014%26volume%3D16%26spage%3D511%26epage%3D528%26doi%3D10.1016%2Fj.neo.2014.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. A.</span><span> </span><span class="NLM_article-title">P53: Protection against tumor growth beyond effects on cell cycle and apoptosis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">5001</span><span class="NLM_x">–</span> <span class="NLM_lpage">5007</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-0563</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1158%2F0008-5472.CAN-15-0563" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=26573797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFensr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=5001-5007&author=X.+Wangauthor=E.+R.+Simpsonauthor=K.+A.+Brown&title=P53%3A+Protection+against+tumor+growth+beyond+effects+on+cell+cycle+and+apoptosis&doi=10.1158%2F0008-5472.CAN-15-0563"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">p53: Protection against tumor growth beyond effects on cell cycle and apoptosis</span></div><div class="casAuthors">Wang, Xuyi; Simpson, Evan R.; Brown, Kristy A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5001-5007</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The tumor suppressor p53 has established functions in cancer.  Specifically, it has been shown to cause cell-cycle arrest and apoptosis in response to DNA damage.  It is also one of the most commonly mutated or silenced genes in cancer and for this reason has been extensively studied.  Recently, the role of p53 has been shown to go beyond its effects on cell cycle and apoptosis, with effects on metab. emerging as a key contributor to cancer growth in situations where p53 is lost.  Beyond this, the role of p53 in the tumor microenvironment is poorly understood.  The publication by Wang and colleagues demonstrates for the first time that p53 is a key neg. regulator of aromatase and, hence, estrogen prodn. in the breast tumor microenvironment.  It goes further by demonstrating that an important regulator of aromatase, the obesity-assocd. and tumor-derived factor prostaglandin E2, inhibits p53 in the breast adipose stroma.  This review presents these findings in the context of established and emerging roles of p53 and discusses possible implications for the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQXGebO5TNHLVg90H21EOLACvtfcHk0lj5LNz14rzATg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFensr%252FN&md5=c0061124e8b99cf3e3244bc177291755</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-0563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-0563%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSimpson%26aufirst%3DE.%2BR.%26aulast%3DBrown%26aufirst%3DK.%2BA.%26atitle%3DP53%253A%2520Protection%2520against%2520tumor%2520growth%2520beyond%2520effects%2520on%2520cell%2520cycle%2520and%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D5001%26epage%3D5007%26doi%3D10.1158%2F0008-5472.CAN-15-0563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Multidrug resistance in cancer: Role of atp-dependent transporters</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1038/nrc706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+resistance+in+cancer%3A+Role+of+atp-dependent+transporters&doi=10.1038%2Fnrc706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0lhrAJHPkAPWhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520resistance%2520in%2520cancer%253A%2520Role%2520of%2520atp-dependent%2520transporters%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58%26doi%3D10.1038%2Fnrc706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Yen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grill, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutschman, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y. C.</span><span> </span><span class="NLM_article-title">Characterization of a hydroxyurea-resistant human kb cell line with supersensitivity to 6-thioguanine</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3686</span><span class="NLM_x">–</span> <span class="NLM_lpage">3691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=3686-3691&author=Y.+Yenauthor=S.+P.+Grillauthor=G.+E.+Dutschmanauthor=C.+N.+Changauthor=B.+S.+Zhouauthor=Y.+C.+Cheng&title=Characterization+of+a+hydroxyurea-resistant+human+kb+cell+line+with+supersensitivity+to+6-thioguanine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYen%26aufirst%3DY.%26aulast%3DGrill%26aufirst%3DS.%2BP.%26aulast%3DDutschman%26aufirst%3DG.%2BE.%26aulast%3DChang%26aufirst%3DC.%2BN.%26aulast%3DZhou%26aufirst%3DB.%2BS.%26aulast%3DCheng%26aufirst%3DY.%2BC.%26atitle%3DCharacterization%2520of%2520a%2520hydroxyurea-resistant%2520human%2520kb%2520cell%2520line%2520with%2520supersensitivity%2520to%25206-thioguanine%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D3686%26epage%3D3691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Schuttelkopf, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Aalten, D. M.</span><span> </span><span class="NLM_article-title">Prodrg: A tool for high-throughput crystallography of protein-ligand complexes</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span><span class="refDoi"> DOI: 10.1107/S0907444904011679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1107%2FS0907444904011679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=15272157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=1355-1363&author=A.+W.+Schuttelkopfauthor=D.+M.+van+Aalten&title=Prodrg%3A+A+tool+for+high-throughput+crystallography+of+protein-ligand+complexes&doi=10.1107%2FS0907444904011679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span></div><div class="casAuthors">Schuttelkopf Alexander W; van Aalten Daan M F</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">Pt 8</span>),
    <span class="NLM_cas:pages">1355-63</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">The small-molecule topology generator PRODRG is described, which takes input from existing coordinates or various two-dimensional formats and automatically generates coordinates and molecular topologies suitable for X-ray refinement of protein-ligand complexes.  Test results are described for automatic generation of topologies followed by energy minimization for a subset of compounds from the Cambridge Structural Database, which shows that, within the limits of the empirical GROMOS87 force field used, structures with good geometries are generated.  X-ray refinement in X-PLOR/CNS, REFMAC and SHELX using PRODRG-generated topologies produces results comparable to refinement with topologies from the standard libraries.  However, tests with distorted starting coordinates show that PRODRG topologies perform better, both in terms of ligand geometry and of crystallographic R factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdNRIcoht5aXy-c-E1v-fmfW6udTcc2eYKTEjgC0Mi7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D&md5=1adce6cd2cacdace513a69efa33c4e93</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1107%2FS0907444904011679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904011679%26sid%3Dliteratum%253Aachs%26aulast%3DSchuttelkopf%26aufirst%3DA.%2BW.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%2BM.%26atitle%3DProdrg%253A%2520A%2520tool%2520for%2520high-throughput%2520crystallography%2520of%2520protein-ligand%2520complexes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D1355%26epage%3D1363%26doi%3D10.1107%2FS0907444904011679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Laskowski, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swindells, M. B.</span><span> </span><span class="NLM_article-title">Ligplot+: Multiple ligand-protein interaction diagrams for drug discovery</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2778</span><span class="NLM_x">–</span> <span class="NLM_lpage">2786</span><span class="refDoi"> DOI: 10.1021/ci200227u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200227u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1KjtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2778-2786&author=R.+A.+Laskowskiauthor=M.+B.+Swindells&title=Ligplot%2B%3A+Multiple+ligand-protein+interaction+diagrams+for+drug+discovery&doi=10.1021%2Fci200227u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery</span></div><div class="casAuthors">Laskowski, Roman A.; Swindells, Mark B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2778-2786</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe a graphical system for automatically generating multiple 2D diagrams of ligand-protein interactions from 3D coordinates.  The diagrams portray the hydrogen-bond interaction patterns and hydrophobic contacts between the ligand(s) and the main-chain or side-chain elements of the protein.  The system is able to plot, in the same orientation, related sets of ligand-protein interactions.  This facilitates popular research tasks, such as analyzing a series of small mols. binding to the same protein target, a single ligand binding to homologous proteins, or the completely general case where both protein and ligand change.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYuWvYH7Nel7Vg90H21EOLACvtfcHk0lhrAJHPkAPWhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1KjtrzP&md5=576e59ad4f0c4304d01c6c80301ecf39</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fci200227u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200227u%26sid%3Dliteratum%253Aachs%26aulast%3DLaskowski%26aufirst%3DR.%2BA.%26aulast%3DSwindells%26aufirst%3DM.%2BB.%26atitle%3DLigplot%252B%253A%2520Multiple%2520ligand-protein%2520interaction%2520diagrams%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D2778%26epage%3D2786%26doi%3D10.1021%2Fci200227u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Le Mercier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roland, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegl-Kreinecker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haibe-Kains, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bontempi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decaestecker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Galectin 1 proangiogenic and promigratory effects in the hs683 oligodendroglioma model are partly mediated through the control of bex2 expression</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1593/neo.81526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1593%2Fneo.81526" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=485-496&author=M.+Le+Mercierauthor=S.+Fortinauthor=V.+Mathieuauthor=I.+Rolandauthor=S.+Spiegl-Kreineckerauthor=B.+Haibe-Kainsauthor=G.+Bontempiauthor=C.+Decaesteckerauthor=W.+Bergerauthor=F.+Lefrancauthor=R.+Kiss&title=Galectin+1+proangiogenic+and+promigratory+effects+in+the+hs683+oligodendroglioma+model+are+partly+mediated+through+the+control+of+bex2+expression&doi=10.1593%2Fneo.81526"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1593%2Fneo.81526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.81526%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BMercier%26aufirst%3DM.%26aulast%3DFortin%26aufirst%3DS.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DRoland%26aufirst%3DI.%26aulast%3DSpiegl-Kreinecker%26aufirst%3DS.%26aulast%3DHaibe-Kains%26aufirst%3DB.%26aulast%3DBontempi%26aufirst%3DG.%26aulast%3DDecaestecker%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DGalectin%25201%2520proangiogenic%2520and%2520promigratory%2520effects%2520in%2520the%2520hs683%2520oligodendroglioma%2520model%2520are%2520partly%2520mediated%2520through%2520the%2520control%2520of%2520bex2%2520expression%26jtitle%3DNeoplasia%26date%3D2009%26volume%3D11%26spage%3D485%26epage%3D496%26doi%3D10.1593%2Fneo.81526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Torsvik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stieber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enger, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golebiewska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molven, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svendsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westermark, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niclou, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chekenya Enger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjerkvig, R.</span><span> </span><span class="NLM_article-title">U-251 revisited: Genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells</span> <span class="citation_source-journal">Cancer Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">824</span><span class="refDoi"> DOI: 10.1002/cam4.219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1002%2Fcam4.219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=24810477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12gurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=812-824&author=A.+Torsvikauthor=D.+Stieberauthor=P.+O.+Engerauthor=A.+Golebiewskaauthor=A.+Molvenauthor=A.+Svendsenauthor=B.+Westermarkauthor=S.+P.+Niclouauthor=T.+K.+Olsenauthor=M.+Chekenya+Engerauthor=R.+Bjerkvig&title=U-251+revisited%3A+Genetic+drift+and+phenotypic+consequences+of+long-term+cultures+of+glioblastoma+cells&doi=10.1002%2Fcam4.219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells</span></div><div class="casAuthors">Torsvik, Anja; Stieber, Daniel; Enger, Per Oyvind; Golebiewska, Anna; Molven, Anders; Svendsen, Agnete; Westermark, Bengt; Niclou, Simone P.; Olsen, Thale Kristin; Chekenya Enger, Martha; Bjerkvig, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">812-824</span>CODEN:
                <span class="NLM_cas:coden">CMAEDL</span>;
        ISSN:<span class="NLM_cas:issn">2045-7634</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">It is well known that in vitro subculture represents a selection pressure on cell lines, and over time this may result in a genetic drift in the cancer cells.  In addn., long-term cultures harbor the risk of cross-contamination with other cell lines.  The consequences may have major impact on exptl. results obtained in various labs., where the cell lines no longer reflect the original tumors that they are supposed to represent.  Much neglected in the scientific community is a close monitoring of cell cultures by regular phenotypic and genetic characterization.  In this report, we present a thorough characterization of the commonly used glioblastoma (GBM) model U-251, which in numerous publications has been wrongly identified as U-373, due to an earlier cross-contamination.  In this work, the original U-251 and three subclones of U-251, commonly referred to as U-251 or U-373, were analyzed with regard to their DNA profile, morphol., phenotypic expression, and growth pattern.  By array comparative genomic hybridization (aCGH), we show that only the original low-passaged U-251 cells, established in the 1960s, maintain a DNA copy no. resembling a typical GBM profile, whereas all long-term subclones lost the typical GBM profile.  Also the long-term passaged subclones displayed variations in phenotypic marker expression and showed an increased growth rate in vitro and a more aggressive growth in vivo.  Taken together, the variations in genotype and phenotype as well as differences in growth characteristics may explain different results reported in various labs. related to the U-251 cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEUN6oz1uC7LVg90H21EOLACvtfcHk0ljHKvixSszjWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12gurvJ&md5=134f8a56de09404f9a176747f6ff2598</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fcam4.219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcam4.219%26sid%3Dliteratum%253Aachs%26aulast%3DTorsvik%26aufirst%3DA.%26aulast%3DStieber%26aufirst%3DD.%26aulast%3DEnger%26aufirst%3DP.%2BO.%26aulast%3DGolebiewska%26aufirst%3DA.%26aulast%3DMolven%26aufirst%3DA.%26aulast%3DSvendsen%26aufirst%3DA.%26aulast%3DWestermark%26aufirst%3DB.%26aulast%3DNiclou%26aufirst%3DS.%2BP.%26aulast%3DOlsen%26aufirst%3DT.%2BK.%26aulast%3DChekenya%2BEnger%26aufirst%3DM.%26aulast%3DBjerkvig%26aufirst%3DR.%26atitle%3DU-251%2520revisited%253A%2520Genetic%2520drift%2520and%2520phenotypic%2520consequences%2520of%2520long-term%2520cultures%2520of%2520glioblastoma%2520cells%26jtitle%3DCancer%2520Med.%26date%3D2014%26volume%3D3%26spage%3D812%26epage%3D824%26doi%3D10.1002%2Fcam4.219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Stein, G. H.</span><span> </span><span class="NLM_article-title">T98g: An anchorage-independent human tumor cell line that exhibits stationary phase g1 arrest in vitro</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1002/jcp.1040990107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1002%2Fjcp.1040990107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=222778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A280%3ADyaE1M3hs1Kjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1979&pages=43-54&author=G.+H.+Stein&title=T98g%3A+An+anchorage-independent+human+tumor+cell+line+that+exhibits+stationary+phase+g1+arrest+in+vitro&doi=10.1002%2Fjcp.1040990107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro</span></div><div class="casAuthors">Stein G H</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular physiology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-54</span>
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    </div><div class="casAbstract">T98 and T98G are two related cell lines that were derived from a human glioblastoma multiforma tumor.  T98G has almost twice as many chromosomes as T98, suggesting that it is a polyploid variant of T98.  Three aspects of control of cellular proliferation were studied in T98 and T98G cells in comparison to WI-38 normal human diploid cells.  WI-38 cells have the following properties: (1) they can undergo only a limited number of population doublings in vitro; (2) they cannot proliferate without anchorage; and (3) they become arrested in G1 phase under stationary phase conditions.  T98 cells differ from normal cells in all three of these properties, as do many other transformed cell lines.  However, the derivative of T98, namely T98G, expresses an unique combination of normal and transformed aspects of the control of cellular proliferation.  T98G cells are like normal cells in that they become arrested in G1 phase under stationary phase conditions, yet they also exhibit the transformed characteristics of anchorage independence and immortality.  Thus, T98G cells demonstrate that transformation to immortality and anchorage independence can exist without concomitant loss of the normal mechanism for G1 arrest in response to stationary phase conditions.  This result supports the hypothesis that each of these three aspects of control of cellular proliferation can be altered independently.  Partially transformed cell lines, such as T98G, should be useful for sorting out the biochemical changes associated with transformation in each of these aspects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOplptjUccRQWRJ3OJdH_qfW6udTcc2eZTPmzF22PnHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1M3hs1Kjuw%253D%253D&md5=f844a5a41b966c01c11e443fbffd4829</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fjcp.1040990107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.1040990107%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DG.%2BH.%26atitle%3DT98g%253A%2520An%2520anchorage-independent%2520human%2520tumor%2520cell%2520line%2520that%2520exhibits%2520stationary%2520phase%2520g1%2520arrest%2520in%2520vitro%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D1979%26volume%3D99%26spage%3D43%26epage%3D54%26doi%3D10.1002%2Fjcp.1040990107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Roninson, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gros, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Housman, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastan, I.</span><span> </span><span class="NLM_article-title">Isolation of human mdr DNA sequences amplified in multidrug-resistant kb carcinoma cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">4538</span><span class="NLM_x">–</span> <span class="NLM_lpage">4542</span><span class="refDoi"> DOI: 10.1073/pnas.83.12.4538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1073%2Fpnas.83.12.4538" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=4538-4542&author=I.+B.+Roninsonauthor=J.+E.+Chinauthor=K.+G.+Choiauthor=P.+Grosauthor=D.+E.+Housmanauthor=A.+Fojoauthor=D.+W.+Shenauthor=M.+M.+Gottesmanauthor=I.+Pastan&title=Isolation+of+human+mdr+DNA+sequences+amplified+in+multidrug-resistant+kb+carcinoma+cells&doi=10.1073%2Fpnas.83.12.4538"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.83.12.4538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.83.12.4538%26sid%3Dliteratum%253Aachs%26aulast%3DRoninson%26aufirst%3DI.%2BB.%26aulast%3DChin%26aufirst%3DJ.%2BE.%26aulast%3DChoi%26aufirst%3DK.%2BG.%26aulast%3DGros%26aufirst%3DP.%26aulast%3DHousman%26aufirst%3DD.%2BE.%26aulast%3DFojo%26aufirst%3DA.%26aulast%3DShen%26aufirst%3DD.%2BW.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DPastan%26aufirst%3DI.%26atitle%3DIsolation%2520of%2520human%2520mdr%2520DNA%2520sequences%2520amplified%2520in%2520multidrug-resistant%2520kb%2520carcinoma%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D83%26spage%3D4538%26epage%3D4542%26doi%3D10.1073%2Fpnas.83.12.4538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Bunz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutriaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedivy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span> </span><span class="NLM_article-title">Requirement for p53 and p21 to sustain g2 arrest after DNA damage</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">1497</span><span class="NLM_x">–</span> <span class="NLM_lpage">1501</span><span class="refDoi"> DOI: 10.1126/science.282.5393.1497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1126%2Fscience.282.5393.1497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=9822382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADyaK1cXns1yqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=1497-1501&author=F.+Bunzauthor=A.+Dutriauxauthor=C.+Lengauerauthor=T.+Waldmanauthor=S.+Zhouauthor=J.+P.+Brownauthor=J.+M.+Sedivyauthor=K.+W.+Kinzlerauthor=B.+Vogelstein&title=Requirement+for+p53+and+p21+to+sustain+g2+arrest+after+DNA+damage&doi=10.1126%2Fscience.282.5393.1497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for p53 and p21 to sustain G2 arrest after DNA damage</span></div><div class="casAuthors">Bunz, F.; Dutriaux, A.; Lengauer, C.; Waldman, T.; Zhou, S.; Brown, J. P.; Sedivy, J. M.; Kinzler, K. W.; Vogelstein, B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">5393</span>),
    <span class="NLM_cas:pages">1497-1501</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">After DNA damage, many cells appear to enter a sustained arrest in the G2 phase of the cell cycle.  It is shown here that this arrest could be sustained only when p53 was present in the cell and capable of transcriptionally activating the cyclin-dependent kinase inhibitor p21.  After disruption of either the p53 or the p21 gene, γ radiated cells progressed into mitosis and exhibited a G2 DNA content only because of a failure of cytokinesis.  Thus, p53 and p21 appear to be essential for maintaining the G2 checkpoint in human cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO6NPwYqRmK7Vg90H21EOLACvtfcHk0lihqnHnyx48MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXns1yqurc%253D&md5=e6f0dc856f71915dbd2b8cfb11de4bad</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1126%2Fscience.282.5393.1497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.282.5393.1497%26sid%3Dliteratum%253Aachs%26aulast%3DBunz%26aufirst%3DF.%26aulast%3DDutriaux%26aufirst%3DA.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DWaldman%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DJ.%2BP.%26aulast%3DSedivy%26aufirst%3DJ.%2BM.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DRequirement%2520for%2520p53%2520and%2520p21%2520to%2520sustain%2520g2%2520arrest%2520after%2520DNA%2520damage%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D1497%26epage%3D1501%26doi%3D10.1126%2Fscience.282.5393.1497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Schuurhuis, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broxterman, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lange, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinedo, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Heijningen, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuiper, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheffer, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheper, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Kalken, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lankelma, J.</span><span> </span><span class="NLM_article-title">Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of p-glycoprotein</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span><span class="refDoi"> DOI: 10.1038/bjc.1991.413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1038%2Fbjc.1991.413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1681887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADyaK38XhsFCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1991&pages=857-861&author=G.+J.+Schuurhuisauthor=H.+J.+Broxtermanauthor=J.+H.+de+Langeauthor=H.+M.+Pinedoauthor=T.+H.+van+Heijningenauthor=C.+M.+Kuiperauthor=G.+L.+Schefferauthor=R.+J.+Scheperauthor=C.+K.+van+Kalkenauthor=J.+P.+Baakauthor=J.+Lankelma&title=Early+multidrug+resistance%2C+defined+by+changes+in+intracellular+doxorubicin+distribution%2C+independent+of+p-glycoprotein&doi=10.1038%2Fbjc.1991.413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein</span></div><div class="casAuthors">Schuurhuis, G. J.; Broxterman, H. J.; De Lange, J. H. M.; Pinedo, H. M.; Van Heijningen, T. H. M.; Kuiper, C. M.; Scheffer, G. L.; Scheper, R. J.; Van Kalken, C. K.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">857-61</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">Resistance to multiple antitumor drugs, mostly antibiotics or alkaloids, has been assocd. with the cellular plasma membrane P-glycoprotein (Pgp) causing energy-dependent transport of drugs out of cells.  In many common chemotherapy-resistant human cancers there is no overexpression of Pgp that could explain drug resistance.  To characterize early steps in multidrug resistance, P-glycoprotein-pos. (Pgp/+) and P-glycoprotein-neg. (Pgp/-) multidrug resistant cell lines were derived from the human non-small lung cancer cell line.  SW-1573 by stepwise selection with increasing concns. of doxorubicin.  The cells were exposed to doxorubicin and its fluorescence in nucleus (N) and cytoplasm (C) was quantified with laserscan microscopy and image anal.  The fluorescence N/C ratio in parent cells was 3.8 and decreased both in Pgp/+ and Pgp/- cells with increasing selection pressure to 1.2-2.6 for cells with a resistance factor of 7-17.  N/C ratios could be restored partly with verapamil only in Pgp/+ cells.  N/C ratio measurements may define a general Pgp-independent type of defense of mammalian cells against certain anticancer agents which may precede Pgp expression in early doxorubicin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqszaVFvCorerVg90H21EOLACvtfcHk0lihqnHnyx48MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsFCrsg%253D%253D&md5=9d500635d2d49f1559b418caa4ac3f26</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1991.413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1991.413%26sid%3Dliteratum%253Aachs%26aulast%3DSchuurhuis%26aufirst%3DG.%2BJ.%26aulast%3DBroxterman%26aufirst%3DH.%2BJ.%26aulast%3Dde%2BLange%26aufirst%3DJ.%2BH.%26aulast%3DPinedo%26aufirst%3DH.%2BM.%26aulast%3Dvan%2BHeijningen%26aufirst%3DT.%2BH.%26aulast%3DKuiper%26aufirst%3DC.%2BM.%26aulast%3DScheffer%26aufirst%3DG.%2BL.%26aulast%3DScheper%26aufirst%3DR.%2BJ.%26aulast%3Dvan%2BKalken%26aufirst%3DC.%2BK.%26aulast%3DBaak%26aufirst%3DJ.%2BP.%26aulast%3DLankelma%26aufirst%3DJ.%26atitle%3DEarly%2520multidrug%2520resistance%252C%2520defined%2520by%2520changes%2520in%2520intracellular%2520doxorubicin%2520distribution%252C%2520independent%2520of%2520p-glycoprotein%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1991%26volume%3D64%26spage%3D857%26epage%3D861%26doi%3D10.1038%2Fbjc.1991.413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandjenette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghelfi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karius, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foliguet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Sustained exposure to the DNA demethylating agent, 2′-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagy</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span><span class="refDoi"> DOI: 10.1016/j.bcp.2010.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.bcp.2010.10.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2011&pages=364-378&author=M.+Schnekenburgerauthor=C.+Grandjenetteauthor=J.+Ghelfiauthor=T.+Kariusauthor=B.+Foliguetauthor=M.+Dicatoauthor=M.+Diederich&title=Sustained+exposure+to+the+DNA+demethylating+agent%2C+2%E2%80%B2-deoxy-5-azacytidine%2C+leads+to+apoptotic+cell+death+in+chronic+myeloid+leukemia+by+promoting+differentiation%2C+senescence%2C+and+autophagy&doi=10.1016%2Fj.bcp.2010.10.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DGrandjenette%26aufirst%3DC.%26aulast%3DGhelfi%26aufirst%3DJ.%26aulast%3DKarius%26aufirst%3DT.%26aulast%3DFoliguet%26aufirst%3DB.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DSustained%2520exposure%2520to%2520the%2520DNA%2520demethylating%2520agent%252C%25202%25E2%2580%25B2-deoxy-5-azacytidine%252C%2520leads%2520to%2520apoptotic%2520cell%2520death%2520in%2520chronic%2520myeloid%2520leukemia%2520by%2520promoting%2520differentiation%252C%2520senescence%252C%2520and%2520autophagy%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D81%26spage%3D364%26epage%3D378%26doi%3D10.1016%2Fj.bcp.2010.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Goffin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamoral-Theys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajeddine, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Tullio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mondin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gailly, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogister, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirotte, B.</span><span> </span><span class="NLM_article-title">N-aryl-n′-(chroman-4-yl)ureas and thioureas display in vitro anticancer activity and selectivity on apoptosis-resistant glioblastoma cells: Screening, synthesis of simplified derivatives, and structure-activity relationship analysis</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">834</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.06.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.ejmech.2012.06.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2012&pages=834-844&author=E.+Goffinauthor=D.+Lamoral-Theysauthor=N.+Tajeddineauthor=P.+de+Tullioauthor=L.+Mondinauthor=F.+Lefrancauthor=P.+Gaillyauthor=B.+Rogisterauthor=R.+Kissauthor=B.+Pirotte&title=N-aryl-n%E2%80%B2-%28chroman-4-yl%29ureas+and+thioureas+display+in+vitro+anticancer+activity+and+selectivity+on+apoptosis-resistant+glioblastoma+cells%3A+Screening%2C+synthesis+of+simplified+derivatives%2C+and+structure-activity+relationship+analysis&doi=10.1016%2Fj.ejmech.2012.06.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.06.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.06.050%26sid%3Dliteratum%253Aachs%26aulast%3DGoffin%26aufirst%3DE.%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DTajeddine%26aufirst%3DN.%26aulast%3Dde%2BTullio%26aufirst%3DP.%26aulast%3DMondin%26aufirst%3DL.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DGailly%26aufirst%3DP.%26aulast%3DRogister%26aufirst%3DB.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DPirotte%26aufirst%3DB.%26atitle%3DN-aryl-n%25E2%2580%25B2-%2528chroman-4-yl%2529ureas%2520and%2520thioureas%2520display%2520in%2520vitro%2520anticancer%2520activity%2520and%2520selectivity%2520on%2520apoptosis-resistant%2520glioblastoma%2520cells%253A%2520Screening%252C%2520synthesis%2520of%2520simplified%2520derivatives%252C%2520and%2520structure-activity%2520relationship%2520analysis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D54%26spage%3D834%26epage%3D844%26doi%3D10.1016%2Fj.ejmech.2012.06.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Frederick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruyere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vancraeynest, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reniers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinguet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pochet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backlund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span> </span><span class="NLM_article-title">Novel trisubstituted harmine derivatives with original in vitro anticancer activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6489</span><span class="NLM_x">–</span> <span class="NLM_lpage">6501</span><span class="refDoi"> DOI: 10.1021/jm300542e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300542e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6489-6501&author=R.+Frederickauthor=C.+Bruyereauthor=C.+Vancraeynestauthor=J.+Reniersauthor=C.+Meinguetauthor=L.+Pochetauthor=A.+Backlundauthor=B.+Masereelauthor=R.+Kissauthor=J.+Wouters&title=Novel+trisubstituted+harmine+derivatives+with+original+in+vitro+anticancer+activity&doi=10.1021%2Fjm300542e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm300542e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300542e%26sid%3Dliteratum%253Aachs%26aulast%3DFrederick%26aufirst%3DR.%26aulast%3DBruyere%26aufirst%3DC.%26aulast%3DVancraeynest%26aufirst%3DC.%26aulast%3DReniers%26aufirst%3DJ.%26aulast%3DMeinguet%26aufirst%3DC.%26aulast%3DPochet%26aufirst%3DL.%26aulast%3DBacklund%26aufirst%3DA.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DWouters%26aufirst%3DJ.%26atitle%3DNovel%2520trisubstituted%2520harmine%2520derivatives%2520with%2520original%2520in%2520vitro%2520anticancer%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6489%26epage%3D6501%26doi%3D10.1021%2Fjm300542e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chantome, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimmino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miklos, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulitschke, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evidente, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delpire, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Sphaeropsidin a shows promising activity against drug-resistant cancer cells by targeting regulatory volume increase</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">3731</span><span class="NLM_x">–</span> <span class="NLM_lpage">3746</span><span class="refDoi"> DOI: 10.1007/s00018-015-1902-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1007%2Fs00018-015-1902-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=25868554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsFSnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2015&pages=3731-3746&author=V.+Mathieuauthor=A.+Chantomeauthor=F.+Lefrancauthor=A.+Cimminoauthor=W.+Miklosauthor=V.+Paulitschkeauthor=T.+Mohrauthor=L.+Maddauauthor=A.+Kornienkoauthor=W.+Bergerauthor=C.+Vandierauthor=A.+Evidenteauthor=E.+Delpireauthor=R.+Kiss&title=Sphaeropsidin+a+shows+promising+activity+against+drug-resistant+cancer+cells+by+targeting+regulatory+volume+increase&doi=10.1007%2Fs00018-015-1902-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Sphaeropsidin A shows promising activity against drug-resistant cancer cells by targeting regulatory volume increase</span></div><div class="casAuthors">Mathieu, Veronique; Chantome, Aurelie; Lefranc, Florence; Cimmino, Alessio; Miklos, Walter; Paulitschke, Verena; Mohr, Thomas; Maddau, Lucia; Kornienko, Alexander; Berger, Walter; Vandier, Christophe; Evidente, Antonio; Delpire, Eric; Kiss, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3731-3746</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Despite the recent advances in the treatment of tumors with intrinsic chemotherapy resistance, such as melanoma and renal cancers, their prognosis remains poor and new chem. agents with promising activity against these cancers are urgently needed.  Sphaeropsidin A, a fungal metabolite whose anticancer potential had previously received little attention, was isolated from Diplodia cupressi and found to display specific anticancer activity in vitro against melanoma and kidney cancer subpanels in the National Cancer Institute (NCI) 60-cell line screen.  The NCI data revealed a mean LC50 of ca. 10 μM and a cellular sensitivity profile that did not match that of any other agent in the 765,000 compd. database.  Subsequent mechanistic studies in melanoma and other multidrug-resistant in vitro cancer models showed that sphaeropsidin A can overcome apoptosis as well as multidrug resistance by inducing a marked and rapid cellular shrinkage related to the loss of intracellular Cl- and the decreased HCO3- concn. in the culture supernatant.  These changes in ion homeostasis and the absence of effects on the plasma membrane potential were attributed to the sphaeropsidin A-induced impairment of regulatory vol. increase (RVI).  Preliminary results also indicate that depending on the type of cancer, the sphaeropsidin A effects on RVI could be related to Na-K-2Cl electroneutral cotransporter or Cl-/HCO3- anion exchanger(s) targeting.  This study underscores the modulation of ion-transporter activity as a promising therapeutic strategy to combat drug-resistant cancers and identifies the fungal metabolite, sphaeropsidin A, as a lead to develop anticancer agents targeting RVI in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8aC9H1vpLSrVg90H21EOLACvtfcHk0lhXfFkBN0Tuhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsFSnsrk%253D&md5=8271722f9c0e434d964b5cc9144e369d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs00018-015-1902-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-015-1902-6%26sid%3Dliteratum%253Aachs%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DChantome%26aufirst%3DA.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DCimmino%26aufirst%3DA.%26aulast%3DMiklos%26aufirst%3DW.%26aulast%3DPaulitschke%26aufirst%3DV.%26aulast%3DMohr%26aufirst%3DT.%26aulast%3DMaddau%26aufirst%3DL.%26aulast%3DKornienko%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DVandier%26aufirst%3DC.%26aulast%3DEvidente%26aufirst%3DA.%26aulast%3DDelpire%26aufirst%3DE.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DSphaeropsidin%2520a%2520shows%2520promising%2520activity%2520against%2520drug-resistant%2520cancer%2520cells%2520by%2520targeting%2520regulatory%2520volume%2520increase%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2015%26volume%3D72%26spage%3D3731%26epage%3D3746%26doi%3D10.1007%2Fs00018-015-1902-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Den Berge, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceusters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konopka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cops, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruyere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trieu-Van, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serteyn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robiette, R.</span><span> </span><span class="NLM_article-title">New 5-aryl-1h-imidazoles display in vitro antitumor activity against apoptosis-resistant cancer models, including melanomas, through mitochondrial targeting</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6626</span><span class="NLM_x">–</span> <span class="NLM_lpage">6637</span><span class="refDoi"> DOI: 10.1021/jm400287v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400287v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6626-6637&author=V.+Mathieuauthor=E.+Van+Den+Bergeauthor=J.+Ceustersauthor=T.+Konopkaauthor=A.+Copsauthor=C.+Bruyereauthor=C.+Pirkerauthor=W.+Bergerauthor=T.+Trieu-Vanauthor=D.+Serteynauthor=R.+Kissauthor=R.+Robiette&title=New+5-aryl-1h-imidazoles+display+in+vitro+antitumor+activity+against+apoptosis-resistant+cancer+models%2C+including+melanomas%2C+through+mitochondrial+targeting&doi=10.1021%2Fjm400287v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm400287v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400287v%26sid%3Dliteratum%253Aachs%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DVan%2BDen%2BBerge%26aufirst%3DE.%26aulast%3DCeusters%26aufirst%3DJ.%26aulast%3DKonopka%26aufirst%3DT.%26aulast%3DCops%26aufirst%3DA.%26aulast%3DBruyere%26aufirst%3DC.%26aulast%3DPirker%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DTrieu-Van%26aufirst%3DT.%26aulast%3DSerteyn%26aufirst%3DD.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DRobiette%26aufirst%3DR.%26atitle%3DNew%25205-aryl-1h-imidazoles%2520display%2520in%2520vitro%2520antitumor%2520activity%2520against%2520apoptosis-resistant%2520cancer%2520models%252C%2520including%2520melanomas%252C%2520through%2520mitochondrial%2520targeting%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6626%26epage%3D6637%26doi%3D10.1021%2Fjm400287v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Seidel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazumder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teiten, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">4-hydroxybenzoic acid derivatives as hdac6-specific inhibitors modulating microtubular structure and hsp90alpha chaperone activity against prostate cancer</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1016/j.bcp.2015.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.bcp.2015.11.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2016&pages=31-52&author=C.+Seidelauthor=M.+Schnekenburgerauthor=A.+Mazumderauthor=M.+H.+Teitenauthor=G.+Kirschauthor=M.+Dicatoauthor=M.+Diederich&title=4-hydroxybenzoic+acid+derivatives+as+hdac6-specific+inhibitors+modulating+microtubular+structure+and+hsp90alpha+chaperone+activity+against+prostate+cancer&doi=10.1016%2Fj.bcp.2015.11.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2015.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2015.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DSeidel%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DMazumder%26aufirst%3DA.%26aulast%3DTeiten%26aufirst%3DM.%2BH.%26aulast%3DKirsch%26aufirst%3DG.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3D4-hydroxybenzoic%2520acid%2520derivatives%2520as%2520hdac6-specific%2520inhibitors%2520modulating%2520microtubular%2520structure%2520and%2520hsp90alpha%2520chaperone%2520activity%2520against%2520prostate%2520cancer%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2016%26volume%3D99%26spage%3D31%26epage%3D52%26doi%3D10.1016%2Fj.bcp.2015.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Piccinini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tesei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arienti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevilacqua, A.</span><span> </span><span class="NLM_article-title">Cancer multicellular spheroids: Volume assessment from a single 2d projection</span> <span class="citation_source-journal">Comput. Methods Programs Biomed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1016/j.cmpb.2014.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.cmpb.2014.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=25561413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A280%3ADC%252BC2MvjslGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2015&pages=95-106&author=F.+Piccininiauthor=A.+Teseiauthor=C.+Arientiauthor=A.+Bevilacqua&title=Cancer+multicellular+spheroids%3A+Volume+assessment+from+a+single+2d+projection&doi=10.1016%2Fj.cmpb.2014.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer multicellular spheroids: volume assessment from a single 2D projection</span></div><div class="casAuthors">Piccinini Filippo; Tesei Anna; Arienti Chiara; Bevilacqua Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">Computer methods and programs in biomedicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-106</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Volume is one of the most important features for the characterization of a tumour on a macroscopic scale.  It is often used to assess the effectiveness of care treatments, thus making its correct evaluation a crucial issue for patient care.  Similarly, volume is a key feature on a microscopic scale.  Multicellular cancer spheroids are 3D tumour models widely employed in pre-clinical studies to test the effects of drugs and radiotherapy treatments.  Very few methods have been proposed to estimate the tumour volume arising from a 2D projection of multicellular spheroids, and even fewer have been designed to provide a 3D reconstruction of the tumour shape.  In this work, we propose Reconstruction and Visualization from a Single Projection (ReViSP), an automatic method conceived to reconstruct the 3D surface and estimate the volume of single cancer multicellular spheroids, or even of spheroid cultures.  As the input parameter ReViSP requires only one 2D projection, which could be a widefield microscope image.  We assessed the effectiveness of our method by comparing it with other approaches.  To this purpose, we used a new strategy that allowed us to achieve accurate volume measurements based on the analysis of home-made 3D objects, built by mimicking the spheroid morphology.  The results confirmed the effectiveness of our method for both 3D reconstruction and volume assessment.  ReViSP software is distributed as an open source tool.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwdSEe9YwQDLxanA7vODO6fW6udTcc2eYH-oOGO-yw7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvjslGmsA%253D%253D&md5=8cc3bf5625a8da6022c18b9f42731958</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.cmpb.2014.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmpb.2014.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DPiccinini%26aufirst%3DF.%26aulast%3DTesei%26aufirst%3DA.%26aulast%3DArienti%26aufirst%3DC.%26aulast%3DBevilacqua%26aufirst%3DA.%26atitle%3DCancer%2520multicellular%2520spheroids%253A%2520Volume%2520assessment%2520from%2520a%2520single%25202d%2520projection%26jtitle%3DComput.%2520Methods%2520Programs%2520Biomed.%26date%3D2015%26volume%3D118%26spage%3D95%26epage%3D106%26doi%3D10.1016%2Fj.cmpb.2014.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Florean, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazumder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandjenette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christov, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proksch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Discovery and characterization of isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to trail in cancer cells</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">24027</span><span class="NLM_x">–</span> <span class="NLM_lpage">24049</span><span class="refDoi"> DOI: 10.18632/oncotarget.8210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.18632%2Foncotarget.8210" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=24027-24049&author=C.+Floreanauthor=M.+Schnekenburgerauthor=J.+Y.+Leeauthor=K.+R.+Kimauthor=A.+Mazumderauthor=S.+Songauthor=J.+M.+Kimauthor=C.+Grandjenetteauthor=J.+G.+Kimauthor=A.+Y.+Yoonauthor=M.+Dicatoauthor=K.+W.+Kimauthor=C.+Christovauthor=B.+W.+Hanauthor=P.+Prokschauthor=M.+Diederich&title=Discovery+and+characterization+of+isofistularin-3%2C+a+marine+brominated+alkaloid%2C+as+a+new+DNA+demethylating+agent+inducing+cell+cycle+arrest+and+sensitization+to+trail+in+cancer+cells&doi=10.18632%2Foncotarget.8210"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8210%26sid%3Dliteratum%253Aachs%26aulast%3DFlorean%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DK.%2BR.%26aulast%3DMazumder%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DGrandjenette%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DJ.%2BG.%26aulast%3DYoon%26aufirst%3DA.%2BY.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DChristov%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DB.%2BW.%26aulast%3DProksch%26aufirst%3DP.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520isofistularin-3%252C%2520a%2520marine%2520brominated%2520alkaloid%252C%2520as%2520a%2520new%2520DNA%2520demethylating%2520agent%2520inducing%2520cell%2520cycle%2520arrest%2520and%2520sensitization%2520to%2520trail%2520in%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D24027%26epage%3D24049%26doi%3D10.18632%2Foncotarget.8210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">El Amrani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debbab, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aly, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siems, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaigneaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proksch, P.</span><span> </span><span class="NLM_article-title">Protein kinase and hdac inhibitors from the endophytic fungus epicoccum nigrum</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1021/np4005745</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np4005745" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2014&pages=49-56&author=M.+El+Amraniauthor=D.+Laiauthor=A.+Debbabauthor=A.+H.+Alyauthor=K.+Siemsauthor=C.+Seidelauthor=M.+Schnekenburgerauthor=A.+Gaigneauxauthor=M.+Diederichauthor=D.+Fegerauthor=W.+Linauthor=P.+Proksch&title=Protein+kinase+and+hdac+inhibitors+from+the+endophytic+fungus+epicoccum+nigrum&doi=10.1021%2Fnp4005745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum</span></div><div class="casAuthors">El Amrani, Mustapha; Lai, Daowan; Debbab, Abdessamad; Aly, Amal H.; Siems, Karsten; Seidel, Carole; Schnekenburger, Michael; Gaigneaux, Anthoula; Diederich, Marc; Feger, Daniel; Lin, Wenhan; Proksch, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A chem. investigation of the endophytic fungus Epicoccum nigrum isolated from leaves of Mentha suaveolens collected in Morocco resulted in the isolation of five new polyketides, epicocconigrones A and B (1 and 2), 3-methoxyepicoccone B (3), 3-methoxyepicoccone (4), and 2,3,4-trihydroxy-6-(methoxymethyl)-5-methylbenzaldehyde (5), together with five known compds. (6-10).  The structures of the new compds. were unambiguously detd. by extensive anal. of the 1D and 2D NMR and mass spectroscopic data.  Compds. 1 and 10 showed potent inhibition of at least 15 protein kinases with IC50 values ranging from 0.07 to 9.00 μM.  Moreover, compds. 1 and 10 inhibited histone deacetylase (HDAC) activities with IC50 values of 9.8 and 14.2 μM, resp.  A preliminary structure-activity relationship is discussed.  Interestingly, compds. 1 and 10 exert mainly cytostatic effects in human lymphoma RAJI and U-937 cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4D_3dYPnTYbVg90H21EOLACvtfcHk0lhTRqCS4CsZsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsLvN&md5=be6445a06b38cd3cf2dd373ef6ced949</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fnp4005745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp4005745%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BAmrani%26aufirst%3DM.%26aulast%3DLai%26aufirst%3DD.%26aulast%3DDebbab%26aufirst%3DA.%26aulast%3DAly%26aufirst%3DA.%2BH.%26aulast%3DSiems%26aufirst%3DK.%26aulast%3DSeidel%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DGaigneaux%26aufirst%3DA.%26aulast%3DDiederich%26aufirst%3DM.%26aulast%3DFeger%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DW.%26aulast%3DProksch%26aufirst%3DP.%26atitle%3DProtein%2520kinase%2520and%2520hdac%2520inhibitors%2520from%2520the%2520endophytic%2520fungus%2520epicoccum%2520nigrum%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2014%26volume%3D77%26spage%3D49%26epage%3D56%26doi%3D10.1021%2Fnp4005745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Seidel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Antiproliferative and proapoptotic activities of 4-hydroxybenzoic acid-based inhibitors of histone deacetylases</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span><span class="refDoi"> DOI: 10.1016/j.canlet.2013.09.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.canlet.2013.09.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=24080339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CqtL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2014&pages=134-146&author=C.+Seidelauthor=M.+Schnekenburgerauthor=M.+Dicatoauthor=M.+Diederich&title=Antiproliferative+and+proapoptotic+activities+of+4-hydroxybenzoic+acid-based+inhibitors+of+histone+deacetylases&doi=10.1016%2Fj.canlet.2013.09.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative and proapoptotic activities of 4-hydroxybenzoic acid-based inhibitors of histone deacetylases</span></div><div class="casAuthors">Seidel, Carole; Schnekenburger, Michael; Dicato, Mario; Diederich, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-146</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Histone acetyltransferases (HATs) and histone deacetylases (HDACs) regulate cellular processes by modifying the acetylation status of many proteins.  Pathol. altered HDAC activity contributes to cancer development and thus characterization of novel acetylation modulators is important for future anti-cancer therapies.  In this study, we identified three novel 4-hydroxybenzoic acid derivs. as pan-HDAC inhibitors that increased protein acetylation levels, arrested cell cycle progression and triggered apoptotic cell death, without affecting viability of normal cells.  Our data support the potential of 4-hydroxybenzoic acid derivs. as pan-HDAC inhibitors with anticancer properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxVAfK3A-ObbVg90H21EOLACvtfcHk0lhTRqCS4CsZsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CqtL%252FJ&md5=7fda5b73dfdb10e0437d2f47b459247c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2013.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2013.09.026%26sid%3Dliteratum%253Aachs%26aulast%3DSeidel%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DAntiproliferative%2520and%2520proapoptotic%2520activities%2520of%25204-hydroxybenzoic%2520acid-based%2520inhibitors%2520of%2520histone%2520deacetylases%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D343%26spage%3D134%26epage%3D146%26doi%3D10.1016%2Fj.canlet.2013.09.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Nunes, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milagre, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gama, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, E.</span><span> </span><span class="NLM_article-title">Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of cyp46a1 gene transcription</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2010.06612.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1111%2Fj.1471-4159.2010.06612.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=20096088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVChtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2010&pages=418-431&author=M.+J.+Nunesauthor=I.+Milagreauthor=M.+Schnekenburgerauthor=M.+J.+Gamaauthor=M.+Diederichauthor=E.+Rodrigues&title=Sp+proteins+play+a+critical+role+in+histone+deacetylase+inhibitor-mediated+derepression+of+cyp46a1+gene+transcription&doi=10.1111%2Fj.1471-4159.2010.06612.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of CYP46A1 gene transcription</span></div><div class="casAuthors">Nunes, Maria Joao; Milagre, Ines; Schnekenburger, Michael; Gama, Maria Joao; Diederich, Marc; Rodrigues, Elsa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">418-431</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">We investigated whether the CYP46A1 gene, a neuronal-specific cytochrome P 450, responsible for the majority of brain cholesterol turnover, is subject to transcriptional modulation through modifications in histone acetylation.  We demonstrated that inhibition of histone deacetylase activity by trichostatin A (TSA), valproic acid and sodium butyrate caused a potent induction of both CYP46A1 promoter activity and endogenous expression.  Silencing of Sp transcription factors through specific small interfering RNAs, or impairing Sp binding to the proximal promoter, by site-directed mutagenesis, led to a significant decrease in TSA-mediated induction of CYP46A1 expression/promoter activity.  Electrophoretic mobility shift assay, DNA affinity pptn. assays and chromatin immunopptn. assays were used to det. the multiprotein complex recruited to the CYP46A1 promoter, upon TSA treatment.  Our data showed that a decrease in Sp3 binding at particular responsive elements, can shift the Sp1/Sp3/Sp4 ratio, and favor the detachment of histone deacetylase (HDAC) 1 and HDAC2 and the recruitment of p300/CBP.  Moreover, we obsd. a dynamic change in the chromatin structure upon TSA treatment, characterized by an increase in the local recruitment of euchromatic markers and RNA polymerase II.  Our results show the crit. participation of an epigenetic program in the control of CYP46A1 gene transcription, and suggest that brain cholesterol catabolism may be affected upon treatment with HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ5PM8_4MYYLVg90H21EOLACvtfcHk0lh4Ode3uiS7Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVChtbg%253D&md5=4c495619589253be12656ad9ed0a9446</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2010.06612.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2010.06612.x%26sid%3Dliteratum%253Aachs%26aulast%3DNunes%26aufirst%3DM.%2BJ.%26aulast%3DMilagre%26aufirst%3DI.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DGama%26aufirst%3DM.%2BJ.%26aulast%3DDiederich%26aufirst%3DM.%26aulast%3DRodrigues%26aufirst%3DE.%26atitle%3DSp%2520proteins%2520play%2520a%2520critical%2520role%2520in%2520histone%2520deacetylase%2520inhibitor-mediated%2520derepression%2520of%2520cyp46a1%2520gene%2520transcription%26jtitle%3DJ.%2520Neurochem.%26date%3D2010%26volume%3D113%26spage%3D418%26epage%3D431%26doi%3D10.1111%2Fj.1471-4159.2010.06612.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Karius, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghelfi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Reversible epigenetic fingerprint-mediated glutathione-s-transferase p1 gene silencing in human leukemia cell lines</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1342</span><span class="refDoi"> DOI: 10.1016/j.bcp.2011.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.bcp.2011.03.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2011&pages=1329-1342&author=T.+Kariusauthor=M.+Schnekenburgerauthor=J.+Ghelfiauthor=J.+Walterauthor=M.+Dicatoauthor=M.+Diederich&title=Reversible+epigenetic+fingerprint-mediated+glutathione-s-transferase+p1+gene+silencing+in+human+leukemia+cell+lines&doi=10.1016%2Fj.bcp.2011.03.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DKarius%26aufirst%3DT.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DGhelfi%26aufirst%3DJ.%26aulast%3DWalter%26aufirst%3DJ.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DReversible%2520epigenetic%2520fingerprint-mediated%2520glutathione-s-transferase%2520p1%2520gene%2520silencing%2520in%2520human%2520leukemia%2520cell%2520lines%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D81%26spage%3D1329%26epage%3D1342%26doi%3D10.1016%2Fj.bcp.2011.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Pirotte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florence, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goffin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medeiros, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Tullio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebrun, P.</span><span> </span><span class="NLM_article-title">4-phenylureido/thioureido-substituted 2,2-dimethylchroman analogs of cromakalim bearing a bulky “carbamate” moiety at the 6-position as potent inhibitors of glucose-sensitive insulin secretion</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.ejmech.2016.05.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2016&pages=338-351&author=B.+Pirotteauthor=X.+Florenceauthor=E.+Goffinauthor=M.+B.+Medeirosauthor=P.+de+Tullioauthor=P.+Lebrun&title=4-phenylureido%2Fthioureido-substituted+2%2C2-dimethylchroman+analogs+of+cromakalim+bearing+a+bulky+%E2%80%9Ccarbamate%E2%80%9D+moiety+at+the+6-position+as+potent+inhibitors+of+glucose-sensitive+insulin+secretion&doi=10.1016%2Fj.ejmech.2016.05.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DFlorence%26aufirst%3DX.%26aulast%3DGoffin%26aufirst%3DE.%26aulast%3DMedeiros%26aufirst%3DM.%2BB.%26aulast%3Dde%2BTullio%26aufirst%3DP.%26aulast%3DLebrun%26aufirst%3DP.%26atitle%3D4-phenylureido%252Fthioureido-substituted%25202%252C2-dimethylchroman%2520analogs%2520of%2520cromakalim%2520bearing%2520a%2520bulky%2520%25E2%2580%259Ccarbamate%25E2%2580%259D%2520moiety%2520at%2520the%25206-position%2520as%2520potent%2520inhibitors%2520of%2520glucose-sensitive%2520insulin%2520secretion%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D121%26spage%3D338%26epage%3D351%26doi%3D10.1016%2Fj.ejmech.2016.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Arun K. Ghosh, <span class="NLM_string-name hlFld-ContribAuthor">Margherita Brindisi</span>. </span><span class="cited-content_cbyCitation_article-title">Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 2751-2788. <a href="https://doi.org/10.1021/acs.jmedchem.9b01541" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01541%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUrea%252BDerivatives%252Bin%252BModern%252BDrug%252BDiscovery%252Band%252BMedicinal%252BChemistry%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D16092019%26date%3D02122019%26volume%3D63%26issue%3D6%26spage%3D2751%26epage%3D2788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simin  Sun</span>, <span class="hlFld-ContribAuthor ">Wenwen  Zhao</span>, <span class="hlFld-ContribAuthor ">Yongliang  Li</span>, <span class="hlFld-ContribAuthor ">Ziwei  Chi</span>, <span class="hlFld-ContribAuthor ">Xixi  Fang</span>, <span class="hlFld-ContribAuthor ">Qiang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhiwu  Han</span>, <span class="hlFld-ContribAuthor ">Yepeng  Luan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and antitumor activity evaluation of novel HDAC inhibitors with tetrahydrobenzothiazole as the skeleton. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>108 </em>, 104652. <a href="https://doi.org/10.1016/j.bioorg.2021.104652" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104652</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104652%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bantitumor%252Bactivity%252Bevaluation%252Bof%252Bnovel%252BHDAC%252Binhibitors%252Bwith%252Btetrahydrobenzothiazole%252Bas%252Bthe%252Bskeleton%26aulast%3DSun%26aufirst%3DSimin%26date%3D2021%26volume%3D108%26spage%3D104652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pedro  Reimunde</span>, <span class="hlFld-ContribAuthor ">Alba  Pensado-López</span>, <span class="hlFld-ContribAuthor ">Martín  Carreira Crende</span>, <span class="hlFld-ContribAuthor ">Vanesa  Lombao Iglesias</span>, <span class="hlFld-ContribAuthor ">Laura  Sánchez</span>, <span class="hlFld-ContribAuthor ">Marta  Torrecilla-Parra</span>, <span class="hlFld-ContribAuthor ">Cristina M.  Ramírez</span>, <span class="hlFld-ContribAuthor ">Clément  Anfray</span>, <span class="hlFld-ContribAuthor ">Fernando  Torres Andón</span>. </span><span class="cited-content_cbyCitation_article-title">Cellular and Molecular Mechanisms Underlying Glioblastoma and Zebrafish Models for the Discovery of New Treatments. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (5)
                                     , 1087. <a href="https://doi.org/10.3390/cancers13051087" title="DOI URL">https://doi.org/10.3390/cancers13051087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13051087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13051087%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DCellular%252Band%252BMolecular%252BMechanisms%252BUnderlying%252BGlioblastoma%252Band%252BZebrafish%252BModels%252Bfor%252Bthe%252BDiscovery%252Bof%252BNew%252BTreatments%26aulast%3DReimunde%26aufirst%3DPedro%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D5%26spage%3D1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manon  Lernoux</span>, <span class="hlFld-ContribAuthor ">Michael  Schnekenburger</span>, <span class="hlFld-ContribAuthor ">Hélène  Losson</span>, <span class="hlFld-ContribAuthor ">Koen  Vermeulen</span>, <span class="hlFld-ContribAuthor ">Hyunggu  Hahn</span>, <span class="hlFld-ContribAuthor ">Déborah  Gérard</span>, <span class="hlFld-ContribAuthor ">Jin-Young  Lee</span>, <span class="hlFld-ContribAuthor ">Aloran  Mazumder</span>, <span class="hlFld-ContribAuthor ">Muneer  Ahamed</span>, <span class="hlFld-ContribAuthor ">Christo  Christov</span>, <span class="hlFld-ContribAuthor ">Dong-Wook  Kim</span>, <span class="hlFld-ContribAuthor ">Mario  Dicato</span>, <span class="hlFld-ContribAuthor ">Guy  Bormans</span>, <span class="hlFld-ContribAuthor ">Byung Woo  Han</span>, <span class="hlFld-ContribAuthor ">Marc  Diederich</span>. </span><span class="cited-content_cbyCitation_article-title">Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells. </span><span class="cited-content_cbyCitation_journal-name">Clinical Epigenetics</span><span> <strong>2020,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13148-020-00839-z" title="DOI URL">https://doi.org/10.1186/s13148-020-00839-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13148-020-00839-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13148-020-00839-z%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Epigenetics%26atitle%3DNovel%252BHDAC%252Binhibitor%252BMAKV-8%252Band%252Bimatinib%252Bsynergistically%252Bkill%252Bchronic%252Bmyeloid%252Bleukemia%252Bcells%252Bvia%252Binhibition%252Bof%252BBCR-ABL%25252FMYC-signaling%25253A%252Beffect%252Bon%252Bimatinib%252Bresistance%252Band%252Bstem%252Bcells%26aulast%3DLernoux%26aufirst%3DManon%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ange  Mouithys-Mickalad</span>, <span class="hlFld-ContribAuthor ">Justine  Ceusters</span>, <span class="hlFld-ContribAuthor ">Mounia  Charif</span>, <span class="hlFld-ContribAuthor ">Benaïssa  El Moualij</span>, <span class="hlFld-ContribAuthor ">Mathieu  Schoumacher</span>, <span class="hlFld-ContribAuthor ">Simon  Plyte</span>, <span class="hlFld-ContribAuthor ">Thierry  Franck</span>, <span class="hlFld-ContribAuthor ">Lucien  Bettendorff</span>, <span class="hlFld-ContribAuthor ">Bernard  Pirotte</span>, <span class="hlFld-ContribAuthor ">Didier  Serteyn</span>, <span class="hlFld-ContribAuthor ">Pascal  de Tullio</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of mitochondrial respiration rate and calcium-induced swelling by new cromakalim analogues. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2020,</strong> <em>331 </em>, 109272. <a href="https://doi.org/10.1016/j.cbi.2020.109272" title="DOI URL">https://doi.org/10.1016/j.cbi.2020.109272</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2020.109272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2020.109272%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DModulation%252Bof%252Bmitochondrial%252Brespiration%252Brate%252Band%252Bcalcium-induced%252Bswelling%252Bby%252Bnew%252Bcromakalim%252Banalogues%26aulast%3DMouithys-Mickalad%26aufirst%3DAnge%26date%3D2020%26volume%3D331%26spage%3D109272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenyu  Yang</span>, <span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Huilin  Su</span>, <span class="hlFld-ContribAuthor ">Rong  Li</span>, <span class="hlFld-ContribAuthor ">Chen  Song</span>, <span class="hlFld-ContribAuthor ">Zhouyu  Wang</span>, <span class="hlFld-ContribAuthor ">Lingling  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the development of histone deacylase SIRT2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (61)
                                     , 37382-37390. <a href="https://doi.org/10.1039/D0RA06316A" title="DOI URL">https://doi.org/10.1039/D0RA06316A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA06316A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA06316A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdevelopment%252Bof%252Bhistone%252Bdeacylase%252BSIRT2%252Binhibitors%26aulast%3DYang%26aufirst%3DWenyu%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D61%26spage%3D37382%26epage%3D37390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hélène  Losson</span>, <span class="hlFld-ContribAuthor ">Sruthi Reddy  Gajulapalli</span>, <span class="hlFld-ContribAuthor ">Manon  Lernoux</span>, <span class="hlFld-ContribAuthor ">Jin-Young  Lee</span>, <span class="hlFld-ContribAuthor ">Aloran  Mazumder</span>, <span class="hlFld-ContribAuthor ">Déborah  Gérard</span>, <span class="hlFld-ContribAuthor ">Carole  Seidel</span>, <span class="hlFld-ContribAuthor ">Hyunggu  Hahn</span>, <span class="hlFld-ContribAuthor ">Christo  Christov</span>, <span class="hlFld-ContribAuthor ">Mario  Dicato</span>, <span class="hlFld-ContribAuthor ">Gilbert  Kirsch</span>, <span class="hlFld-ContribAuthor ">Byung Woo  Han</span>, <span class="hlFld-ContribAuthor ">Michael  Schnekenburger</span>, <span class="hlFld-ContribAuthor ">Marc  Diederich</span>. </span><span class="cited-content_cbyCitation_article-title">The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>160 </em>, 105058. <a href="https://doi.org/10.1016/j.phrs.2020.105058" title="DOI URL">https://doi.org/10.1016/j.phrs.2020.105058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2020.105058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2020.105058%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DThe%252BHDAC6%252Binhibitor%252B7b%252Binduces%252BBCR-ABL%252Bubiquitination%252Band%252Bdownregulation%252Band%252Bsynergizes%252Bwith%252Bimatinib%252Bto%252Btrigger%252Bapoptosis%252Bin%252Bchronic%252Bmyeloid%252Bleukemia%26aulast%3DLosson%26aufirst%3DH%25C3%25A9l%25C3%25A8ne%26date%3D2020%26volume%3D160%26spage%3D105058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chi-Yuan  Chen</span>, <span class="hlFld-ContribAuthor ">Chin-Chuan  Chen</span>, <span class="hlFld-ContribAuthor ">Wen-Yu  Chuang</span>, <span class="hlFld-ContribAuthor ">Yann-Lii  Leu</span>, <span class="hlFld-ContribAuthor ">Shir-Hwa  Ueng</span>, <span class="hlFld-ContribAuthor ">Chuen  Hsueh</span>, <span class="hlFld-ContribAuthor ">Chau-Ting  Yeh</span>, <span class="hlFld-ContribAuthor ">Tong-Hong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.00216" title="DOI URL">https://doi.org/10.3389/fonc.2020.00216</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.00216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.00216%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DHydroxygenkwanin%252BInhibits%252BClass%252BI%252BHDAC%252BExpression%252Band%252BSynergistically%252BEnhances%252Bthe%252BAntitumor%252BActivity%252Bof%252BSorafenib%252Bin%252BLiver%252BCancer%252BCells%26aulast%3DChen%26aufirst%3DChi-Yuan%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxwell T  Laws</span>, <span class="hlFld-ContribAuthor ">Robin E  Bonomi</span>, <span class="hlFld-ContribAuthor ">David J  Gelovani</span>, <span class="hlFld-ContribAuthor ">Jeremy  Llaniguez</span>, <span class="hlFld-ContribAuthor ">Xin  Lu</span>, <span class="hlFld-ContribAuthor ">Thomas  Mangner</span>, <span class="hlFld-ContribAuthor ">Juri G  Gelovani</span>. </span><span class="cited-content_cbyCitation_article-title">Noninvasive quantification of SIRT1 expression–activity and pharmacologic inhibition in a rat model of intracerebral glioma using 2-[18F]BzAHA PET/CT/MRI. </span><span class="cited-content_cbyCitation_journal-name">Neuro-Oncology Advances</span><span> <strong>2020,</strong> <em>2 </em>
                                    (1)
                                     <a href="https://doi.org/10.1093/noajnl/vdaa006" title="DOI URL">https://doi.org/10.1093/noajnl/vdaa006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/noajnl/vdaa006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnoajnl%2Fvdaa006%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuro-Oncology%2520Advances%26atitle%3DNoninvasive%252Bquantification%252Bof%252BSIRT1%252Bexpression%2525E2%252580%252593activity%252Band%252Bpharmacologic%252Binhibition%252Bin%252Ba%252Brat%252Bmodel%252Bof%252Bintracerebral%252Bglioma%252Busing%252B2-%25255B18F%25255DBzAHA%252BPET%25252FCT%25252FMRI%26aulast%3DLaws%26aufirst%3DMaxwell%2BT%26date%3D2020%26date%3D2020%26volume%3D2%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sylvain  Broussy</span>, <span class="hlFld-ContribAuthor ">Hanna  Laaroussi</span>, <span class="hlFld-ContribAuthor ">Michel  Vidal</span>. </span><span class="cited-content_cbyCitation_article-title">Biochemical mechanism and biological effects of the inhibition of silent information regulator 1 (SIRT1) by EX-527 (SEN0014196 or selisistat). </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 1124-1136. <a href="https://doi.org/10.1080/14756366.2020.1758691" title="DOI URL">https://doi.org/10.1080/14756366.2020.1758691</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1758691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1758691%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DBiochemical%252Bmechanism%252Band%252Bbiological%252Beffects%252Bof%252Bthe%252Binhibition%252Bof%252Bsilent%252Binformation%252Bregulator%252B1%252B%252528SIRT1%252529%252Bby%252BEX-527%252B%252528SEN0014196%252Bor%252Bselisistat%252529%26aulast%3DBroussy%26aufirst%3DSylvain%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D1124%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minna  Rahnasto-Rilla</span>, <span class="hlFld-ContribAuthor ">Jonna  Tyni</span>, <span class="hlFld-ContribAuthor ">Maija  Lahtela-Kakkonen</span>. </span><span class="cited-content_cbyCitation_article-title">Sirtuin Inhibitors and Activators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 55-92. <a href="https://doi.org/10.1007/7355_2019_70" title="DOI URL">https://doi.org/10.1007/7355_2019_70</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2019_70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2019_70%26sid%3Dliteratum%253Aachs%26atitle%3DSirtuin%252BInhibitors%252Band%252BActivators%26aulast%3DRahnasto-Rilla%26aufirst%3DMinna%26date%3D2019%26date%3D2019%26spage%3D55%26epage%3D92%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DChemical%252BEpigenetics%26aulast%3DMai%26aufirst%3DAntonello%26date%3D2020%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan-Hong  Chen</span>, <span class="hlFld-ContribAuthor ">Wen-jing  Zeng</span>, <span class="hlFld-ContribAuthor ">Zhi-peng  Wen</span>, <span class="hlFld-ContribAuthor ">Quan  Cheng</span>, <span class="hlFld-ContribAuthor ">Xiao-Ping  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Under explored epigenetic modulators: role in glioma chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2018,</strong> <em>833 </em>, 201-209. <a href="https://doi.org/10.1016/j.ejphar.2018.05.047" title="DOI URL">https://doi.org/10.1016/j.ejphar.2018.05.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2018.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2018.05.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DUnder%252Bexplored%252Bepigenetic%252Bmodulators%25253A%252Brole%252Bin%252Bglioma%252Bchemotherapy%26aulast%3DChen%26aufirst%3DYan-Hong%26date%3D2018%26volume%3D833%26spage%3D201%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ziyan  Zhou</span>, <span class="hlFld-ContribAuthor ">Tianfang  Ma</span>, <span class="hlFld-ContribAuthor ">Qihua  Zhu</span>, <span class="hlFld-ContribAuthor ">Yungen  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Zha</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in inhibitors of sirtuin1/2: an update and perspective. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (8)
                                     , 907-934. <a href="https://doi.org/10.4155/fmc-2017-0207" title="DOI URL">https://doi.org/10.4155/fmc-2017-0207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0207%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Binhibitors%252Bof%252Bsirtuin1%25252F2%25253A%252Ban%252Bupdate%252Band%252Bperspective%26aulast%3DZhou%26aufirst%3DZiyan%26date%3D2018%26volume%3D10%26issue%3D8%26spage%3D907%26epage%3D934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Schnekenburger</span>, <span class="hlFld-ContribAuthor ">Véronique  Mathieu</span>, <span class="hlFld-ContribAuthor ">Florence  Lefranc</span>, <span class="hlFld-ContribAuthor ">Jun Young  Jang</span>, <span class="hlFld-ContribAuthor ">Marco  Masi</span>, <span class="hlFld-ContribAuthor ">Anake  Kijjoa</span>, <span class="hlFld-ContribAuthor ">Antonio  Evidente</span>, <span class="hlFld-ContribAuthor ">Hyun-Jung  Kim</span>, <span class="hlFld-ContribAuthor ">Robert  Kiss</span>, <span class="hlFld-ContribAuthor ">Mario  Dicato</span>, <span class="hlFld-ContribAuthor ">Byung Woo  Han</span>, <span class="hlFld-ContribAuthor ">Marc  Diederich</span>. </span><span class="cited-content_cbyCitation_article-title">The Fungal Metabolite Eurochevalierine, a Sequiterpene Alkaloid, Displays Anti-Cancer Properties through Selective Sirtuin 1/2 Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (2)
                                     , 333. <a href="https://doi.org/10.3390/molecules23020333" title="DOI URL">https://doi.org/10.3390/molecules23020333</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23020333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23020333%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252BFungal%252BMetabolite%252BEurochevalierine%25252C%252Ba%252BSequiterpene%252BAlkaloid%25252C%252BDisplays%252BAnti-Cancer%252BProperties%252Bthrough%252BSelective%252BSirtuin%252B1%25252F2%252BInhibition%26aulast%3DSchnekenburger%26aufirst%3DMichael%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D2%26spage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reference HDAC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structure of cromakalim (<b>5</b>) and general formula of 4-arylurea/arylthiourea-substituted 2,2-dimethylchromans (<b>6</b>) previously reported as K<sub>ATP</sub> channel openers. Compounds <b>7</b> and <b>8</b> are examples of 2,2-dimethylchromans exerting antiproliferative activity against glioma cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0014.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) X-C<sub>6</sub>H<sub>4</sub>-N═C═O, CH<sub>2</sub>Cl<sub>2</sub>, rt, 75–85%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0015.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) 5 N HCl in EtOH, rt, 80% ; (ii) HCOOH, Ac<sub>2</sub>O, THF, rt., 80–85%; (iii) H<sub>2</sub>, Raney nickel<sup>0</sup>, EtOH, 65%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0016.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, 50%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0017.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (i) 3-cyanophenyl isocyanate, CH<sub>2</sub>Cl<sub>2</sub>, rt, 90–95%.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. SIRT1/2 silencing decreases glioblastoma cell proliferation. (A) Constitutive SIRT1 and SIRT2 protein expression levels in U373 and Hs683 cell lines analyzed by Western blot. α-Tubulin was used as a loading control. (B, C) U373 and Hs683 cell lines were transfected with the indicated siRNA. (B) SIRT1 and SIRT2 protein expression levels were analyzed 24 h post-transfection. β-Actin was used as loading control. (C) 24 h post-transfection cell proliferation was monitored by time-lapse videomicroscopy. Graphs are representative of three independent experiments and correspond to the mean ± SD of 16 pictures per well acquired in triplicate. Blots are representative of three independent experiments, and quantifications are indicated under the blots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>18</b> docked into human SIRT1 and SIRT2. (A) Docking pose of compound <b>18</b> on the crystal structure of SIRT1 (light pink; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5I">4I5I</a>). Close-up view on the right shows that compound <b>18</b> (lime) binds to the active site of SIRT1 structure. Hydrogen bonds are shown as dashed black lines. The residues forming hydrophobic interactions are represented as gray colored sticks. (B) Docking pose of compound <b>18</b> on the crystal structure of SIRT2 (wheat; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RMG">4RMG</a>). Close-up view on the right shows that compound <b>18</b> (lime) binds to the active site of SIRT2 structure. The hydrogen bond is shown as dashed black lines. The residues forming hydrophobic interactions are represented as gray colored sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro HDAC inhibition potential of compound <b>18</b>. (A) Residual inhibition of total HDAC activity. (B) Effect of <b>18</b> on activity of selected HDAC isoenzymes. Data are the mean ± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In cellulo assessment of HDAC inhibition by compound <b>18</b> through the study of histone and α-tubulin acetylation levels. Cells were treated for 8 h at the indicated concentrations of compound <b>18</b>. The acetylation (Ac) of histone H4 (H4) and α-tubulin was analyzed by Western blot. Histone H1 (H1) and β-actin were used as loading controls for the analysis of acid (top panel) and total (bottom panel) extracts, respectively. <b>38</b> (2 μM) was used as a reference HDAC inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. SIRT1 or SIRT2 knock-down enhances the growth inhibitory effects of <b>18</b> in glioblastoma cells. U373 and Hs683 cell lines were transfected with the indicated siRNA. 24 h post-transfection cells were treated with compound <b>18</b> at the respective IC<sub>50</sub> values calculated from MTT assays (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>), and proliferation was monitored by time-lapse videomicroscopy. Graphs are representative of three independent experiments and correspond to the mean ± SD of 16 pictures per well acquired in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Digitized images of Hs683 oligodendroglial (A) and U373 glioblastoma (B) cells were obtained using computer-assisted phase-contrast microscopy (quantitative videomicroscopy). A global growth ratio (the GGR index) was calculated, resulting in a value that can be directly compared to the IC<sub>50</sub> value determined by the MTT colorimetric assay (the hatched horizontal line in the bottom chart, i.e., ∼10 μM (see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>)). First, the global growth (GG) is calculated for each control and each treated condition at 24, 48, and 72 h by dividing the number of cells on the last image by the number of cells on the first image. The GGR index is obtained by dividing the GG values calculated for Hs683 tumor cells treated with <b>18</b> by the GG values calculated for the control. The experiment was performed once in triplicate, and the data represent the mean ± SEM values. White, gray, and black bars represent the data obtained at 24, 48 and 72 h, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0009.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Compound <b>18</b> induces G1 cell cycle arrest in glioblastoma cell lines and promotes the accumulation of senescent U373 cells. (A) Cells were treated, or not, with <b>18</b>, <b>2</b>, <b>3</b>, <b>4</b> (at the respective IC<sub>50</sub> values for each cell lines reported in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>) and 2 μM <b>38</b>. After 24 and 48 h of exposure, cell cycle distribution was analyzed. Histograms correspond to the mean ± SD of the quantification of three independent experiments. ∗, ∗∗ indicate <i>p</i> < 0.05, <i>p</i> < 0.01 compared to control cells, respectively. (B) Cells were incubated in a medium containing DMSO as a vehicle control or 5 μM <b>18</b> for 6 days and were stained for β-galactosidase activity. Representative pictures of two independent experiments are depicted where SA-β-gal-positive cells are revealed by blue staining. The percentage of senescent cells, expressed as a percentage of the total number of cells counted, is indicated for each picture. Data represent the mean ± SD of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0010.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0023.jpeg" id="rightTab-gr14.5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Antitumor potential of compound <b>18</b>. (A) Representative bright field images and 3D plots of spheroids generated from Hs683 cells (top panels). Cells were pretreated for 24 h with the indicated concentrations of <b>18</b> and then left untreated for 96 h (4-day incubation, upper left panel), or untreated cells were cultured for 96 h in the presence of the indicated concentrations of <b>18</b> (24 h pretreated cells, upper right panel). The surface, volume, and ATP levels of spheroids were measured as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> (bottom panels). Data are the mean ± SD of three independent experiments. (B) Fluorescent Hs683 and U373 cells were treated, or not, in vitro at 5 or 10 μM compound <b>18</b> for 30 or 36 h and then injected in the zebrafish yolk sac. The figure represents results obtained with a pretreatment of 36 h at 10 μM; for the other conditions of treatment we refer to <a href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf" class="ext-link">Figure SI-5</a>. After 72 h, fluorescence was quantified and representative images from a total of eight fish per condition are shown. For each fish, the upper panel represents the bright field, the middle panel the red fluorescence, and the bottom panel the merged picture. Fluorescence intensity quantification graphs are shown. PBS injection was used as a control for injection side effects. ∗, ∗∗, ∗∗∗ indicate <i>p</i> < 0.05, <i>p</i> < 0.01, <i>p</i> < 0.05 compared to control cells, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0010.jpeg jm-2017-005335_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0011.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Characterization of the growth inhibitory effects exerted by compound <b>18</b> in the NCI 60-cell-line panel (National Cancer Institute Developmental Therapeutics Program, mean graphs).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0012.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Impact of clinically significant drug resistance mechanisms on the anticancer activity of <b>18</b>. (A) HCT-116 p53wt and HCT-116 p53ko (p53 knockout), (B) SW1573, SW1573 2R120 (ABCC1- and LRP-overexpressing) and 2R160 (ABCB1-overexpressing), (C) A2780 and A2780cis (cisplatin resistant), and (D) KB-3-1, KB-C-1 (ABCB1-overexpressing) and KB-HU (ribonucleotide reductase subunit 2-overexpressing) were treated with the indicated concentrations of compound <b>18</b>. After 72 h of continuous drug exposure, cell viability was determined by MTT assay. The experiments were performed in quintuplicate, and results are shown as the mean ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/medium/jm-2017-005335_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0013.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Effect of compound <b>18</b> on the viability of healthy peripheral blood mononuclear cells. Histograms correspond to the mean ± SD of three independent experiments. ∗, ∗∗ indicate <i>p</i> < 0.05, <i>p</i> < 0.01 compared to control cells, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00533/20170602/images/large/jm-2017-005335_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00533&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25807" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25807" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 56 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2411</span><span class="NLM_x">–</span> <span class="NLM_lpage">2422</span><span class="refDoi"> DOI: 10.1200/JCO.2005.03.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1200%2FJCO.2005.03.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=15800333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsVyhsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=2411-2422&author=F.+Lefrancauthor=J.+Brotchiauthor=R.+Kiss&title=Possible+future+issues+in+the+treatment+of+glioblastomas%3A+Special+emphasis+on+cell+migration+and+the+resistance+of+migrating+glioblastoma+cells+to+apoptosis&doi=10.1200%2FJCO.2005.03.089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis</span></div><div class="casAuthors">Lefranc, Florence; Brotchi, Jacques; Kiss, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2411-2422</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The present review aims to emphasize that malignant gliomas are characterized by the diffuse invasion of distant brain tissue by a myriad of single migrating cells that exhibit decreased levels of apoptosis (programmed cell death type I), thus a resistance to cytotoxic insult.  The present review surveys the mol. mechanisms of migration in malignant gliomas and potential issues arising from treatments, in addn. to relationships between glioma cell migration and resistance to apoptosis in terms of the mol. signaling pathways.  Clin. and exptl. data demonstrate that glioma cell migration is a complex combination of multiple mol. processes, including the alteration of tumor cell adhesion to a modified extracellular matrix, the secretion of proteases by the cells, and modifications to the actin cytoskeleton.  Intracellular signaling pathways involved in the acquisition of resistance to apoptosis by migrating glioma cells concern Pl3K, Akt, mTOR, NF-κB, and autophagy (programmed cell death type II).  A no. of signaling pathways can be constitutively activated in migrating glioma cells, thus rendering these cells resistant to cytotoxic insults.  However, these pathways are not all constitutively activated at the same time in any one glioma.  Particular inhibitors should therefore only be chosen if the target is present in the tumor tissue, but this is only possible if individual patients are submitted to the mol. profiling of their tumors before undergoing any treatment to combat their migratory glioma cells.  Specific antimigratory compds. should be added to conventional radio- and/or chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRxPKR4Wm5vbVg90H21EOLACvtfcHk0lgtjjzsOZi5Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsVyhsrY%253D&md5=9195f4ac3a7cccda1ca747dbb35f3023</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.089%26sid%3Dliteratum%253Aachs%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DPossible%2520future%2520issues%2520in%2520the%2520treatment%2520of%2520glioblastomas%253A%2520Special%2520emphasis%2520on%2520cell%2520migration%2520and%2520the%2520resistance%2520of%2520migrating%2520glioblastoma%2520cells%2520to%2520apoptosis%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D2411%26epage%3D2422%26doi%3D10.1200%2FJCO.2005.03.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Stupp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegi, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Bent, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taphoorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzer, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allgeier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandes, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijtenbeek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marosi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecht, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokhtari, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesseling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhauer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorlia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairncross, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirimanoff, R. O.</span><span> </span><span class="NLM_article-title">Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase iii study: 5-year analysis of the eortc-ncic trial</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span><span class="refDoi"> DOI: 10.1016/S1470-2045(09)70025-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2FS1470-2045%2809%2970025-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=19269895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVKhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=459-466&author=R.+Stuppauthor=M.+E.+Hegiauthor=W.+P.+Masonauthor=M.+J.+van+den+Bentauthor=M.+J.+Taphoornauthor=R.+C.+Janzerauthor=S.+K.+Ludwinauthor=A.+Allgeierauthor=B.+Fisherauthor=K.+Belangerauthor=P.+Hauauthor=A.+A.+Brandesauthor=J.+Gijtenbeekauthor=C.+Marosiauthor=C.+J.+Vechtauthor=K.+Mokhtariauthor=P.+Wesselingauthor=S.+Villaauthor=E.+Eisenhauerauthor=T.+Gorliaauthor=M.+Wellerauthor=D.+Lacombeauthor=J.+G.+Cairncrossauthor=R.+O.+Mirimanoff&title=Effects+of+radiotherapy+with+concomitant+and+adjuvant+temozolomide+versus+radiotherapy+alone+on+survival+in+glioblastoma+in+a+randomised+phase+iii+study%3A+5-year+analysis+of+the+eortc-ncic+trial&doi=10.1016%2FS1470-2045%2809%2970025-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial</span></div><div class="casAuthors">Stupp, Roger; Hegi, Monika E.; Mason, Warren P.; van den Bent, Martin J.; Taphoorn, Martin J. B.; Janzer, Robert C.; Ludwin, Samuel K.; Allgeier, Anouk; Fisher, Barbara; Belanger, Karl; Hau, Peter; Brandes, Alba A.; Gijtenbeek, Johanna; Marosi, Christine; Vecht, Charles J.; Mokhtari, Karima; Wesseling, Pieter; Villa, Salvador; Eisenhauer, Elizabeth; Gorlia, Thierry; Weller, Michael; Lacombe, Denis; Cairncross, J. Gregory; Mirimanoff, Rene-Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">459-466</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In 2004, a randomized phase III trial by the European Organization for Research and Treatment of Cancer (EORTC) and National Cancer Institute of Canada Clin. Trials Group (NCIC) reported improved median and 2-yr survival for patients with glioblastoma treated with concomitant and adjuvant temozolomide and radiotherapy.  We report the final results with a median follow-up of more than 5 years.  Adult patients with newly diagnosed glioblastoma were randomly assigned to receive either std. radiotherapy or identical radiotherapy with concomitant temozolomide followed by up to six cycles of adjuvant temozolomide.  The methylation status of the methyl-guanine Me transferase gene, MGMT, was detd. retrospectively from the tumor tissue of 206 patients.  The primary endpoint was overall survival.  Analyses were by intention to treat.  This trial is registered with, no.  Between Aug 17, 2000, and March 22, 2002, 573 patients were assigned to treatment. 278 (97%) of 286 patients in the radiotherapy alone group and 254 (89%) of 287 in the combined-treatment group died during 5 years of follow-up.  Overall survival was 27.2% (95% CI 22.2-32.5) at 2 years, 16.0% (12.0-20.6) at 3 years, 12.1% (8.5-16.4) at 4 years, and 9.8% (6.4-14.0) at 5 years with temozolomide, vs. 10.9% (7.6-14.8), 4.4% (2.4-7.2), 3.0% (1.4-5.7), and 1.9% (0.6-4.4) with radiotherapy alone (hazard ratio 0.6, 95% CI 0.5-0.7; p<0.0001).  A benefit of combined therapy was recorded in all clin. prognostic subgroups, including patients aged 60-70 years.  Methylation of the MGMT promoter was the strongest predictor for outcome and benefit from temozolomide chemotherapy.  Benefits of adjuvant temozolomide with radiotherapy lasted throughout 5 years of follow-up.  A few patients in favorable prognostic categories survive longer than 5 years.  MGMT methylation status identifies patients most likely to benefit from the addn. of temozolomide.  Funding: EORTC, NCIC, Nelia and Amadeo Barletta Foundation, Schering-Plough.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodXEfj7tq5LLVg90H21EOLACvtfcHk0li1ONLxuvExKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVKhs74%253D&md5=5cc84038ab5ca34ce0f18049c053483b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2809%2970025-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252809%252970025-7%26sid%3Dliteratum%253Aachs%26aulast%3DStupp%26aufirst%3DR.%26aulast%3DHegi%26aufirst%3DM.%2BE.%26aulast%3DMason%26aufirst%3DW.%2BP.%26aulast%3Dvan%2Bden%2BBent%26aufirst%3DM.%2BJ.%26aulast%3DTaphoorn%26aufirst%3DM.%2BJ.%26aulast%3DJanzer%26aufirst%3DR.%2BC.%26aulast%3DLudwin%26aufirst%3DS.%2BK.%26aulast%3DAllgeier%26aufirst%3DA.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DBelanger%26aufirst%3DK.%26aulast%3DHau%26aufirst%3DP.%26aulast%3DBrandes%26aufirst%3DA.%2BA.%26aulast%3DGijtenbeek%26aufirst%3DJ.%26aulast%3DMarosi%26aufirst%3DC.%26aulast%3DVecht%26aufirst%3DC.%2BJ.%26aulast%3DMokhtari%26aufirst%3DK.%26aulast%3DWesseling%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DS.%26aulast%3DEisenhauer%26aufirst%3DE.%26aulast%3DGorlia%26aufirst%3DT.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DLacombe%26aufirst%3DD.%26aulast%3DCairncross%26aufirst%3DJ.%2BG.%26aulast%3DMirimanoff%26aufirst%3DR.%2BO.%26atitle%3DEffects%2520of%2520radiotherapy%2520with%2520concomitant%2520and%2520adjuvant%2520temozolomide%2520versus%2520radiotherapy%2520alone%2520on%2520survival%2520in%2520glioblastoma%2520in%2520a%2520randomised%2520phase%2520iii%2520study%253A%25205-year%2520analysis%2520of%2520the%2520eortc-ncic%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2009%26volume%3D10%26spage%3D459%26epage%3D466%26doi%3D10.1016%2FS1470-2045%2809%2970025-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Cuperlovic-Culf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Touaibia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Coeur, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poitras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culf, A. S.</span><span> </span><span class="NLM_article-title">Metabolic effects of known and novel hdac and sirt inhibitors in glioblastomas independently or combined with temozolomide</span> <span class="citation_source-journal">Metabolites</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span><span class="refDoi"> DOI: 10.3390/metabo4030807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.3390%2Fmetabo4030807" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=807-830&author=M.+Cuperlovic-Culfauthor=M.+Touaibiaauthor=P.+D.+St-Coeurauthor=J.+Poitrasauthor=P.+Morinauthor=A.+S.+Culf&title=Metabolic+effects+of+known+and+novel+hdac+and+sirt+inhibitors+in+glioblastomas+independently+or+combined+with+temozolomide&doi=10.3390%2Fmetabo4030807"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fmetabo4030807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmetabo4030807%26sid%3Dliteratum%253Aachs%26aulast%3DCuperlovic-Culf%26aufirst%3DM.%26aulast%3DTouaibia%26aufirst%3DM.%26aulast%3DSt-Coeur%26aufirst%3DP.%2BD.%26aulast%3DPoitras%26aufirst%3DJ.%26aulast%3DMorin%26aufirst%3DP.%26aulast%3DCulf%26aufirst%3DA.%2BS.%26atitle%3DMetabolic%2520effects%2520of%2520known%2520and%2520novel%2520hdac%2520and%2520sirt%2520inhibitors%2520in%2520glioblastomas%2520independently%2520or%2520combined%2520with%2520temozolomide%26jtitle%3DMetabolites%26date%3D2014%26volume%3D4%26spage%3D807%26epage%3D830%26doi%3D10.3390%2Fmetabo4030807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Folmer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlikova, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Naturally occurring regulators of histone acetylation/deacetylation</span> <span class="citation_source-journal">Curr. Nutr. Food Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.2174/157340110790909581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.2174%2F157340110790909581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXms1ansL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=78-99&author=F.+Folmerauthor=B.+Orlikovaauthor=M.+Schnekenburgerauthor=M.+Dicatoauthor=M.+Diederich&title=Naturally+occurring+regulators+of+histone+acetylation%2Fdeacetylation&doi=10.2174%2F157340110790909581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Naturally occurring regulators of histone acetylation/deacetylation</span></div><div class="casAuthors">Folmer, Florence; Orlikova, Barbora; Schnekenburger, Michael; Dicato, Mario; Diederich, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Current Nutrition & Food Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-99</span>CODEN:
                <span class="NLM_cas:coden">CNFSCQ</span>;
        ISSN:<span class="NLM_cas:issn">1573-4013</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Acetylation and deacetylation of lysine residues on histones, which are catalyzed by histone acetyltransferases (HATs) and histone deacetylases (HDACs), are epigenetic modifications that play a very important role in the regulation of gene transcription.  Perturbation of the balance between histone acetylation and deacetylation leads to a myriad of diseases, including cancer, AIDS, malaria, neurodegenerative diseases, and diabetes.  HATs and HDACs have recently been recognized as key targets for chemoprevention and drug discovery, and numerous natural and synthetic compds. have been screened in order to identify promising regulators of subtle balance between histone acetylation and deacetylation.  Here, we present dietary compds. and other natural products that have emerged as potent HAT or HDAC activity modulators, and we discuss their current and future applications as chemopreventive or therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsTjMuCy_GY7Vg90H21EOLACvtfcHk0liHyUtdMPTgiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXms1ansL4%253D&md5=fc66f2ee7dea84979bdf5c8d4303f5c1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F157340110790909581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157340110790909581%26sid%3Dliteratum%253Aachs%26aulast%3DFolmer%26aufirst%3DF.%26aulast%3DOrlikova%26aufirst%3DB.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DNaturally%2520occurring%2520regulators%2520of%2520histone%2520acetylation%252Fdeacetylation%26jtitle%3DCurr.%2520Nutr.%2520Food%2520Sci.%26date%3D2010%26volume%3D6%26spage%3D78%26epage%3D99%26doi%3D10.2174%2F157340110790909581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Seidel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Histone deacetylase modulators provided by mother nature</span> <span class="citation_source-journal">Genes Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1007/s12263-012-0283-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1007%2Fs12263-012-0283-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=22328271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFWgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=357-367&author=C.+Seidelauthor=M.+Schnekenburgerauthor=M.+Dicatoauthor=M.+Diederich&title=Histone+deacetylase+modulators+provided+by+mother+nature&doi=10.1007%2Fs12263-012-0283-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase modulators provided by Mother Nature</span></div><div class="casAuthors">Seidel, Carole; Schnekenburger, Michael; Dicato, Mario; Diederich, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Genes and Nutrition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-367</span>CODEN:
                <span class="NLM_cas:coden">GNEUAZ</span>;
        ISSN:<span class="NLM_cas:issn">1555-8932</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Protein acetylation status results from a balance between histone acetyltransferase and histone deacetylase (HDAC) activities.  Alteration of this balance leads to a disruption of cellular integrity and participates in the development of numerous diseases, including cancer.  Therefore, modulation of these activities appears to be a promising approach for anticancer therapy.  Histone deacetylase inhibitors (HDACi) are epigenetically active drugs that induce the hyperacetylation of lysine residues within histone and non-histone proteins, thus affecting gene expression and cellular processes such as protein-protein interactions, protein stability, DNA binding and protein sub-cellular localization.  Therefore, HDACi are promising anti-tumor agents as they may affect the cell cycle, inhibit proliferation, stimulate differentiation and induce apoptotic cell death.  Over the last 30 years, numerous synthetic and natural products, including a broad range of dietary compds., have been identified as HDACi.  This review focuses on mols. from natural origins modulating HDAC activities and presenting promising anticancer activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT709dfz24zbVg90H21EOLACvtfcHk0liOfp5rMUtSaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFWgu7w%253D&md5=9b6a9f9dce5e59164f16d7e9dc105a77</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs12263-012-0283-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12263-012-0283-9%26sid%3Dliteratum%253Aachs%26aulast%3DSeidel%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DHistone%2520deacetylase%2520modulators%2520provided%2520by%2520mother%2520nature%26jtitle%3DGenes%2520Nutr.%26date%3D2012%26volume%3D7%26spage%3D357%26epage%3D367%26doi%3D10.1007%2Fs12263-012-0283-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florean, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span><span class="refDoi"> DOI: 10.2174/1568026615666150825141330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.2174%2F1568026615666150825141330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=26303418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVGnsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=745-776&author=M.+Schnekenburgerauthor=C.+Floreanauthor=M.+Dicatoauthor=M.+Diederich&title=Epigenetic+alterations+as+a+universal+feature+of+cancer+hallmarks+and+a+promising+target+for+personalized+treatments&doi=10.2174%2F1568026615666150825141330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments</span></div><div class="casAuthors">Schnekenburger, Michael; Florean, Cristina; Dicato, Mario; Diederich, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">745-776</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Despite considerable scientific progress, the burden of cancer in our society remains a major public health problem.  Tumorigenesis is recognized as a complex and multistep process that involves the accumulation of successive transformational events with multi-factorial etiol.  Nevertheless, such events result in the acquisition of key hallmark characteristics that are shared by all cancer cells.  Accumulating evidence indicates that, besides genetic alterations, epigenetic mechanisms (heritable changes in gene expression caused by modifications in chromatin structure without alterations of DNA sequence) are implicated in the acquisition of malignant phenotype.  The potential reversibility of epigenetic alterations linked to tumorigenesis offers a promising avenue for therapeutic intervention.  This review focuses on the epigenetic regulation of the cancer hallmarks and the foreseeable use of epigenetic drugs to target these features as a promising strategy for anti-cancer therapy.  Based on this body of evidence, we believe that epigenetic deregulations can affect virtually all cell functions and therefore therapeutic approaches with epigenetic drugs could allow multi-target approach against the hallmarks of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3l2qKFb0VhbVg90H21EOLACvtfcHk0ljxBkZ7sOuSRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVGnsLnN&md5=0a0e44b061720bd1baff96e6e7365fa9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150825141330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150825141330%26sid%3Dliteratum%253Aachs%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DFlorean%26aufirst%3DC.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DEpigenetic%2520alterations%2520as%2520a%2520universal%2520feature%2520of%2520cancer%2520hallmarks%2520and%2520a%2520promising%2520target%2520for%2520personalized%2520treatments%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D745%26epage%3D776%26doi%3D10.2174%2F1568026615666150825141330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Seidel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florean, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Chromatin-modifying agents in anti-cancer therapy</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">2264</span><span class="NLM_x">–</span> <span class="NLM_lpage">2279</span><span class="refDoi"> DOI: 10.1016/j.biochi.2012.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.biochi.2012.05.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2012&pages=2264-2279&author=C.+Seidelauthor=C.+Floreanauthor=M.+Schnekenburgerauthor=M.+Dicatoauthor=M.+Diederich&title=Chromatin-modifying+agents+in+anti-cancer+therapy&doi=10.1016%2Fj.biochi.2012.05.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2012.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2012.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DSeidel%26aufirst%3DC.%26aulast%3DFlorean%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DChromatin-modifying%2520agents%2520in%2520anti-cancer%2520therapy%26jtitle%3DBiochimie%26date%3D2012%26volume%3D94%26spage%3D2264%26epage%3D2279%26doi%3D10.1016%2Fj.biochi.2012.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Mei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Y.</span><span> </span><span class="NLM_article-title">Sirtuins in metabolism, DNA repair and cancer</span> <span class="citation_source-journal">J. Exp. Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="refDoi"> DOI: 10.1186/s13046-016-0461-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1186%2Fs13046-016-0461-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=27916001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A280%3ADC%252BC2sjjtlSlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=182&author=Z.+Meiauthor=X.+Zhangauthor=J.+Yiauthor=J.+Huangauthor=J.+Heauthor=Y.+Tao&title=Sirtuins+in+metabolism%2C+DNA+repair+and+cancer&doi=10.1186%2Fs13046-016-0461-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuins in metabolism, DNA repair and cancer</span></div><div class="casAuthors">Mei Zhen; Zhang Xian; Yi Jiarong; Huang Junjie; He Jian; Tao Yongguang; Mei Zhen; Zhang Xian; Yi Jiarong; Huang Junjie; He Jian; Tao Yongguang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of experimental & clinical cancer research : CR</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The mammalian sirtuin family has attracted tremendous attention over the past few years as stress adaptors and post-translational modifier.  They have involved in diverse cellular processes including DNA repair, energy metabolism, and tumorigenesis.  Notably, genomic instability and metabolic reprogramming are two of characteristic hallmarks in cancer.  In this review, we summarize current knowledge on the functions of sirtuins mainly regarding DNA repair and energy metabolism, and further discuss the implication of sirtuins in cancer specifically by regulating genome integrity and cancer-related metabolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYJnknlDW2rny-c-E1v-fmfW6udTcc2eZIa5kAJpsbN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sjjtlSlsg%253D%253D&md5=86aa35b880235a56dacabc455d57cada</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1186%2Fs13046-016-0461-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-016-0461-5%26sid%3Dliteratum%253Aachs%26aulast%3DMei%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYi%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DTao%26aufirst%3DY.%26atitle%3DSirtuins%2520in%2520metabolism%252C%2520DNA%2520repair%2520and%2520cancer%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D35%26spage%3D182%26doi%3D10.1186%2Fs13046-016-0461-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Carafa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotili, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forgione, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuomo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serretiello, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hailu, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarho, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahtela-Kakkonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altucci, L.</span><span> </span><span class="NLM_article-title">Sirtuin functions and modulation: From chemistry to the clinic</span> <span class="citation_source-journal">Clin. Epigenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="refDoi"> DOI: 10.1186/s13148-016-0224-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1186%2Fs13148-016-0224-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=27226812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFKlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=61&author=V.+Carafaauthor=D.+Rotiliauthor=M.+Forgioneauthor=F.+Cuomoauthor=E.+Serretielloauthor=G.+S.+Hailuauthor=E.+Jarhoauthor=M.+Lahtela-Kakkonenauthor=A.+Maiauthor=L.+Altucci&title=Sirtuin+functions+and+modulation%3A+From+chemistry+to+the+clinic&doi=10.1186%2Fs13148-016-0224-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin functions and modulation: from chemistry to the clinic</span></div><div class="casAuthors">Carafa, Vincenzo; Rotili, Dante; Forgione, Mariantonietta; Cuomo, Francesca; Serretiello, Enrica; Hailu, Gebremedhin Solomon; Jarho, Elina; Lahtela-Kakkonen, Maija; Mai, Antonello; Altucci, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Epigenetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61/1-61/21</span>CODEN:
                <span class="NLM_cas:coden">CELPCI</span>;
        ISSN:<span class="NLM_cas:issn">1868-7083</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Sirtuins are NAD+-dependent histone deacetylases regulating important metabolic pathways in prokaryotes and eukaryotes and are involved in many biol. processes such as cell survival, senescence, proliferation, apoptosis, DNA repair, cell metab., and caloric restriction.  The seven members of this family of enzymes are considered potential targets for the treatment of human pathologies including neurodegenerative diseases, cardiovascular diseases, and cancer.  Furthermore, recent interest focusing on sirtuin modulators as epigenetic players in the regulation of fundamental biol. pathways has prompted increased efforts to discover new small mols. able to modify sirtuin activity.  Here, we review the role, mechanism of action, and biol. function of the seven sirtuins, as well as their inhibitors and activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIH3R2LEVdxLVg90H21EOLACvtfcHk0lhRO82443_M9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFKlsbY%253D&md5=67fd293f52235a36c45acdbcdca540bf</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1186%2Fs13148-016-0224-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13148-016-0224-3%26sid%3Dliteratum%253Aachs%26aulast%3DCarafa%26aufirst%3DV.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DForgione%26aufirst%3DM.%26aulast%3DCuomo%26aufirst%3DF.%26aulast%3DSerretiello%26aufirst%3DE.%26aulast%3DHailu%26aufirst%3DG.%2BS.%26aulast%3DJarho%26aufirst%3DE.%26aulast%3DLahtela-Kakkonen%26aufirst%3DM.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DAltucci%26aufirst%3DL.%26atitle%3DSirtuin%2520functions%2520and%2520modulation%253A%2520From%2520chemistry%2520to%2520the%2520clinic%26jtitle%3DClin.%2520Epigenet.%26date%3D2016%26volume%3D8%26spage%3D61%26doi%3D10.1186%2Fs13148-016-0224-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Peck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fruscia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myatt, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, E. W.</span><span> </span><span class="NLM_article-title">Sirt inhibitors induce cell death and p53 acetylation through targeting both sirt1 and sirt2</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1158%2F1535-7163.MCT-09-0971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=20371709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlCqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=844-855&author=B.+Peckauthor=C.+Y.+Chenauthor=K.+K.+Hoauthor=P.+Di+Frusciaauthor=S.+S.+Myattauthor=R.+C.+Coombesauthor=M.+J.+Fuchterauthor=C.+D.+Hsiaoauthor=E.+W.+Lam&title=Sirt+inhibitors+induce+cell+death+and+p53+acetylation+through+targeting+both+sirt1+and+sirt2&doi=10.1158%2F1535-7163.MCT-09-0971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2</span></div><div class="casAuthors">Peck, Barrie; Chen, Chun-Yuan; Ho, Ka-Kei; Di Fruscia, Paolo; Myatt, Stephen S.; Coombes, R. Charles; Fuchter, Matthew J.; Hsiao, Chwan-Deng; Lam, Eric W.-F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">844-855</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">SIRT proteins play an important role in the survival and drug resistance of tumor cells, esp. during chemotherapy.  In this study, we investigated the potency, specificity, and cellular targets of three SIRT inhibitors, Sirtinol, Salermide, and EX527.  Cell proliferative and cell cycle analyses showed that Sirtinol and Salermide, but not EX527, were effective in inducing cell death at concns. of 50 μmol/L or over in MCF-7 cells.  Instead, EX527 caused cell cycle arrest at G1 at comparable concns.  In vitro SIRT assays using a p53 peptide substrate showed that all three compds. are potent SIRT1/2 inhibitors, with EX527 having the highest inhibitory activity for SIRT1.  Computational docking anal. showed that Sirtinol and Salermide have high degrees of selectivity for SIRT1/2, whereas EX527 has high specificity for SIRT1 but not SIRT2.  Consistently, Sirtinol and Salermide, but not EX527, treatment resulted in the in vivo acetylation of the SIRT1/2 target p53 and SIRT2 target tubulin in MCF-7 cells, suggesting that EX527 is ineffective in inhibiting SIRT2 and that p53 mediates the cytotoxic function of Sirtinol and Salermide.  Studies using breast carcinoma cell lines and p53-deficient mouse fibroblasts confirmed that p53 is essential for the Sirtinol and Salermide-induced apoptosis.  Further, we showed using small interfering RNA that silencing both SIRTs, but not SIRT1 and SIRT2 individually, can induce cell death in MCF-7 cells.  Together, our results identify the specificity and cellular targets of these novel inhibitors and suggest that SIRT inhibitors require combined targeting of both SIRT1 and SIRT2 to induce p53 acetylation and cell death.  Mol Cancer Ther; 9(4); 844-55.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruOOb1TBGW47Vg90H21EOLACvtfcHk0li9Csk_FuM-gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlCqt74%253D&md5=d2cf2c3adb9d6218c94ad143011082bd</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0971%26sid%3Dliteratum%253Aachs%26aulast%3DPeck%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DHo%26aufirst%3DK.%2BK.%26aulast%3DDi%2BFruscia%26aufirst%3DP.%26aulast%3DMyatt%26aufirst%3DS.%2BS.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26aulast%3DFuchter%26aufirst%3DM.%2BJ.%26aulast%3DHsiao%26aufirst%3DC.%2BD.%26aulast%3DLam%26aufirst%3DE.%2BW.%26atitle%3DSirt%2520inhibitors%2520induce%2520cell%2520death%2520and%2520p53%2520acetylation%2520through%2520targeting%2520both%2520sirt1%2520and%2520sirt2%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D844%26epage%3D855%26doi%3D10.1158%2F1535-7163.MCT-09-0971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sakkiah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arooj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eom, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. W.</span><span> </span><span class="NLM_article-title">Identification of inhibitor binding site in human sirtuin 2 using molecular docking and dynamics simulations</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e51429</span><span class="refDoi"> DOI: 10.1371/journal.pone.0051429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1371%2Fjournal.pone.0051429" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e51429&author=S.+Sakkiahauthor=M.+Aroojauthor=M.+R.+Kumarauthor=S.+H.+Eomauthor=K.+W.+Lee&title=Identification+of+inhibitor+binding+site+in+human+sirtuin+2+using+molecular+docking+and+dynamics+simulations&doi=10.1371%2Fjournal.pone.0051429"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0051429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0051429%26sid%3Dliteratum%253Aachs%26aulast%3DSakkiah%26aufirst%3DS.%26aulast%3DArooj%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DM.%2BR.%26aulast%3DEom%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DK.%2BW.%26atitle%3DIdentification%2520of%2520inhibitor%2520binding%2520site%2520in%2520human%2520sirtuin%25202%2520using%2520molecular%2520docking%2520and%2520dynamics%2520simulations%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De51429%26doi%3D10.1371%2Fjournal.pone.0051429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Trapp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jochum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goekjian, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Adenosine mimetics as inhibitors of nad+-dependent histone deacetylases, from kinase to sirtuin inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7307</span><span class="NLM_x">–</span> <span class="NLM_lpage">7316</span><span class="refDoi"> DOI: 10.1021/jm060118b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060118b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2it7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7307-7316&author=J.+Trappauthor=A.+Jochumauthor=R.+Meierauthor=L.+Saundersauthor=B.+Marshallauthor=C.+Kunickauthor=E.+Verdinauthor=P.+Goekjianauthor=W.+Sipplauthor=M.+Jung&title=Adenosine+mimetics+as+inhibitors+of+nad%2B-dependent+histone+deacetylases%2C+from+kinase+to+sirtuin+inhibition&doi=10.1021%2Fjm060118b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine Mimetics as Inhibitors of NAD+-Dependent Histone Deacetylases, from Kinase to Sirtuin Inhibition</span></div><div class="casAuthors">Trapp, Johannes; Jochum, Anne; Meier, Rene; Saunders, Laura; Marshall, Brett; Kunick, Conrad; Verdin, Eric; Goekjian, Peter; Sippl, Wolfgang; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7307-7316</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">NAD+-dependent histone deacetylases, sirtuins, cleave acetyl groups from lysines of histones and other proteins to regulate their activity.  Identification of potent selective inhibitors would help to elucidate sirtuin biol. and could lead to useful therapeutic agents.  NAD+ has an adenosine moiety that is also present in the kinase cofactor ATP.  Kinase inhibitors based upon adenosine mimesis may thus also target NAD+-dependent enzymes.  We present a systematic approach using adenosine mimics from one cofactor class (kinase inhibitors) as a viable method to generate new lead structures in another cofactor class (sirtuin inhibitors).  Our findings have broad implications for medicinal chem. and specifically for sirtuin inhibitor design.  Our results also raise a question as to whether selectivity profiling for kinase inhibitors should be limited to ATP-dependent targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsPuIQW02_4bVg90H21EOLACvtfcHk0lhwoHCP2_Q6UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2it7fL&md5=ed26cd66275abf4366d650a2d30e2f4f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm060118b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060118b%26sid%3Dliteratum%253Aachs%26aulast%3DTrapp%26aufirst%3DJ.%26aulast%3DJochum%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DR.%26aulast%3DSaunders%26aufirst%3DL.%26aulast%3DMarshall%26aufirst%3DB.%26aulast%3DKunick%26aufirst%3DC.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DGoekjian%26aufirst%3DP.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DAdenosine%2520mimetics%2520as%2520inhibitors%2520of%2520nad%252B-dependent%2520histone%2520deacetylases%252C%2520from%2520kinase%2520to%2520sirtuin%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7307%26epage%3D7316%26doi%3D10.1021%2Fjm060118b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Medda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slawin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, N. J.</span><span> </span><span class="NLM_article-title">Novel cambinol analogs as sirtuin inhibitors: Synthesis, biological evaluation, and rationalization of activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2673</span><span class="NLM_x">–</span> <span class="NLM_lpage">2682</span><span class="refDoi"> DOI: 10.1021/jm8014298</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8014298" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFKltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2673-2682&author=F.+Meddaauthor=R.+J.+Russellauthor=M.+Higginsauthor=A.+R.+McCarthyauthor=J.+Campbellauthor=A.+M.+Slawinauthor=D.+P.+Laneauthor=S.+Lainauthor=N.+J.+Westwood&title=Novel+cambinol+analogs+as+sirtuin+inhibitors%3A+Synthesis%2C+biological+evaluation%2C+and+rationalization+of+activity&doi=10.1021%2Fjm8014298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Cambinol Analogs as Sirtuin Inhibitors: Synthesis, Biological Evaluation, and Rationalization of Activity</span></div><div class="casAuthors">Medda, Federico; Russell, Rupert J. M.; Higgins, Maureen; McCarthy, Anna R.; Campbell, Johanna; Slawin, Alexandra M. Z.; Lane, David P.; Lain, Sonia; Westwood, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2673-2682</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The tenovins and cambinol are two classes of sirtuin inhibitor that exhibit antitumor activity in preclin. models.  This report describes modifications to the core structure of cambinol, in particular by incorporation of substituents at the N1-position, which lead to increased potency and modified selectivity.  These improvements have been rationalized using mol. modeling techniques.  The expected functional selectivity in cells was also obsd. for both a SIRT1 and a SIRT2 selective analog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEkyITsDCBvbVg90H21EOLACvtfcHk0li-AvT09PvZbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFKltbo%253D&md5=9080cf969afe9433ad20514c281298af</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm8014298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014298%26sid%3Dliteratum%253Aachs%26aulast%3DMedda%26aufirst%3DF.%26aulast%3DRussell%26aufirst%3DR.%2BJ.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DMcCarthy%26aufirst%3DA.%2BR.%26aulast%3DCampbell%26aufirst%3DJ.%26aulast%3DSlawin%26aufirst%3DA.%2BM.%26aulast%3DLane%26aufirst%3DD.%2BP.%26aulast%3DLain%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DN.%2BJ.%26atitle%3DNovel%2520cambinol%2520analogs%2520as%2520sirtuin%2520inhibitors%253A%2520Synthesis%252C%2520biological%2520evaluation%252C%2520and%2520rationalization%2520of%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2673%26epage%3D2682%26doi%3D10.1021%2Fjm8014298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Outeiro, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontopoulos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmann, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strathearn, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amore, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feany, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazantsev, A. G.</span><span> </span><span class="NLM_article-title">Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span><span class="refDoi"> DOI: 10.1126/science.1143780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1126%2Fscience.1143780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=17588900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFylurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=516-519&author=T.+F.+Outeiroauthor=E.+Kontopoulosauthor=S.+M.+Altmannauthor=I.+Kufarevaauthor=K.+E.+Strathearnauthor=A.+M.+Amoreauthor=C.+B.+Volkauthor=M.+M.+Maxwellauthor=J.+C.+Rochetauthor=P.+J.+McLeanauthor=A.+B.+Youngauthor=R.+Abagyanauthor=M.+B.+Feanyauthor=B.+T.+Hymanauthor=A.+G.+Kazantsev&title=Sirtuin+2+inhibitors+rescue+alpha-synuclein-mediated+toxicity+in+models+of+Parkinson%E2%80%99s+disease&doi=10.1126%2Fscience.1143780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease</span></div><div class="casAuthors">Outeiro, Tiago Fleming; Kontopoulos, Eirene; Altmann, Stephen M.; Kufareva, Irina; Strathearn, Katherine E.; Amore, Allison M.; Volk, Catherine B.; Maxwell, Michele M.; Rochet, Jean-Christophe; McLean, Pamela J.; Young, Anne B.; Abagyan, Ruben; Feany, Mel B.; Hyman, Bradley T.; Kazantsev, Aleksey G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5837</span>),
    <span class="NLM_cas:pages">516-519</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The sirtuins are members of the histone deacetylase family of proteins that participate in a variety of cellular functions and play a role in aging.  We identified a potent inhibitor of sirtuin 2 (SIRT2) and found that inhibition of SIRT2 rescued α-synuclein toxicity and modified inclusion morphol. in a cellular model of Parkinson's disease.  Genetic inhibition of SIRT2 via small interfering RNA similarly rescued α-synuclein toxicity.  Furthermore, the inhibitors protected against dopaminergic cell death both in vitro and in a Drosophila model of Parkinson's disease.  The results suggest a link between neurodegeneration and aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm5psHCGzkkLVg90H21EOLACvtfcHk0lh7SCmhKO83rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFylurs%253D&md5=4b8914c34ad0f45fb51b94701609bfa6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.1143780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1143780%26sid%3Dliteratum%253Aachs%26aulast%3DOuteiro%26aufirst%3DT.%2BF.%26aulast%3DKontopoulos%26aufirst%3DE.%26aulast%3DAltmann%26aufirst%3DS.%2BM.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DStrathearn%26aufirst%3DK.%2BE.%26aulast%3DAmore%26aufirst%3DA.%2BM.%26aulast%3DVolk%26aufirst%3DC.%2BB.%26aulast%3DMaxwell%26aufirst%3DM.%2BM.%26aulast%3DRochet%26aufirst%3DJ.%2BC.%26aulast%3DMcLean%26aufirst%3DP.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BB.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DFeany%26aufirst%3DM.%2BB.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DKazantsev%26aufirst%3DA.%2BG.%26atitle%3DSirtuin%25202%2520inhibitors%2520rescue%2520alpha-synuclein-mediated%2520toxicity%2520in%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D516%26epage%3D519%26doi%3D10.1126%2Fscience.1143780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kim, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, S. G.</span><span> </span><span class="NLM_article-title">Sirtuin inhibitors, ex527 and agk2, suppress cell migration by inhibiting hsf1 protein stability</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.3892/or.2015.4381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.3892%2For.2015.4381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=26530275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=235-242&author=H.+W.+Kimauthor=S.+A.+Kimauthor=S.+G.+Ahn&title=Sirtuin+inhibitors%2C+ex527+and+agk2%2C+suppress+cell+migration+by+inhibiting+hsf1+protein+stability&doi=10.3892%2For.2015.4381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin inhibitors, EX527 and AGK2, suppress cell migration by inhibiting HSF1 protein stability</span></div><div class="casAuthors">Kim, Hyun-Woo; Kim, Soo-A.; Ahn, Sang-Gun</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1791-2431</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The histone deacetylases (HDACs), Sirtuin 1 (Sirt1) and Sirt2, play crucial roles in many biol. processes, including cell proliferation, differentiation and apoptosis.  HDAC inhibitors have been considered as a potential therapeutic approach for various types of cancers.  Here, we demonstrated that the Sirt1 and Sirt2 inhibitors EX527 and AGK2 suppressed cell growth and caused G1 phase arrest by inhibiting the expression of Cdk6 and/or Cdk4.  An agar colony formation assay revealed that EX527 and AGK2 decreased colony formation in soft agar.  Furthermore, EX527 and AGK2 pretreatment inhibited the expression of HSF1 and HSP27 and induced HSF1 ubiquitination.  Sirt1 overexpression increased HSF1 expression and/or stabilization and induced cell migration in a scratch assay.  Overall, these results indicate that EX527 and AGK2 suppress cell growth and migration by inhibiting HSF1 protein stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS8CqhdC4wHbVg90H21EOLACvtfcHk0lj7ClQyYQxdCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslCrsg%253D%253D&md5=6d9a62fb1129aeab09dca40f2f124412</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3892%2For.2015.4381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2015.4381%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BW.%26aulast%3DKim%26aufirst%3DS.%2BA.%26aulast%3DAhn%26aufirst%3DS.%2BG.%26atitle%3DSirtuin%2520inhibitors%252C%2520ex527%2520and%2520agk2%252C%2520suppress%2520cell%2520migration%2520by%2520inhibiting%2520hsf1%2520protein%2520stability%26jtitle%3DOncol.%2520Rep.%26date%3D2016%26volume%3D35%26spage%3D235%26epage%3D242%26doi%3D10.3892%2For.2015.4381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Florence, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dilly, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Tullio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirotte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebrun, P.</span><span> </span><span class="NLM_article-title">Modulation of the 6-position of benzopyran derivatives and inhibitory effects on the insulin releasing process</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3919</span><span class="NLM_x">–</span> <span class="NLM_lpage">3928</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.05.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.bmc.2011.05.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3919-3928&author=X.+Florenceauthor=S.+Dillyauthor=P.+de+Tullioauthor=B.+Pirotteauthor=P.+Lebrun&title=Modulation+of+the+6-position+of+benzopyran+derivatives+and+inhibitory+effects+on+the+insulin+releasing+process&doi=10.1016%2Fj.bmc.2011.05.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DFlorence%26aufirst%3DX.%26aulast%3DDilly%26aufirst%3DS.%26aulast%3Dde%2BTullio%26aufirst%3DP.%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DLebrun%26aufirst%3DP.%26atitle%3DModulation%2520of%2520the%25206-position%2520of%2520benzopyran%2520derivatives%2520and%2520inhibitory%2520effects%2520on%2520the%2520insulin%2520releasing%2520process%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3919%26epage%3D3928%26doi%3D10.1016%2Fj.bmc.2011.05.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Khelili, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florence, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhadja, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelaziz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechouch, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Tullio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebrun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirotte, B.</span><span> </span><span class="NLM_article-title">Synthesis and activity on rat aorta rings and rat pancreatic beta-cells of ring-opened analogues of benzopyran-type potassium channel activators</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6124</span><span class="NLM_x">–</span> <span class="NLM_lpage">6130</span><span class="refDoi"> DOI: 10.1016/j.bmc.2008.04.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.bmc.2008.04.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=6124-6130&author=S.+Kheliliauthor=X.+Florenceauthor=M.+Bouhadjaauthor=S.+Abdelazizauthor=N.+Mechouchauthor=Y.+Mohamedauthor=P.+de+Tullioauthor=P.+Lebrunauthor=B.+Pirotte&title=Synthesis+and+activity+on+rat+aorta+rings+and+rat+pancreatic+beta-cells+of+ring-opened+analogues+of+benzopyran-type+potassium+channel+activators&doi=10.1016%2Fj.bmc.2008.04.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.04.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.04.043%26sid%3Dliteratum%253Aachs%26aulast%3DKhelili%26aufirst%3DS.%26aulast%3DFlorence%26aufirst%3DX.%26aulast%3DBouhadja%26aufirst%3DM.%26aulast%3DAbdelaziz%26aufirst%3DS.%26aulast%3DMechouch%26aufirst%3DN.%26aulast%3DMohamed%26aufirst%3DY.%26aulast%3Dde%2BTullio%26aufirst%3DP.%26aulast%3DLebrun%26aufirst%3DP.%26aulast%3DPirotte%26aufirst%3DB.%26atitle%3DSynthesis%2520and%2520activity%2520on%2520rat%2520aorta%2520rings%2520and%2520rat%2520pancreatic%2520beta-cells%2520of%2520ring-opened%2520analogues%2520of%2520benzopyran-type%2520potassium%2520channel%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D6124%26epage%3D6130%26doi%3D10.1016%2Fj.bmc.2008.04.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruwge, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strambi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Milito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodin, B.</span><span> </span><span class="NLM_article-title">Sirt1 and sirt2 inhibition impairs pediatric soft tissue sarcoma growth</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1483</span><span class="refDoi"> DOI: 10.1038/cddis.2014.385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1038%2Fcddis.2014.385" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1483&author=L.+Maauthor=W.+Maruwgeauthor=A.+Strambiauthor=P.+D%E2%80%99Arcyauthor=P.+Pellegriniauthor=L.+Kisauthor=A.+de+Militoauthor=S.+Lainauthor=B.+Brodin&title=Sirt1+and+sirt2+inhibition+impairs+pediatric+soft+tissue+sarcoma+growth&doi=10.1038%2Fcddis.2014.385"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.385%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DMaruwge%26aufirst%3DW.%26aulast%3DStrambi%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DPellegrini%26aufirst%3DP.%26aulast%3DKis%26aufirst%3DL.%26aulast%3Dde%2BMilito%26aufirst%3DA.%26aulast%3DLain%26aufirst%3DS.%26aulast%3DBrodin%26aufirst%3DB.%26atitle%3DSirt1%2520and%2520sirt2%2520inhibition%2520impairs%2520pediatric%2520soft%2520tissue%2520sarcoma%2520growth%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1483%26doi%3D10.1038%2Fcddis.2014.385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Trott, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">Autodock vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span><span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=Autodock+vina%3A+Improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0likNGcXcD7CLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutodock%2520vina%253A%2520Improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Rumpf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiedel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karaman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roessler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehotzky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladwein, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidtkunz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steegborn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovadi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einsle, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Selective sirt2 inhibition by ligand-induced rearrangement of the active site</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">6263</span><span class="refDoi"> DOI: 10.1038/ncomms7263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1038%2Fncomms7263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=25672491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFemsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6263&author=T.+Rumpfauthor=M.+Schiedelauthor=B.+Karamanauthor=C.+Roesslerauthor=B.+J.+Northauthor=A.+Lehotzkyauthor=J.+Olahauthor=K.+I.+Ladweinauthor=K.+Schmidtkunzauthor=M.+Gajerauthor=M.+Pannekauthor=C.+Steegbornauthor=D.+A.+Sinclairauthor=S.+Gerhardtauthor=J.+Ovadiauthor=M.+Schutkowskiauthor=W.+Sipplauthor=O.+Einsleauthor=M.+Jung&title=Selective+sirt2+inhibition+by+ligand-induced+rearrangement+of+the+active+site&doi=10.1038%2Fncomms7263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Sirt2 inhibition by ligand-induced rearrangement of the active site</span></div><div class="casAuthors">Rumpf, Tobias; Schiedel, Matthias; Karaman, Berin; Roessler, Claudia; North, Brian J.; Lehotzky, Attila; Olah, Judit; Ladwein, Kathrin I.; Schmidtkunz, Karin; Gajer, Markus; Pannek, Martin; Steegborn, Clemens; Sinclair, David A.; Gerhardt, Stefan; Ovadi, Judit; Schutkowski, Mike; Sippl, Wolfgang; Einsle, Oliver; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6263</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sirtuins are a highly conserved class of NAD-dependent lysine deacylases.  Human isotype Sirt2 has been implicated in the pathogenesis of cancer, inflammation, and neurodegeneration, which makes the modulation of Sirt2 activity a promising strategy for pharmaceutical intervention.  However, a rational basis for the development of optimized Sirt2 inhibitors is lacking so far.  Here, the authors present high-resoln. structures of human Sirt2 in complex with highly selective drug-like inhibitors that show a unique inhibitory mechanism.  The potency and the unprecedented Sirt2 selectivity were based on a ligand-induced structural rearrangement of the active site unveiling a yet-unexploited binding pocket.  The application of the most potent sirtuin-rearranging ligand, termed SirReal2, led to tubulin hyperacetylation in HeLa cells and induced destabilization of checkpoint protein BubR1, consistent with Sirt2 inhibition in vivo.  The structural insights into this unique mechanism of selective sirtuin inhibition provide the basis for further inhibitor development and selective tools for sirtuin biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN2LzipheDFLVg90H21EOLACvtfcHk0litGBdgUMnBng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFemsr4%253D&md5=bc3c61af5e456f4483746a588db91643</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fncomms7263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms7263%26sid%3Dliteratum%253Aachs%26aulast%3DRumpf%26aufirst%3DT.%26aulast%3DSchiedel%26aufirst%3DM.%26aulast%3DKaraman%26aufirst%3DB.%26aulast%3DRoessler%26aufirst%3DC.%26aulast%3DNorth%26aufirst%3DB.%2BJ.%26aulast%3DLehotzky%26aufirst%3DA.%26aulast%3DOlah%26aufirst%3DJ.%26aulast%3DLadwein%26aufirst%3DK.%2BI.%26aulast%3DSchmidtkunz%26aufirst%3DK.%26aulast%3DGajer%26aufirst%3DM.%26aulast%3DPannek%26aufirst%3DM.%26aulast%3DSteegborn%26aufirst%3DC.%26aulast%3DSinclair%26aufirst%3DD.%2BA.%26aulast%3DGerhardt%26aufirst%3DS.%26aulast%3DOvadi%26aufirst%3DJ.%26aulast%3DSchutkowski%26aufirst%3DM.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DEinsle%26aufirst%3DO.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DSelective%2520sirt2%2520inhibition%2520by%2520ligand-induced%2520rearrangement%2520of%2520the%2520active%2520site%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D6263%26doi%3D10.1038%2Fncomms7263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Moniot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steegborn, C.</span><span> </span><span class="NLM_article-title">Crystal structure analysis of human sirt2 and its adp-ribose complex</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span><span class="refDoi"> DOI: 10.1016/j.jsb.2013.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.jsb.2013.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=23454361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlGhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2013&pages=136-143&author=S.+Moniotauthor=M.+Schutkowskiauthor=C.+Steegborn&title=Crystal+structure+analysis+of+human+sirt2+and+its+adp-ribose+complex&doi=10.1016%2Fj.jsb.2013.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure analysis of human Sirt2 and its ADP-ribose complex</span></div><div class="casAuthors">Moniot, Sebastien; Schutkowski, Mike; Steegborn, Clemens</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Structural Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">136-143</span>CODEN:
                <span class="NLM_cas:coden">JSBIEM</span>;
        ISSN:<span class="NLM_cas:issn">1047-8477</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Sirtuins are NAD+-dependent protein deacetylases that regulate metab. and aging-related processes.  Sirt2 is the only cytoplasmic isoform among the seven mammalian Sirtuins (Sirt1-7) and structural information concerning this isoform is limited.  The authors crystd. Sirt2 in complex with a product analog, ADP-ribose, and solved this first crystal structure of a Sirt2 ligand complex at 2.3 Å resoln.  Addnl., the authors re-refined the structure of the Sirt2 apoform and analyzed the conformational changes assocd. with ligand binding to derive insights into the dynamics of the enzyme.  The authors' analyses also provide information on Sirt2 peptide substrate binding and structural states of a Sirt2-specific protein region, and the authors' insights and the novel Sirt2 crystal form provide helpful tools for the development of Sirt2 specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW7XI0QpfrLVg90H21EOLACvtfcHk0lhMjPUZtauN4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlGhtLs%253D&md5=caae1bfc3feaf3766bf55e5dd84d2700</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.jsb.2013.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsb.2013.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DMoniot%26aufirst%3DS.%26aulast%3DSchutkowski%26aufirst%3DM.%26aulast%3DSteegborn%26aufirst%3DC.%26atitle%3DCrystal%2520structure%2520analysis%2520of%2520human%2520sirt2%2520and%2520its%2520adp-ribose%2520complex%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2013%26volume%3D182%26spage%3D136%26epage%3D143%26doi%3D10.1016%2Fj.jsb.2013.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Finnin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donigian, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structure of the histone deacetylase sirt2</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span><span class="refDoi"> DOI: 10.1038/89668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1038%2F89668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=11427894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvFCrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=621-625&author=M.+S.+Finninauthor=J.+R.+Donigianauthor=N.+P.+Pavletich&title=Structure+of+the+histone+deacetylase+sirt2&doi=10.1038%2F89668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the histone deacetylase SIRT2</span></div><div class="casAuthors">Finnin, Michael S.; Donigian, Jill R.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">621-625</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Sir2 is an NAD-dependent histone deacetylase that mediates transcriptional silencing at mating-type loci, telomeres, and ribosomal gene clusters, and plays a crit. role in the detn. of life span in yeast and Caenorhabditis elegans.  Here, the 1.7 Å crystal structure of the 323-amino-acid catalytic core of human SIRT2, a homolog of yeast Sir2, revealed an NAD-binding domain, which was a variant of the Rossmann fold, and a smaller domain composed of a helical module and a Zn-binding module.  A conserved large groove at the interface of the 2 domains was the likely site of catalysis based on mutagenesis.  Intersecting this large groove, there was a pocket formed by the helical module.  The pocket was lined with hydrophobic residues conserved within each of the 5 Sir2 classes, suggesting that it is a class-specific protein-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDNi1R8KPeQ7Vg90H21EOLACvtfcHk0lhhh3z76W1fFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvFCrtLs%253D&md5=6d305c420bff2690da780fc23938c22f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2F89668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F89668%26sid%3Dliteratum%253Aachs%26aulast%3DFinnin%26aufirst%3DM.%2BS.%26aulast%3DDonigian%26aufirst%3DJ.%2BR.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520the%2520histone%2520deacetylase%2520sirt2%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D621%26epage%3D625%26doi%3D10.1038%2F89668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Schiedel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumpf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karaman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehotzky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovadi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einsle, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Aminothiazoles as potent and selective sirt2 inhibitors: A structure-activity relationship study</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1599</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01517</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01517" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrs73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1599-1612&author=M.+Schiedelauthor=T.+Rumpfauthor=B.+Karamanauthor=A.+Lehotzkyauthor=J.+Olahauthor=S.+Gerhardtauthor=J.+Ovadiauthor=W.+Sipplauthor=O.+Einsleauthor=M.+Jung&title=Aminothiazoles+as+potent+and+selective+sirt2+inhibitors%3A+A+structure-activity+relationship+study&doi=10.1021%2Facs.jmedchem.5b01517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study</span></div><div class="casAuthors">Schiedel, Matthias; Rumpf, Tobias; Karaman, Berin; Lehotzky, Attila; Olah, Judit; Gerhardt, Stefan; Ovadi, Judit; Sippl, Wolfgang; Einsle, Oliver; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1599-1612</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sirtuins are NAD+-dependent protein deacylases that cleave off acetyl but also other acyl groups from the ε-amino group of lysines in histones and other substrate proteins.  Dysregulation of human Sirt2 (hSirt2) activity has been assocd. with the pathogenesis of cancer, inflammation, and neurodegeneration, which makes the modulation of hSirt2 activity a promising strategy for pharmaceutical intervention.  The sirtuin rearranging ligands (SirReals) have recently been discovered by us as highly potent and isotype-selective hSirt2 inhibitors.  Here, we present a well-defined structure-activity relationship study, which rationalizes the unique features of the SirReals and probes the limits of modifications on this scaffold regarding inhibitor potency.  Moreover, we present a crystal structure of hSirt2 in complex with an optimized SirReal deriv. that exhibits an improved in vitro activity.  Lastly, we show cellular hyperacetylation of the hSirt2 targeted tubulin caused by our improved lead structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow3tFNLizRV7Vg90H21EOLACvtfcHk0li2mdoUHS5i5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrs73K&md5=4e912cc141b51655833799beaacb630b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01517%26sid%3Dliteratum%253Aachs%26aulast%3DSchiedel%26aufirst%3DM.%26aulast%3DRumpf%26aufirst%3DT.%26aulast%3DKaraman%26aufirst%3DB.%26aulast%3DLehotzky%26aufirst%3DA.%26aulast%3DOlah%26aufirst%3DJ.%26aulast%3DGerhardt%26aufirst%3DS.%26aulast%3DOvadi%26aufirst%3DJ.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DEinsle%26aufirst%3DO.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DAminothiazoles%2520as%2520potent%2520and%2520selective%2520sirt2%2520inhibitors%253A%2520A%2520structure-activity%2520relationship%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1599%26epage%3D1612%26doi%3D10.1021%2Facs.jmedchem.5b01517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Davenport, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelz, A.</span><span> </span><span class="NLM_article-title">Structural and functional analysis of human sirt1</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span><span class="refDoi"> DOI: 10.1016/j.jmb.2013.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.jmb.2013.10.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2014&pages=526-541&author=A.+M.+Davenportauthor=F.+M.+Huberauthor=A.+Hoelz&title=Structural+and+functional+analysis+of+human+sirt1&doi=10.1016%2Fj.jmb.2013.10.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2013.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2013.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DDavenport%26aufirst%3DA.%2BM.%26aulast%3DHuber%26aufirst%3DF.%2BM.%26aulast%3DHoelz%26aufirst%3DA.%26atitle%3DStructural%2520and%2520functional%2520analysis%2520of%2520human%2520sirt1%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D426%26spage%3D526%26epage%3D541%26doi%3D10.1016%2Fj.jmb.2013.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Dai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riera, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Considine, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamuro, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweitzer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disch, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczepankiewicz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oalmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee Ng, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casaubon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koppetsch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbonais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlasuk, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. L.</span><span> </span><span class="NLM_article-title">Crystallographic structure of a small molecule sirt1 activator-enzyme complex</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">7645</span><span class="refDoi"> DOI: 10.1038/ncomms8645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1038%2Fncomms8645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=26134520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A280%3ADC%252BC28%252Fgs1WqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=7645&author=H.+Daiauthor=A.+W.+Caseauthor=T.+V.+Rieraauthor=T.+Considineauthor=J.+E.+Leeauthor=Y.+Hamuroauthor=H.+Zhaoauthor=Y.+Jiangauthor=S.+M.+Sweitzerauthor=B.+Pietrakauthor=B.+Schwartzauthor=C.+A.+Blumauthor=J.+S.+Dischauthor=R.+Caldwellauthor=B.+Szczepankiewiczauthor=C.+Oalmannauthor=P.+Yee+Ngauthor=B.+H.+Whiteauthor=R.+Casaubonauthor=R.+Narayanauthor=K.+Koppetschauthor=F.+Bourbonaisauthor=B.+Wuauthor=J.+Wangauthor=D.+Qianauthor=F.+Jiangauthor=C.+Maoauthor=M.+Wangauthor=E.+Huauthor=J.+C.+Wuauthor=R.+B.+Perniauthor=G.+P.+Vlasukauthor=J.+L.+Ellis&title=Crystallographic+structure+of+a+small+molecule+sirt1+activator-enzyme+complex&doi=10.1038%2Fncomms8645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic structure of a small molecule SIRT1 activator-enzyme complex</span></div><div class="casAuthors">Dai Han; Ellis James L; Case April W; Riera Thomas V; Considine Thomas; Blum Charles A; Disch Jeremy S; Caldwell Richard; Szczepankiewicz Bruce; Oalmann Christopher; Yee Ng Pui; White Brian H; Casaubon Rebecca; Narayan Radha; Koppetsch Karsten; Bourbonais Francis; Wu Joe C; Perni Robert B; Vlasuk George P; Lee Jessica E; Hamuro Yoshitomo; Zhao Huizhen; Jiang Yong; Sweitzer Sharon M; Pietrak Beth; Schwartz Benjamin; Wang Minghui; Hu Erding; Wu Bo; Wang Junfeng; Qian Dongming; Jiang Fan; Mao Cheney</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7645</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">SIRT1, the founding member of the mammalian family of seven NAD(+)-dependent sirtuins, is composed of 747 amino acids forming a catalytic domain and extended N- and C-terminal regions.  We report the design and characterization of an engineered human SIRT1 construct (mini-hSIRT1) containing the minimal structural elements required for lysine deacetylation and catalytic activation by small molecule sirtuin-activating compounds (STACs).  Using this construct, we solved the crystal structure of a mini-hSIRT1-STAC complex, which revealed the STAC-binding site within the N-terminal domain of hSIRT1.  Together with hydrogen-deuterium exchange mass spectrometry (HDX-MS) and site-directed mutagenesis using full-length hSIRT1, these data establish a specific STAC-binding site and identify key intermolecular interactions with hSIRT1.  The determination of the interface governing the binding of STACs with human SIRT1 facilitates greater understanding of STAC activation of this enzyme, which holds significant promise as a therapeutic target for multiple human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUuRoXD3S0w9j_Vg2vObihfW6udTcc2ebCWrnoYyR6prntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252Fgs1WqsQ%253D%253D&md5=d29f8cc1296653bb4f6f3c97de921af0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fncomms8645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms8645%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DH.%26aulast%3DCase%26aufirst%3DA.%2BW.%26aulast%3DRiera%26aufirst%3DT.%2BV.%26aulast%3DConsidine%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DHamuro%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSweitzer%26aufirst%3DS.%2BM.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DBlum%26aufirst%3DC.%2BA.%26aulast%3DDisch%26aufirst%3DJ.%2BS.%26aulast%3DCaldwell%26aufirst%3DR.%26aulast%3DSzczepankiewicz%26aufirst%3DB.%26aulast%3DOalmann%26aufirst%3DC.%26aulast%3DYee%2BNg%26aufirst%3DP.%26aulast%3DWhite%26aufirst%3DB.%2BH.%26aulast%3DCasaubon%26aufirst%3DR.%26aulast%3DNarayan%26aufirst%3DR.%26aulast%3DKoppetsch%26aufirst%3DK.%26aulast%3DBourbonais%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DVlasuk%26aufirst%3DG.%2BP.%26aulast%3DEllis%26aufirst%3DJ.%2BL.%26atitle%3DCrystallographic%2520structure%2520of%2520a%2520small%2520molecule%2520sirt1%2520activator-enzyme%2520complex%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D7645%26doi%3D10.1038%2Fncomms8645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R. M.</span><span> </span><span class="NLM_article-title">Structural basis for allosteric, substrate-dependent stimulation of sirt1 activity by resveratrol</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1316</span><span class="NLM_x">–</span> <span class="NLM_lpage">1325</span><span class="refDoi"> DOI: 10.1101/gad.265462.115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1101%2Fgad.265462.115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=26109052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFynsbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=1316-1325&author=D.+Caoauthor=M.+Wangauthor=X.+Qiuauthor=D.+Liuauthor=H.+Jiangauthor=N.+Yangauthor=R.+M.+Xu&title=Structural+basis+for+allosteric%2C+substrate-dependent+stimulation+of+sirt1+activity+by+resveratrol&doi=10.1101%2Fgad.265462.115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol</span></div><div class="casAuthors">Cao, Duanfang; Wang, Mingzhu; Qiu, Xiayang; Liu, Dongxiang; Jiang, Hualiang; Yang, Na; Xu, Rui-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1316-1325</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Sirtuins with an extended N-terminal domain (NTD), represented by yeast Sir2 and human SIRT1, harbor intrinsic mechanisms for regulation of their NAD-dependent deacetylase activities.  Elucidation of the regulatory mechanisms is crucial for understanding the biol. functions of sirtuins and development of potential therapeutics.  In particular, SIRT1 has emerged as an attractive therapeutic target, and the search for SIRT1-activating compds. (STACs) has been actively pursued.  However, the effectiveness of a class of reported STACs (represented by resveratrol) as direct SIRT1 activators is under debate due to the complication involving the use of fluorogenic substrates in in vitro assays.  Future efforts of SIRT1-based therapeutics necessitate the dissection of the mol. mechanism of SIRT1 stimulation.  We solved the structure of SIRT1 in complex with resveratrol and a 7-amino-4-methylcoumarin (AMC)-contg. peptide.  The structure reveals the presence of three resveratrol mols., two of which mediate the interaction between the AMC peptide and the NTD of SIRT1.  The two NTD-bound resveratrol mols. are principally responsible for promoting tighter binding between SIRT1 and the peptide and the stimulation of SIRT1 activity.  The structural information provides valuable insights into regulation of SIRT1 activity and should benefit the development of authentic SIRT1 activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR12x9jJ-rzLVg90H21EOLACvtfcHk0lg1UJCOuh631A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFynsbzL&md5=3013c25b9a2ee804adfb6d143e1462cd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1101%2Fgad.265462.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.265462.115%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DR.%2BM.%26atitle%3DStructural%2520basis%2520for%2520allosteric%252C%2520substrate-dependent%2520stimulation%2520of%2520sirt1%2520activity%2520by%2520resveratrol%26jtitle%3DGenes%2520Dev.%26date%3D2015%26volume%3D29%26spage%3D1316%26epage%3D1325%26doi%3D10.1101%2Fgad.265462.115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacEwan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamison, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luz, J. G.</span><span> </span><span class="NLM_article-title">The 2.5 a crystal structure of the sirt1 catalytic domain bound to nicotinamide adenine dinucleotide (nad+) and an indole (ex527 analogue) reveals a novel mechanism of histone deacetylase inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span><span class="refDoi"> DOI: 10.1021/jm301431y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301431y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=963-969&author=X.+Zhaoauthor=D.+Allisonauthor=B.+Condonauthor=F.+Zhangauthor=T.+Gheyiauthor=A.+Zhangauthor=S.+Ashokauthor=M.+Russellauthor=I.+MacEwanauthor=Y.+Qianauthor=J.+A.+Jamisonauthor=J.+G.+Luz&title=The+2.5+a+crystal+structure+of+the+sirt1+catalytic+domain+bound+to+nicotinamide+adenine+dinucleotide+%28nad%2B%29+and+an+indole+%28ex527+analogue%29+reveals+a+novel+mechanism+of+histone+deacetylase+inhibition&doi=10.1021%2Fjm301431y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301431y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301431y%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DAllison%26aufirst%3DD.%26aulast%3DCondon%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DGheyi%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DAshok%26aufirst%3DS.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DMacEwan%26aufirst%3DI.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DJamison%26aufirst%3DJ.%2BA.%26aulast%3DLuz%26aufirst%3DJ.%2BG.%26atitle%3DThe%25202.5%2520a%2520crystal%2520structure%2520of%2520the%2520sirt1%2520catalytic%2520domain%2520bound%2520to%2520nicotinamide%2520adenine%2520dinucleotide%2520%2528nad%252B%2529%2520and%2520an%2520indole%2520%2528ex527%2520analogue%2529%2520reveals%2520a%2520novel%2520mechanism%2520of%2520histone%2520deacetylase%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D963%26epage%3D969%26doi%3D10.1021%2Fjm301431y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Sayd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thirant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Habr, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipecka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogeas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahiri-Jouti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chneiweiss, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junier, M. P.</span><span> </span><span class="NLM_article-title">Sirtuin-2 activity is required for glioma stem cell proliferation arrest but not necrosis induced by resveratrol</span> <span class="citation_source-journal">Stem Cell Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1007/s12015-013-9465-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1007%2Fs12015-013-9465-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=23955573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFCqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=103-113&author=S.+Saydauthor=C.+Thirantauthor=E.+A.+El-Habrauthor=J.+Lipeckaauthor=L.+G.+Duboisauthor=A.+Bogeasauthor=N.+Tahiri-Joutiauthor=H.+Chneiweissauthor=M.+P.+Junier&title=Sirtuin-2+activity+is+required+for+glioma+stem+cell+proliferation+arrest+but+not+necrosis+induced+by+resveratrol&doi=10.1007%2Fs12015-013-9465-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Sirtuin-2 Activity is Required for Glioma Stem Cell Proliferation Arrest but not Necrosis Induced by Resveratrol</span></div><div class="casAuthors">Sayd, Salwa; Thirant, Cecile; El-Habr, Elias A.; Lipecka, Joanna; Dubois, Luiz Gustavo; Bogeas, Alexandra; Tahiri-Jouti, Nadia; Chneiweiss, Herve; Junier, Marie-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cell Reviews and Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-113</span>CODEN:
                <span class="NLM_cas:coden">SCRREE</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Glioblastomas, the most common form of primary brain tumors, are the fourth cause of death by cancer in adults.  Increasing evidences suggest that glioblastoma resistance to existing radio- and chemotherapies rely on glioblastoma stem cells (GSCs).  GSCs are endowed with a unique combination of stem-like properties alike to normal neural stem cells (NSCs), and of tumor initiating properties.  The natural polyphenol resveratrol is known to exert opposite actions on neural cells according to their normal or cancerous status.  Here, we used resveratrol to explore the mol. mechanisms differing between GSCs and NSCs.  We obsd. a dual action of resveratrol on GSCs: resveratrol blocked GSC proliferation up to 150 μM and induced their necrosis at higher doses.  On the opposite, resveratrol had no effect on NSC behavior.  To det. the mechanisms underlying resveratrol effects, we focused our attention on the family of NAD-dependent deacetylases sirtuins (SIRT).  A member of this family, SIRT1, has been repetitively shown to constitute a preferential resveratrol target, at least in normal cells.  Western blot anal. showed that SIRT1 and SIRT3 were expressed by both GSCs and NSCs whereas SIRT2 expression was restricted to GSCs.  Pharmacol. blockade of SIRT2 activity or down-regulation of SIRT2 expression with siRNAs counteracted the inhibitory effect of resveratrol on cell proliferation.  On the contrary, inhibition of SIRT2 activity or expression did not counteract GSC necrosis obsd. in presence of high doses of resveratrol.  Our results highlight SIRT2 as a novel target for altering GSC properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc7aPoQs9Pm7Vg90H21EOLACvtfcHk0li9Xu9vSXJCJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFCqtb0%253D&md5=2453e12fa059a70396684297be0fe981</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs12015-013-9465-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12015-013-9465-0%26sid%3Dliteratum%253Aachs%26aulast%3DSayd%26aufirst%3DS.%26aulast%3DThirant%26aufirst%3DC.%26aulast%3DEl-Habr%26aufirst%3DE.%2BA.%26aulast%3DLipecka%26aufirst%3DJ.%26aulast%3DDubois%26aufirst%3DL.%2BG.%26aulast%3DBogeas%26aufirst%3DA.%26aulast%3DTahiri-Jouti%26aufirst%3DN.%26aulast%3DChneiweiss%26aufirst%3DH.%26aulast%3DJunier%26aufirst%3DM.%2BP.%26atitle%3DSirtuin-2%2520activity%2520is%2520required%2520for%2520glioma%2520stem%2520cell%2520proliferation%2520arrest%2520but%2520not%2520necrosis%2520induced%2520by%2520resveratrol%26jtitle%3DStem%2520Cell%2520Rev.%26date%3D2014%26volume%3D10%26spage%3D103%26epage%3D113%26doi%3D10.1007%2Fs12015-013-9465-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Seidel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Histone deacetylase 6 in health and disease</span> <span class="citation_source-journal">Epigenomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.2217/epi.14.69</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.2217%2Fepi.14.69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=25687470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=103-118&author=C.+Seidelauthor=M.+Schnekenburgerauthor=M.+Dicatoauthor=M.+Diederich&title=Histone+deacetylase+6+in+health+and+disease&doi=10.2217%2Fepi.14.69"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 in health and disease</span></div><div class="casAuthors">Seidel, Carole; Schnekenburger, Michael; Dicato, Mario; Diederich, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Epigenomics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-118</span>CODEN:
                <span class="NLM_cas:coden">EPIGC7</span>;
        ISSN:<span class="NLM_cas:issn">1750-192X</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase (HDAC)6 is a member of the class IIb HDAC family.  This enzyme is zinc-dependent and mainly localized in the cytoplasm.  HDAC6 is a unique isoenzyme with two functional catalytic domains and specific physiol. roles.  Indeed, HDAC6 deacetylates various substrates including α-tubulin and HSP90α, and is involved in protein trafficking and degrdn., cell shape and migration.  Consequently, deregulation of HDAC6 activity was assocd. to a variety of diseases including cancer, neurodegenerative diseases and pathol. autoimmune response.  Therefore, HDAC6 represents an interesting potential therapeutic target.  In this review, we discuss structural features of this histone deacetylase, regulation of its expression and activity, biol. functions, implication in human disease initiation and progression.  Finally will describe novel and selective HDAC6 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0ng4pDM6Ob7Vg90H21EOLACvtfcHk0ljTT6LsfcZ9uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGisbY%253D&md5=21a22233741335632ae499640d799f8d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2217%2Fepi.14.69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fepi.14.69%26sid%3Dliteratum%253Aachs%26aulast%3DSeidel%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DHistone%2520deacetylase%25206%2520in%2520health%2520and%2520disease%26jtitle%3DEpigenomics%26date%3D2015%26volume%3D7%26spage%3D103%26epage%3D118%26doi%3D10.2217%2Fepi.14.69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuzzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamdy, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fakhr, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno Y Banuls, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goietsenoven, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Soest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciavatta, M. L.</span><span> </span><span class="NLM_article-title">In vitro pharmacological and toxicological effects of norterpene peroxides isolated from the red sea sponge diacarnus erythraeanus on normal and cancer cells</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">1541</span><span class="NLM_x">–</span> <span class="NLM_lpage">1547</span><span class="refDoi"> DOI: 10.1021/np400107t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np400107t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2013&pages=1541-1547&author=F.+Lefrancauthor=G.+Nuzzoauthor=N.+A.+Hamdyauthor=I.+Fakhrauthor=L.+Moreno+Y+Banulsauthor=G.+Van+Goietsenovenauthor=G.+Villaniauthor=V.+Mathieuauthor=R.+van+Soestauthor=R.+Kissauthor=M.+L.+Ciavatta&title=In+vitro+pharmacological+and+toxicological+effects+of+norterpene+peroxides+isolated+from+the+red+sea+sponge+diacarnus+erythraeanus+on+normal+and+cancer+cells&doi=10.1021%2Fnp400107t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fnp400107t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp400107t%26sid%3Dliteratum%253Aachs%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DNuzzo%26aufirst%3DG.%26aulast%3DHamdy%26aufirst%3DN.%2BA.%26aulast%3DFakhr%26aufirst%3DI.%26aulast%3DMoreno%2BY%2BBanuls%26aufirst%3DL.%26aulast%3DVan%2BGoietsenoven%26aufirst%3DG.%26aulast%3DVillani%26aufirst%3DG.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3Dvan%2BSoest%26aufirst%3DR.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DCiavatta%26aufirst%3DM.%2BL.%26atitle%3DIn%2520vitro%2520pharmacological%2520and%2520toxicological%2520effects%2520of%2520norterpene%2520peroxides%2520isolated%2520from%2520the%2520red%2520sea%2520sponge%2520diacarnus%2520erythraeanus%2520on%2520normal%2520and%2520cancer%2520cells%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2013%26volume%3D76%26spage%3D1541%26epage%3D1547%26doi%3D10.1021%2Fnp400107t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Branle, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camby, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeuken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geurts-Moespot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprenger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweep, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, I.</span><span> </span><span class="NLM_article-title">Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in c6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span><span class="refDoi"> DOI: 10.1002/cncr.10710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1002%2Fcncr.10710" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2002&pages=641-655&author=F.+Branleauthor=F.+Lefrancauthor=I.+Cambyauthor=J.+Jeukenauthor=A.+Geurts-Moespotauthor=S.+Sprengerauthor=F.+Sweepauthor=R.+Kissauthor=I.+Salmon&title=Evaluation+of+the+efficiency+of+chemotherapy+in+in+vivo+orthotopic+models+of+human+glioma+cells+with+and+without+1p19q+deletions+and+in+c6+rat+orthotopic+allografts+serving+for+the+evaluation+of+surgery+combined+with+chemotherapy&doi=10.1002%2Fcncr.10710"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcncr.10710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcncr.10710%26sid%3Dliteratum%253Aachs%26aulast%3DBranle%26aufirst%3DF.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DCamby%26aufirst%3DI.%26aulast%3DJeuken%26aufirst%3DJ.%26aulast%3DGeurts-Moespot%26aufirst%3DA.%26aulast%3DSprenger%26aufirst%3DS.%26aulast%3DSweep%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DSalmon%26aufirst%3DI.%26atitle%3DEvaluation%2520of%2520the%2520efficiency%2520of%2520chemotherapy%2520in%2520in%2520vivo%2520orthotopic%2520models%2520of%2520human%2520glioma%2520cells%2520with%2520and%2520without%25201p19q%2520deletions%2520and%2520in%2520c6%2520rat%2520orthotopic%2520allografts%2520serving%2520for%2520the%2520evaluation%2520of%2520surgery%2520combined%2520with%2520chemotherapy%26jtitle%3DCancer%26date%3D2002%26volume%3D95%26spage%3D641%26epage%3D655%26doi%3D10.1002%2Fcncr.10710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Grandjenette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karius, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghelfi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaigneaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">5-aza-2′-deoxycytidine-mediated c-myc down-regulation triggers telomere-dependent senescence by regulating human telomerase reverse transcriptase in chronic myeloid leukemia</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span><span class="refDoi"> DOI: 10.1016/j.neo.2014.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.neo.2014.05.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=511-528&author=C.+Grandjenetteauthor=M.+Schnekenburgerauthor=T.+Kariusauthor=J.+Ghelfiauthor=A.+Gaigneauxauthor=E.+Henryauthor=M.+Dicatoauthor=M.+Diederich&title=5-aza-2%E2%80%B2-deoxycytidine-mediated+c-myc+down-regulation+triggers+telomere-dependent+senescence+by+regulating+human+telomerase+reverse+transcriptase+in+chronic+myeloid+leukemia&doi=10.1016%2Fj.neo.2014.05.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.neo.2014.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neo.2014.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DGrandjenette%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DKarius%26aufirst%3DT.%26aulast%3DGhelfi%26aufirst%3DJ.%26aulast%3DGaigneaux%26aufirst%3DA.%26aulast%3DHenry%26aufirst%3DE.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3D5-aza-2%25E2%2580%25B2-deoxycytidine-mediated%2520c-myc%2520down-regulation%2520triggers%2520telomere-dependent%2520senescence%2520by%2520regulating%2520human%2520telomerase%2520reverse%2520transcriptase%2520in%2520chronic%2520myeloid%2520leukemia%26jtitle%3DNeoplasia%26date%3D2014%26volume%3D16%26spage%3D511%26epage%3D528%26doi%3D10.1016%2Fj.neo.2014.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. A.</span><span> </span><span class="NLM_article-title">P53: Protection against tumor growth beyond effects on cell cycle and apoptosis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">5001</span><span class="NLM_x">–</span> <span class="NLM_lpage">5007</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-0563</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1158%2F0008-5472.CAN-15-0563" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=26573797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFensr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=5001-5007&author=X.+Wangauthor=E.+R.+Simpsonauthor=K.+A.+Brown&title=P53%3A+Protection+against+tumor+growth+beyond+effects+on+cell+cycle+and+apoptosis&doi=10.1158%2F0008-5472.CAN-15-0563"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">p53: Protection against tumor growth beyond effects on cell cycle and apoptosis</span></div><div class="casAuthors">Wang, Xuyi; Simpson, Evan R.; Brown, Kristy A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5001-5007</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The tumor suppressor p53 has established functions in cancer.  Specifically, it has been shown to cause cell-cycle arrest and apoptosis in response to DNA damage.  It is also one of the most commonly mutated or silenced genes in cancer and for this reason has been extensively studied.  Recently, the role of p53 has been shown to go beyond its effects on cell cycle and apoptosis, with effects on metab. emerging as a key contributor to cancer growth in situations where p53 is lost.  Beyond this, the role of p53 in the tumor microenvironment is poorly understood.  The publication by Wang and colleagues demonstrates for the first time that p53 is a key neg. regulator of aromatase and, hence, estrogen prodn. in the breast tumor microenvironment.  It goes further by demonstrating that an important regulator of aromatase, the obesity-assocd. and tumor-derived factor prostaglandin E2, inhibits p53 in the breast adipose stroma.  This review presents these findings in the context of established and emerging roles of p53 and discusses possible implications for the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQXGebO5TNHLVg90H21EOLACvtfcHk0lh8pjO6zAgD3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFensr%252FN&md5=c0061124e8b99cf3e3244bc177291755</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-0563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-0563%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSimpson%26aufirst%3DE.%2BR.%26aulast%3DBrown%26aufirst%3DK.%2BA.%26atitle%3DP53%253A%2520Protection%2520against%2520tumor%2520growth%2520beyond%2520effects%2520on%2520cell%2520cycle%2520and%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D5001%26epage%3D5007%26doi%3D10.1158%2F0008-5472.CAN-15-0563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Multidrug resistance in cancer: Role of atp-dependent transporters</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1038/nrc706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+resistance+in+cancer%3A+Role+of+atp-dependent+transporters&doi=10.1038%2Fnrc706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0li1RFAK7ibnvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520resistance%2520in%2520cancer%253A%2520Role%2520of%2520atp-dependent%2520transporters%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58%26doi%3D10.1038%2Fnrc706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Yen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grill, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutschman, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y. C.</span><span> </span><span class="NLM_article-title">Characterization of a hydroxyurea-resistant human kb cell line with supersensitivity to 6-thioguanine</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3686</span><span class="NLM_x">–</span> <span class="NLM_lpage">3691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=3686-3691&author=Y.+Yenauthor=S.+P.+Grillauthor=G.+E.+Dutschmanauthor=C.+N.+Changauthor=B.+S.+Zhouauthor=Y.+C.+Cheng&title=Characterization+of+a+hydroxyurea-resistant+human+kb+cell+line+with+supersensitivity+to+6-thioguanine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYen%26aufirst%3DY.%26aulast%3DGrill%26aufirst%3DS.%2BP.%26aulast%3DDutschman%26aufirst%3DG.%2BE.%26aulast%3DChang%26aufirst%3DC.%2BN.%26aulast%3DZhou%26aufirst%3DB.%2BS.%26aulast%3DCheng%26aufirst%3DY.%2BC.%26atitle%3DCharacterization%2520of%2520a%2520hydroxyurea-resistant%2520human%2520kb%2520cell%2520line%2520with%2520supersensitivity%2520to%25206-thioguanine%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D3686%26epage%3D3691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Schuttelkopf, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Aalten, D. M.</span><span> </span><span class="NLM_article-title">Prodrg: A tool for high-throughput crystallography of protein-ligand complexes</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span><span class="refDoi"> DOI: 10.1107/S0907444904011679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1107%2FS0907444904011679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=15272157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=1355-1363&author=A.+W.+Schuttelkopfauthor=D.+M.+van+Aalten&title=Prodrg%3A+A+tool+for+high-throughput+crystallography+of+protein-ligand+complexes&doi=10.1107%2FS0907444904011679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span></div><div class="casAuthors">Schuttelkopf Alexander W; van Aalten Daan M F</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">Pt 8</span>),
    <span class="NLM_cas:pages">1355-63</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">The small-molecule topology generator PRODRG is described, which takes input from existing coordinates or various two-dimensional formats and automatically generates coordinates and molecular topologies suitable for X-ray refinement of protein-ligand complexes.  Test results are described for automatic generation of topologies followed by energy minimization for a subset of compounds from the Cambridge Structural Database, which shows that, within the limits of the empirical GROMOS87 force field used, structures with good geometries are generated.  X-ray refinement in X-PLOR/CNS, REFMAC and SHELX using PRODRG-generated topologies produces results comparable to refinement with topologies from the standard libraries.  However, tests with distorted starting coordinates show that PRODRG topologies perform better, both in terms of ligand geometry and of crystallographic R factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdNRIcoht5aXy-c-E1v-fmfW6udTcc2eb1NVZGPzhmp7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D&md5=1adce6cd2cacdace513a69efa33c4e93</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1107%2FS0907444904011679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904011679%26sid%3Dliteratum%253Aachs%26aulast%3DSchuttelkopf%26aufirst%3DA.%2BW.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%2BM.%26atitle%3DProdrg%253A%2520A%2520tool%2520for%2520high-throughput%2520crystallography%2520of%2520protein-ligand%2520complexes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D1355%26epage%3D1363%26doi%3D10.1107%2FS0907444904011679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Laskowski, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swindells, M. B.</span><span> </span><span class="NLM_article-title">Ligplot+: Multiple ligand-protein interaction diagrams for drug discovery</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2778</span><span class="NLM_x">–</span> <span class="NLM_lpage">2786</span><span class="refDoi"> DOI: 10.1021/ci200227u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200227u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1KjtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2778-2786&author=R.+A.+Laskowskiauthor=M.+B.+Swindells&title=Ligplot%2B%3A+Multiple+ligand-protein+interaction+diagrams+for+drug+discovery&doi=10.1021%2Fci200227u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery</span></div><div class="casAuthors">Laskowski, Roman A.; Swindells, Mark B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2778-2786</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe a graphical system for automatically generating multiple 2D diagrams of ligand-protein interactions from 3D coordinates.  The diagrams portray the hydrogen-bond interaction patterns and hydrophobic contacts between the ligand(s) and the main-chain or side-chain elements of the protein.  The system is able to plot, in the same orientation, related sets of ligand-protein interactions.  This facilitates popular research tasks, such as analyzing a series of small mols. binding to the same protein target, a single ligand binding to homologous proteins, or the completely general case where both protein and ligand change.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYuWvYH7Nel7Vg90H21EOLACvtfcHk0lgkT6WIv0nf1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1KjtrzP&md5=576e59ad4f0c4304d01c6c80301ecf39</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fci200227u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200227u%26sid%3Dliteratum%253Aachs%26aulast%3DLaskowski%26aufirst%3DR.%2BA.%26aulast%3DSwindells%26aufirst%3DM.%2BB.%26atitle%3DLigplot%252B%253A%2520Multiple%2520ligand-protein%2520interaction%2520diagrams%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D2778%26epage%3D2786%26doi%3D10.1021%2Fci200227u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Le Mercier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roland, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegl-Kreinecker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haibe-Kains, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bontempi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decaestecker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Galectin 1 proangiogenic and promigratory effects in the hs683 oligodendroglioma model are partly mediated through the control of bex2 expression</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1593/neo.81526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1593%2Fneo.81526" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=485-496&author=M.+Le+Mercierauthor=S.+Fortinauthor=V.+Mathieuauthor=I.+Rolandauthor=S.+Spiegl-Kreineckerauthor=B.+Haibe-Kainsauthor=G.+Bontempiauthor=C.+Decaesteckerauthor=W.+Bergerauthor=F.+Lefrancauthor=R.+Kiss&title=Galectin+1+proangiogenic+and+promigratory+effects+in+the+hs683+oligodendroglioma+model+are+partly+mediated+through+the+control+of+bex2+expression&doi=10.1593%2Fneo.81526"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1593%2Fneo.81526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.81526%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BMercier%26aufirst%3DM.%26aulast%3DFortin%26aufirst%3DS.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DRoland%26aufirst%3DI.%26aulast%3DSpiegl-Kreinecker%26aufirst%3DS.%26aulast%3DHaibe-Kains%26aufirst%3DB.%26aulast%3DBontempi%26aufirst%3DG.%26aulast%3DDecaestecker%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DGalectin%25201%2520proangiogenic%2520and%2520promigratory%2520effects%2520in%2520the%2520hs683%2520oligodendroglioma%2520model%2520are%2520partly%2520mediated%2520through%2520the%2520control%2520of%2520bex2%2520expression%26jtitle%3DNeoplasia%26date%3D2009%26volume%3D11%26spage%3D485%26epage%3D496%26doi%3D10.1593%2Fneo.81526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Torsvik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stieber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enger, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golebiewska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molven, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svendsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westermark, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niclou, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chekenya Enger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjerkvig, R.</span><span> </span><span class="NLM_article-title">U-251 revisited: Genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells</span> <span class="citation_source-journal">Cancer Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">824</span><span class="refDoi"> DOI: 10.1002/cam4.219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1002%2Fcam4.219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=24810477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12gurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=812-824&author=A.+Torsvikauthor=D.+Stieberauthor=P.+O.+Engerauthor=A.+Golebiewskaauthor=A.+Molvenauthor=A.+Svendsenauthor=B.+Westermarkauthor=S.+P.+Niclouauthor=T.+K.+Olsenauthor=M.+Chekenya+Engerauthor=R.+Bjerkvig&title=U-251+revisited%3A+Genetic+drift+and+phenotypic+consequences+of+long-term+cultures+of+glioblastoma+cells&doi=10.1002%2Fcam4.219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells</span></div><div class="casAuthors">Torsvik, Anja; Stieber, Daniel; Enger, Per Oyvind; Golebiewska, Anna; Molven, Anders; Svendsen, Agnete; Westermark, Bengt; Niclou, Simone P.; Olsen, Thale Kristin; Chekenya Enger, Martha; Bjerkvig, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">812-824</span>CODEN:
                <span class="NLM_cas:coden">CMAEDL</span>;
        ISSN:<span class="NLM_cas:issn">2045-7634</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">It is well known that in vitro subculture represents a selection pressure on cell lines, and over time this may result in a genetic drift in the cancer cells.  In addn., long-term cultures harbor the risk of cross-contamination with other cell lines.  The consequences may have major impact on exptl. results obtained in various labs., where the cell lines no longer reflect the original tumors that they are supposed to represent.  Much neglected in the scientific community is a close monitoring of cell cultures by regular phenotypic and genetic characterization.  In this report, we present a thorough characterization of the commonly used glioblastoma (GBM) model U-251, which in numerous publications has been wrongly identified as U-373, due to an earlier cross-contamination.  In this work, the original U-251 and three subclones of U-251, commonly referred to as U-251 or U-373, were analyzed with regard to their DNA profile, morphol., phenotypic expression, and growth pattern.  By array comparative genomic hybridization (aCGH), we show that only the original low-passaged U-251 cells, established in the 1960s, maintain a DNA copy no. resembling a typical GBM profile, whereas all long-term subclones lost the typical GBM profile.  Also the long-term passaged subclones displayed variations in phenotypic marker expression and showed an increased growth rate in vitro and a more aggressive growth in vivo.  Taken together, the variations in genotype and phenotype as well as differences in growth characteristics may explain different results reported in various labs. related to the U-251 cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEUN6oz1uC7LVg90H21EOLACvtfcHk0lgnfNOTfv4dnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12gurvJ&md5=134f8a56de09404f9a176747f6ff2598</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fcam4.219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcam4.219%26sid%3Dliteratum%253Aachs%26aulast%3DTorsvik%26aufirst%3DA.%26aulast%3DStieber%26aufirst%3DD.%26aulast%3DEnger%26aufirst%3DP.%2BO.%26aulast%3DGolebiewska%26aufirst%3DA.%26aulast%3DMolven%26aufirst%3DA.%26aulast%3DSvendsen%26aufirst%3DA.%26aulast%3DWestermark%26aufirst%3DB.%26aulast%3DNiclou%26aufirst%3DS.%2BP.%26aulast%3DOlsen%26aufirst%3DT.%2BK.%26aulast%3DChekenya%2BEnger%26aufirst%3DM.%26aulast%3DBjerkvig%26aufirst%3DR.%26atitle%3DU-251%2520revisited%253A%2520Genetic%2520drift%2520and%2520phenotypic%2520consequences%2520of%2520long-term%2520cultures%2520of%2520glioblastoma%2520cells%26jtitle%3DCancer%2520Med.%26date%3D2014%26volume%3D3%26spage%3D812%26epage%3D824%26doi%3D10.1002%2Fcam4.219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Stein, G. H.</span><span> </span><span class="NLM_article-title">T98g: An anchorage-independent human tumor cell line that exhibits stationary phase g1 arrest in vitro</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1002/jcp.1040990107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1002%2Fjcp.1040990107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=222778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A280%3ADyaE1M3hs1Kjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1979&pages=43-54&author=G.+H.+Stein&title=T98g%3A+An+anchorage-independent+human+tumor+cell+line+that+exhibits+stationary+phase+g1+arrest+in+vitro&doi=10.1002%2Fjcp.1040990107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro</span></div><div class="casAuthors">Stein G H</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular physiology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-54</span>
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    </div><div class="casAbstract">T98 and T98G are two related cell lines that were derived from a human glioblastoma multiforma tumor.  T98G has almost twice as many chromosomes as T98, suggesting that it is a polyploid variant of T98.  Three aspects of control of cellular proliferation were studied in T98 and T98G cells in comparison to WI-38 normal human diploid cells.  WI-38 cells have the following properties: (1) they can undergo only a limited number of population doublings in vitro; (2) they cannot proliferate without anchorage; and (3) they become arrested in G1 phase under stationary phase conditions.  T98 cells differ from normal cells in all three of these properties, as do many other transformed cell lines.  However, the derivative of T98, namely T98G, expresses an unique combination of normal and transformed aspects of the control of cellular proliferation.  T98G cells are like normal cells in that they become arrested in G1 phase under stationary phase conditions, yet they also exhibit the transformed characteristics of anchorage independence and immortality.  Thus, T98G cells demonstrate that transformation to immortality and anchorage independence can exist without concomitant loss of the normal mechanism for G1 arrest in response to stationary phase conditions.  This result supports the hypothesis that each of these three aspects of control of cellular proliferation can be altered independently.  Partially transformed cell lines, such as T98G, should be useful for sorting out the biochemical changes associated with transformation in each of these aspects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOplptjUccRQWRJ3OJdH_qfW6udTcc2eZ8Br84Rmw0arntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1M3hs1Kjuw%253D%253D&md5=f844a5a41b966c01c11e443fbffd4829</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fjcp.1040990107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.1040990107%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DG.%2BH.%26atitle%3DT98g%253A%2520An%2520anchorage-independent%2520human%2520tumor%2520cell%2520line%2520that%2520exhibits%2520stationary%2520phase%2520g1%2520arrest%2520in%2520vitro%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D1979%26volume%3D99%26spage%3D43%26epage%3D54%26doi%3D10.1002%2Fjcp.1040990107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Roninson, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gros, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Housman, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastan, I.</span><span> </span><span class="NLM_article-title">Isolation of human mdr DNA sequences amplified in multidrug-resistant kb carcinoma cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">4538</span><span class="NLM_x">–</span> <span class="NLM_lpage">4542</span><span class="refDoi"> DOI: 10.1073/pnas.83.12.4538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1073%2Fpnas.83.12.4538" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=4538-4542&author=I.+B.+Roninsonauthor=J.+E.+Chinauthor=K.+G.+Choiauthor=P.+Grosauthor=D.+E.+Housmanauthor=A.+Fojoauthor=D.+W.+Shenauthor=M.+M.+Gottesmanauthor=I.+Pastan&title=Isolation+of+human+mdr+DNA+sequences+amplified+in+multidrug-resistant+kb+carcinoma+cells&doi=10.1073%2Fpnas.83.12.4538"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.83.12.4538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.83.12.4538%26sid%3Dliteratum%253Aachs%26aulast%3DRoninson%26aufirst%3DI.%2BB.%26aulast%3DChin%26aufirst%3DJ.%2BE.%26aulast%3DChoi%26aufirst%3DK.%2BG.%26aulast%3DGros%26aufirst%3DP.%26aulast%3DHousman%26aufirst%3DD.%2BE.%26aulast%3DFojo%26aufirst%3DA.%26aulast%3DShen%26aufirst%3DD.%2BW.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DPastan%26aufirst%3DI.%26atitle%3DIsolation%2520of%2520human%2520mdr%2520DNA%2520sequences%2520amplified%2520in%2520multidrug-resistant%2520kb%2520carcinoma%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D83%26spage%3D4538%26epage%3D4542%26doi%3D10.1073%2Fpnas.83.12.4538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Bunz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutriaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedivy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span> </span><span class="NLM_article-title">Requirement for p53 and p21 to sustain g2 arrest after DNA damage</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">1497</span><span class="NLM_x">–</span> <span class="NLM_lpage">1501</span><span class="refDoi"> DOI: 10.1126/science.282.5393.1497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1126%2Fscience.282.5393.1497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=9822382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADyaK1cXns1yqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=1497-1501&author=F.+Bunzauthor=A.+Dutriauxauthor=C.+Lengauerauthor=T.+Waldmanauthor=S.+Zhouauthor=J.+P.+Brownauthor=J.+M.+Sedivyauthor=K.+W.+Kinzlerauthor=B.+Vogelstein&title=Requirement+for+p53+and+p21+to+sustain+g2+arrest+after+DNA+damage&doi=10.1126%2Fscience.282.5393.1497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for p53 and p21 to sustain G2 arrest after DNA damage</span></div><div class="casAuthors">Bunz, F.; Dutriaux, A.; Lengauer, C.; Waldman, T.; Zhou, S.; Brown, J. P.; Sedivy, J. M.; Kinzler, K. W.; Vogelstein, B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">5393</span>),
    <span class="NLM_cas:pages">1497-1501</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">After DNA damage, many cells appear to enter a sustained arrest in the G2 phase of the cell cycle.  It is shown here that this arrest could be sustained only when p53 was present in the cell and capable of transcriptionally activating the cyclin-dependent kinase inhibitor p21.  After disruption of either the p53 or the p21 gene, γ radiated cells progressed into mitosis and exhibited a G2 DNA content only because of a failure of cytokinesis.  Thus, p53 and p21 appear to be essential for maintaining the G2 checkpoint in human cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO6NPwYqRmK7Vg90H21EOLACvtfcHk0lim8Bz_3f3V8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXns1yqurc%253D&md5=e6f0dc856f71915dbd2b8cfb11de4bad</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1126%2Fscience.282.5393.1497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.282.5393.1497%26sid%3Dliteratum%253Aachs%26aulast%3DBunz%26aufirst%3DF.%26aulast%3DDutriaux%26aufirst%3DA.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DWaldman%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DJ.%2BP.%26aulast%3DSedivy%26aufirst%3DJ.%2BM.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DRequirement%2520for%2520p53%2520and%2520p21%2520to%2520sustain%2520g2%2520arrest%2520after%2520DNA%2520damage%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D1497%26epage%3D1501%26doi%3D10.1126%2Fscience.282.5393.1497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Schuurhuis, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broxterman, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lange, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinedo, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Heijningen, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuiper, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheffer, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheper, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Kalken, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baak, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lankelma, J.</span><span> </span><span class="NLM_article-title">Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of p-glycoprotein</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span><span class="refDoi"> DOI: 10.1038/bjc.1991.413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1038%2Fbjc.1991.413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1681887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADyaK38XhsFCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1991&pages=857-861&author=G.+J.+Schuurhuisauthor=H.+J.+Broxtermanauthor=J.+H.+de+Langeauthor=H.+M.+Pinedoauthor=T.+H.+van+Heijningenauthor=C.+M.+Kuiperauthor=G.+L.+Schefferauthor=R.+J.+Scheperauthor=C.+K.+van+Kalkenauthor=J.+P.+Baakauthor=J.+Lankelma&title=Early+multidrug+resistance%2C+defined+by+changes+in+intracellular+doxorubicin+distribution%2C+independent+of+p-glycoprotein&doi=10.1038%2Fbjc.1991.413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein</span></div><div class="casAuthors">Schuurhuis, G. J.; Broxterman, H. J.; De Lange, J. H. M.; Pinedo, H. M.; Van Heijningen, T. H. M.; Kuiper, C. M.; Scheffer, G. L.; Scheper, R. J.; Van Kalken, C. K.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">857-61</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">Resistance to multiple antitumor drugs, mostly antibiotics or alkaloids, has been assocd. with the cellular plasma membrane P-glycoprotein (Pgp) causing energy-dependent transport of drugs out of cells.  In many common chemotherapy-resistant human cancers there is no overexpression of Pgp that could explain drug resistance.  To characterize early steps in multidrug resistance, P-glycoprotein-pos. (Pgp/+) and P-glycoprotein-neg. (Pgp/-) multidrug resistant cell lines were derived from the human non-small lung cancer cell line.  SW-1573 by stepwise selection with increasing concns. of doxorubicin.  The cells were exposed to doxorubicin and its fluorescence in nucleus (N) and cytoplasm (C) was quantified with laserscan microscopy and image anal.  The fluorescence N/C ratio in parent cells was 3.8 and decreased both in Pgp/+ and Pgp/- cells with increasing selection pressure to 1.2-2.6 for cells with a resistance factor of 7-17.  N/C ratios could be restored partly with verapamil only in Pgp/+ cells.  N/C ratio measurements may define a general Pgp-independent type of defense of mammalian cells against certain anticancer agents which may precede Pgp expression in early doxorubicin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqszaVFvCorerVg90H21EOLACvtfcHk0liKUqkFdP4eLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsFCrsg%253D%253D&md5=9d500635d2d49f1559b418caa4ac3f26</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1991.413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1991.413%26sid%3Dliteratum%253Aachs%26aulast%3DSchuurhuis%26aufirst%3DG.%2BJ.%26aulast%3DBroxterman%26aufirst%3DH.%2BJ.%26aulast%3Dde%2BLange%26aufirst%3DJ.%2BH.%26aulast%3DPinedo%26aufirst%3DH.%2BM.%26aulast%3Dvan%2BHeijningen%26aufirst%3DT.%2BH.%26aulast%3DKuiper%26aufirst%3DC.%2BM.%26aulast%3DScheffer%26aufirst%3DG.%2BL.%26aulast%3DScheper%26aufirst%3DR.%2BJ.%26aulast%3Dvan%2BKalken%26aufirst%3DC.%2BK.%26aulast%3DBaak%26aufirst%3DJ.%2BP.%26aulast%3DLankelma%26aufirst%3DJ.%26atitle%3DEarly%2520multidrug%2520resistance%252C%2520defined%2520by%2520changes%2520in%2520intracellular%2520doxorubicin%2520distribution%252C%2520independent%2520of%2520p-glycoprotein%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1991%26volume%3D64%26spage%3D857%26epage%3D861%26doi%3D10.1038%2Fbjc.1991.413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandjenette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghelfi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karius, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foliguet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Sustained exposure to the DNA demethylating agent, 2′-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagy</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span><span class="refDoi"> DOI: 10.1016/j.bcp.2010.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.bcp.2010.10.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2011&pages=364-378&author=M.+Schnekenburgerauthor=C.+Grandjenetteauthor=J.+Ghelfiauthor=T.+Kariusauthor=B.+Foliguetauthor=M.+Dicatoauthor=M.+Diederich&title=Sustained+exposure+to+the+DNA+demethylating+agent%2C+2%E2%80%B2-deoxy-5-azacytidine%2C+leads+to+apoptotic+cell+death+in+chronic+myeloid+leukemia+by+promoting+differentiation%2C+senescence%2C+and+autophagy&doi=10.1016%2Fj.bcp.2010.10.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DGrandjenette%26aufirst%3DC.%26aulast%3DGhelfi%26aufirst%3DJ.%26aulast%3DKarius%26aufirst%3DT.%26aulast%3DFoliguet%26aufirst%3DB.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DSustained%2520exposure%2520to%2520the%2520DNA%2520demethylating%2520agent%252C%25202%25E2%2580%25B2-deoxy-5-azacytidine%252C%2520leads%2520to%2520apoptotic%2520cell%2520death%2520in%2520chronic%2520myeloid%2520leukemia%2520by%2520promoting%2520differentiation%252C%2520senescence%252C%2520and%2520autophagy%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D81%26spage%3D364%26epage%3D378%26doi%3D10.1016%2Fj.bcp.2010.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Goffin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamoral-Theys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajeddine, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Tullio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mondin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gailly, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogister, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirotte, B.</span><span> </span><span class="NLM_article-title">N-aryl-n′-(chroman-4-yl)ureas and thioureas display in vitro anticancer activity and selectivity on apoptosis-resistant glioblastoma cells: Screening, synthesis of simplified derivatives, and structure-activity relationship analysis</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">834</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.06.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.ejmech.2012.06.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2012&pages=834-844&author=E.+Goffinauthor=D.+Lamoral-Theysauthor=N.+Tajeddineauthor=P.+de+Tullioauthor=L.+Mondinauthor=F.+Lefrancauthor=P.+Gaillyauthor=B.+Rogisterauthor=R.+Kissauthor=B.+Pirotte&title=N-aryl-n%E2%80%B2-%28chroman-4-yl%29ureas+and+thioureas+display+in+vitro+anticancer+activity+and+selectivity+on+apoptosis-resistant+glioblastoma+cells%3A+Screening%2C+synthesis+of+simplified+derivatives%2C+and+structure-activity+relationship+analysis&doi=10.1016%2Fj.ejmech.2012.06.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.06.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.06.050%26sid%3Dliteratum%253Aachs%26aulast%3DGoffin%26aufirst%3DE.%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DTajeddine%26aufirst%3DN.%26aulast%3Dde%2BTullio%26aufirst%3DP.%26aulast%3DMondin%26aufirst%3DL.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DGailly%26aufirst%3DP.%26aulast%3DRogister%26aufirst%3DB.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DPirotte%26aufirst%3DB.%26atitle%3DN-aryl-n%25E2%2580%25B2-%2528chroman-4-yl%2529ureas%2520and%2520thioureas%2520display%2520in%2520vitro%2520anticancer%2520activity%2520and%2520selectivity%2520on%2520apoptosis-resistant%2520glioblastoma%2520cells%253A%2520Screening%252C%2520synthesis%2520of%2520simplified%2520derivatives%252C%2520and%2520structure-activity%2520relationship%2520analysis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D54%26spage%3D834%26epage%3D844%26doi%3D10.1016%2Fj.ejmech.2012.06.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Frederick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruyere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vancraeynest, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reniers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinguet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pochet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backlund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span> </span><span class="NLM_article-title">Novel trisubstituted harmine derivatives with original in vitro anticancer activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6489</span><span class="NLM_x">–</span> <span class="NLM_lpage">6501</span><span class="refDoi"> DOI: 10.1021/jm300542e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300542e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6489-6501&author=R.+Frederickauthor=C.+Bruyereauthor=C.+Vancraeynestauthor=J.+Reniersauthor=C.+Meinguetauthor=L.+Pochetauthor=A.+Backlundauthor=B.+Masereelauthor=R.+Kissauthor=J.+Wouters&title=Novel+trisubstituted+harmine+derivatives+with+original+in+vitro+anticancer+activity&doi=10.1021%2Fjm300542e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm300542e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300542e%26sid%3Dliteratum%253Aachs%26aulast%3DFrederick%26aufirst%3DR.%26aulast%3DBruyere%26aufirst%3DC.%26aulast%3DVancraeynest%26aufirst%3DC.%26aulast%3DReniers%26aufirst%3DJ.%26aulast%3DMeinguet%26aufirst%3DC.%26aulast%3DPochet%26aufirst%3DL.%26aulast%3DBacklund%26aufirst%3DA.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DWouters%26aufirst%3DJ.%26atitle%3DNovel%2520trisubstituted%2520harmine%2520derivatives%2520with%2520original%2520in%2520vitro%2520anticancer%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6489%26epage%3D6501%26doi%3D10.1021%2Fjm300542e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chantome, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimmino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miklos, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulitschke, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evidente, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delpire, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Sphaeropsidin a shows promising activity against drug-resistant cancer cells by targeting regulatory volume increase</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">3731</span><span class="NLM_x">–</span> <span class="NLM_lpage">3746</span><span class="refDoi"> DOI: 10.1007/s00018-015-1902-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1007%2Fs00018-015-1902-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=25868554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsFSnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2015&pages=3731-3746&author=V.+Mathieuauthor=A.+Chantomeauthor=F.+Lefrancauthor=A.+Cimminoauthor=W.+Miklosauthor=V.+Paulitschkeauthor=T.+Mohrauthor=L.+Maddauauthor=A.+Kornienkoauthor=W.+Bergerauthor=C.+Vandierauthor=A.+Evidenteauthor=E.+Delpireauthor=R.+Kiss&title=Sphaeropsidin+a+shows+promising+activity+against+drug-resistant+cancer+cells+by+targeting+regulatory+volume+increase&doi=10.1007%2Fs00018-015-1902-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Sphaeropsidin A shows promising activity against drug-resistant cancer cells by targeting regulatory volume increase</span></div><div class="casAuthors">Mathieu, Veronique; Chantome, Aurelie; Lefranc, Florence; Cimmino, Alessio; Miklos, Walter; Paulitschke, Verena; Mohr, Thomas; Maddau, Lucia; Kornienko, Alexander; Berger, Walter; Vandier, Christophe; Evidente, Antonio; Delpire, Eric; Kiss, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3731-3746</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Despite the recent advances in the treatment of tumors with intrinsic chemotherapy resistance, such as melanoma and renal cancers, their prognosis remains poor and new chem. agents with promising activity against these cancers are urgently needed.  Sphaeropsidin A, a fungal metabolite whose anticancer potential had previously received little attention, was isolated from Diplodia cupressi and found to display specific anticancer activity in vitro against melanoma and kidney cancer subpanels in the National Cancer Institute (NCI) 60-cell line screen.  The NCI data revealed a mean LC50 of ca. 10 μM and a cellular sensitivity profile that did not match that of any other agent in the 765,000 compd. database.  Subsequent mechanistic studies in melanoma and other multidrug-resistant in vitro cancer models showed that sphaeropsidin A can overcome apoptosis as well as multidrug resistance by inducing a marked and rapid cellular shrinkage related to the loss of intracellular Cl- and the decreased HCO3- concn. in the culture supernatant.  These changes in ion homeostasis and the absence of effects on the plasma membrane potential were attributed to the sphaeropsidin A-induced impairment of regulatory vol. increase (RVI).  Preliminary results also indicate that depending on the type of cancer, the sphaeropsidin A effects on RVI could be related to Na-K-2Cl electroneutral cotransporter or Cl-/HCO3- anion exchanger(s) targeting.  This study underscores the modulation of ion-transporter activity as a promising therapeutic strategy to combat drug-resistant cancers and identifies the fungal metabolite, sphaeropsidin A, as a lead to develop anticancer agents targeting RVI in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8aC9H1vpLSrVg90H21EOLACvtfcHk0lgorcbMDbeJiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsFSnsrk%253D&md5=8271722f9c0e434d964b5cc9144e369d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs00018-015-1902-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-015-1902-6%26sid%3Dliteratum%253Aachs%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DChantome%26aufirst%3DA.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DCimmino%26aufirst%3DA.%26aulast%3DMiklos%26aufirst%3DW.%26aulast%3DPaulitschke%26aufirst%3DV.%26aulast%3DMohr%26aufirst%3DT.%26aulast%3DMaddau%26aufirst%3DL.%26aulast%3DKornienko%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DVandier%26aufirst%3DC.%26aulast%3DEvidente%26aufirst%3DA.%26aulast%3DDelpire%26aufirst%3DE.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DSphaeropsidin%2520a%2520shows%2520promising%2520activity%2520against%2520drug-resistant%2520cancer%2520cells%2520by%2520targeting%2520regulatory%2520volume%2520increase%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2015%26volume%3D72%26spage%3D3731%26epage%3D3746%26doi%3D10.1007%2Fs00018-015-1902-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Den Berge, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceusters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konopka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cops, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruyere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trieu-Van, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serteyn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robiette, R.</span><span> </span><span class="NLM_article-title">New 5-aryl-1h-imidazoles display in vitro antitumor activity against apoptosis-resistant cancer models, including melanomas, through mitochondrial targeting</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6626</span><span class="NLM_x">–</span> <span class="NLM_lpage">6637</span><span class="refDoi"> DOI: 10.1021/jm400287v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400287v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6626-6637&author=V.+Mathieuauthor=E.+Van+Den+Bergeauthor=J.+Ceustersauthor=T.+Konopkaauthor=A.+Copsauthor=C.+Bruyereauthor=C.+Pirkerauthor=W.+Bergerauthor=T.+Trieu-Vanauthor=D.+Serteynauthor=R.+Kissauthor=R.+Robiette&title=New+5-aryl-1h-imidazoles+display+in+vitro+antitumor+activity+against+apoptosis-resistant+cancer+models%2C+including+melanomas%2C+through+mitochondrial+targeting&doi=10.1021%2Fjm400287v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm400287v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400287v%26sid%3Dliteratum%253Aachs%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DVan%2BDen%2BBerge%26aufirst%3DE.%26aulast%3DCeusters%26aufirst%3DJ.%26aulast%3DKonopka%26aufirst%3DT.%26aulast%3DCops%26aufirst%3DA.%26aulast%3DBruyere%26aufirst%3DC.%26aulast%3DPirker%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DTrieu-Van%26aufirst%3DT.%26aulast%3DSerteyn%26aufirst%3DD.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DRobiette%26aufirst%3DR.%26atitle%3DNew%25205-aryl-1h-imidazoles%2520display%2520in%2520vitro%2520antitumor%2520activity%2520against%2520apoptosis-resistant%2520cancer%2520models%252C%2520including%2520melanomas%252C%2520through%2520mitochondrial%2520targeting%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6626%26epage%3D6637%26doi%3D10.1021%2Fjm400287v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Seidel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazumder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teiten, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">4-hydroxybenzoic acid derivatives as hdac6-specific inhibitors modulating microtubular structure and hsp90alpha chaperone activity against prostate cancer</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1016/j.bcp.2015.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.bcp.2015.11.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2016&pages=31-52&author=C.+Seidelauthor=M.+Schnekenburgerauthor=A.+Mazumderauthor=M.+H.+Teitenauthor=G.+Kirschauthor=M.+Dicatoauthor=M.+Diederich&title=4-hydroxybenzoic+acid+derivatives+as+hdac6-specific+inhibitors+modulating+microtubular+structure+and+hsp90alpha+chaperone+activity+against+prostate+cancer&doi=10.1016%2Fj.bcp.2015.11.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2015.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2015.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DSeidel%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DMazumder%26aufirst%3DA.%26aulast%3DTeiten%26aufirst%3DM.%2BH.%26aulast%3DKirsch%26aufirst%3DG.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3D4-hydroxybenzoic%2520acid%2520derivatives%2520as%2520hdac6-specific%2520inhibitors%2520modulating%2520microtubular%2520structure%2520and%2520hsp90alpha%2520chaperone%2520activity%2520against%2520prostate%2520cancer%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2016%26volume%3D99%26spage%3D31%26epage%3D52%26doi%3D10.1016%2Fj.bcp.2015.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Piccinini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tesei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arienti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevilacqua, A.</span><span> </span><span class="NLM_article-title">Cancer multicellular spheroids: Volume assessment from a single 2d projection</span> <span class="citation_source-journal">Comput. Methods Programs Biomed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1016/j.cmpb.2014.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.cmpb.2014.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=25561413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A280%3ADC%252BC2MvjslGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2015&pages=95-106&author=F.+Piccininiauthor=A.+Teseiauthor=C.+Arientiauthor=A.+Bevilacqua&title=Cancer+multicellular+spheroids%3A+Volume+assessment+from+a+single+2d+projection&doi=10.1016%2Fj.cmpb.2014.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer multicellular spheroids: volume assessment from a single 2D projection</span></div><div class="casAuthors">Piccinini Filippo; Tesei Anna; Arienti Chiara; Bevilacqua Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">Computer methods and programs in biomedicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-106</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Volume is one of the most important features for the characterization of a tumour on a macroscopic scale.  It is often used to assess the effectiveness of care treatments, thus making its correct evaluation a crucial issue for patient care.  Similarly, volume is a key feature on a microscopic scale.  Multicellular cancer spheroids are 3D tumour models widely employed in pre-clinical studies to test the effects of drugs and radiotherapy treatments.  Very few methods have been proposed to estimate the tumour volume arising from a 2D projection of multicellular spheroids, and even fewer have been designed to provide a 3D reconstruction of the tumour shape.  In this work, we propose Reconstruction and Visualization from a Single Projection (ReViSP), an automatic method conceived to reconstruct the 3D surface and estimate the volume of single cancer multicellular spheroids, or even of spheroid cultures.  As the input parameter ReViSP requires only one 2D projection, which could be a widefield microscope image.  We assessed the effectiveness of our method by comparing it with other approaches.  To this purpose, we used a new strategy that allowed us to achieve accurate volume measurements based on the analysis of home-made 3D objects, built by mimicking the spheroid morphology.  The results confirmed the effectiveness of our method for both 3D reconstruction and volume assessment.  ReViSP software is distributed as an open source tool.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwdSEe9YwQDLxanA7vODO6fW6udTcc2eZTaIF9rjNUn7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvjslGmsA%253D%253D&md5=8cc3bf5625a8da6022c18b9f42731958</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.cmpb.2014.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmpb.2014.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DPiccinini%26aufirst%3DF.%26aulast%3DTesei%26aufirst%3DA.%26aulast%3DArienti%26aufirst%3DC.%26aulast%3DBevilacqua%26aufirst%3DA.%26atitle%3DCancer%2520multicellular%2520spheroids%253A%2520Volume%2520assessment%2520from%2520a%2520single%25202d%2520projection%26jtitle%3DComput.%2520Methods%2520Programs%2520Biomed.%26date%3D2015%26volume%3D118%26spage%3D95%26epage%3D106%26doi%3D10.1016%2Fj.cmpb.2014.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Florean, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazumder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandjenette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christov, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proksch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Discovery and characterization of isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to trail in cancer cells</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">24027</span><span class="NLM_x">–</span> <span class="NLM_lpage">24049</span><span class="refDoi"> DOI: 10.18632/oncotarget.8210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.18632%2Foncotarget.8210" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=24027-24049&author=C.+Floreanauthor=M.+Schnekenburgerauthor=J.+Y.+Leeauthor=K.+R.+Kimauthor=A.+Mazumderauthor=S.+Songauthor=J.+M.+Kimauthor=C.+Grandjenetteauthor=J.+G.+Kimauthor=A.+Y.+Yoonauthor=M.+Dicatoauthor=K.+W.+Kimauthor=C.+Christovauthor=B.+W.+Hanauthor=P.+Prokschauthor=M.+Diederich&title=Discovery+and+characterization+of+isofistularin-3%2C+a+marine+brominated+alkaloid%2C+as+a+new+DNA+demethylating+agent+inducing+cell+cycle+arrest+and+sensitization+to+trail+in+cancer+cells&doi=10.18632%2Foncotarget.8210"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8210%26sid%3Dliteratum%253Aachs%26aulast%3DFlorean%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DK.%2BR.%26aulast%3DMazumder%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DGrandjenette%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DJ.%2BG.%26aulast%3DYoon%26aufirst%3DA.%2BY.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DChristov%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DB.%2BW.%26aulast%3DProksch%26aufirst%3DP.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520isofistularin-3%252C%2520a%2520marine%2520brominated%2520alkaloid%252C%2520as%2520a%2520new%2520DNA%2520demethylating%2520agent%2520inducing%2520cell%2520cycle%2520arrest%2520and%2520sensitization%2520to%2520trail%2520in%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D24027%26epage%3D24049%26doi%3D10.18632%2Foncotarget.8210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">El Amrani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debbab, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aly, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siems, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaigneaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proksch, P.</span><span> </span><span class="NLM_article-title">Protein kinase and hdac inhibitors from the endophytic fungus epicoccum nigrum</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1021/np4005745</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np4005745" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2014&pages=49-56&author=M.+El+Amraniauthor=D.+Laiauthor=A.+Debbabauthor=A.+H.+Alyauthor=K.+Siemsauthor=C.+Seidelauthor=M.+Schnekenburgerauthor=A.+Gaigneauxauthor=M.+Diederichauthor=D.+Fegerauthor=W.+Linauthor=P.+Proksch&title=Protein+kinase+and+hdac+inhibitors+from+the+endophytic+fungus+epicoccum+nigrum&doi=10.1021%2Fnp4005745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum</span></div><div class="casAuthors">El Amrani, Mustapha; Lai, Daowan; Debbab, Abdessamad; Aly, Amal H.; Siems, Karsten; Seidel, Carole; Schnekenburger, Michael; Gaigneaux, Anthoula; Diederich, Marc; Feger, Daniel; Lin, Wenhan; Proksch, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A chem. investigation of the endophytic fungus Epicoccum nigrum isolated from leaves of Mentha suaveolens collected in Morocco resulted in the isolation of five new polyketides, epicocconigrones A and B (1 and 2), 3-methoxyepicoccone B (3), 3-methoxyepicoccone (4), and 2,3,4-trihydroxy-6-(methoxymethyl)-5-methylbenzaldehyde (5), together with five known compds. (6-10).  The structures of the new compds. were unambiguously detd. by extensive anal. of the 1D and 2D NMR and mass spectroscopic data.  Compds. 1 and 10 showed potent inhibition of at least 15 protein kinases with IC50 values ranging from 0.07 to 9.00 μM.  Moreover, compds. 1 and 10 inhibited histone deacetylase (HDAC) activities with IC50 values of 9.8 and 14.2 μM, resp.  A preliminary structure-activity relationship is discussed.  Interestingly, compds. 1 and 10 exert mainly cytostatic effects in human lymphoma RAJI and U-937 cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4D_3dYPnTYbVg90H21EOLACvtfcHk0lhTMmyeypguIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsLvN&md5=be6445a06b38cd3cf2dd373ef6ced949</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fnp4005745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp4005745%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BAmrani%26aufirst%3DM.%26aulast%3DLai%26aufirst%3DD.%26aulast%3DDebbab%26aufirst%3DA.%26aulast%3DAly%26aufirst%3DA.%2BH.%26aulast%3DSiems%26aufirst%3DK.%26aulast%3DSeidel%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DGaigneaux%26aufirst%3DA.%26aulast%3DDiederich%26aufirst%3DM.%26aulast%3DFeger%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DW.%26aulast%3DProksch%26aufirst%3DP.%26atitle%3DProtein%2520kinase%2520and%2520hdac%2520inhibitors%2520from%2520the%2520endophytic%2520fungus%2520epicoccum%2520nigrum%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2014%26volume%3D77%26spage%3D49%26epage%3D56%26doi%3D10.1021%2Fnp4005745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Seidel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Antiproliferative and proapoptotic activities of 4-hydroxybenzoic acid-based inhibitors of histone deacetylases</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span><span class="refDoi"> DOI: 10.1016/j.canlet.2013.09.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.canlet.2013.09.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=24080339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CqtL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2014&pages=134-146&author=C.+Seidelauthor=M.+Schnekenburgerauthor=M.+Dicatoauthor=M.+Diederich&title=Antiproliferative+and+proapoptotic+activities+of+4-hydroxybenzoic+acid-based+inhibitors+of+histone+deacetylases&doi=10.1016%2Fj.canlet.2013.09.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative and proapoptotic activities of 4-hydroxybenzoic acid-based inhibitors of histone deacetylases</span></div><div class="casAuthors">Seidel, Carole; Schnekenburger, Michael; Dicato, Mario; Diederich, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-146</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Histone acetyltransferases (HATs) and histone deacetylases (HDACs) regulate cellular processes by modifying the acetylation status of many proteins.  Pathol. altered HDAC activity contributes to cancer development and thus characterization of novel acetylation modulators is important for future anti-cancer therapies.  In this study, we identified three novel 4-hydroxybenzoic acid derivs. as pan-HDAC inhibitors that increased protein acetylation levels, arrested cell cycle progression and triggered apoptotic cell death, without affecting viability of normal cells.  Our data support the potential of 4-hydroxybenzoic acid derivs. as pan-HDAC inhibitors with anticancer properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxVAfK3A-ObbVg90H21EOLACvtfcHk0lhj-7pyRKaqZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CqtL%252FJ&md5=7fda5b73dfdb10e0437d2f47b459247c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2013.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2013.09.026%26sid%3Dliteratum%253Aachs%26aulast%3DSeidel%26aufirst%3DC.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DAntiproliferative%2520and%2520proapoptotic%2520activities%2520of%25204-hydroxybenzoic%2520acid-based%2520inhibitors%2520of%2520histone%2520deacetylases%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D343%26spage%3D134%26epage%3D146%26doi%3D10.1016%2Fj.canlet.2013.09.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Nunes, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milagre, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gama, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, E.</span><span> </span><span class="NLM_article-title">Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of cyp46a1 gene transcription</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2010.06612.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1111%2Fj.1471-4159.2010.06612.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=20096088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVChtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2010&pages=418-431&author=M.+J.+Nunesauthor=I.+Milagreauthor=M.+Schnekenburgerauthor=M.+J.+Gamaauthor=M.+Diederichauthor=E.+Rodrigues&title=Sp+proteins+play+a+critical+role+in+histone+deacetylase+inhibitor-mediated+derepression+of+cyp46a1+gene+transcription&doi=10.1111%2Fj.1471-4159.2010.06612.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of CYP46A1 gene transcription</span></div><div class="casAuthors">Nunes, Maria Joao; Milagre, Ines; Schnekenburger, Michael; Gama, Maria Joao; Diederich, Marc; Rodrigues, Elsa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">418-431</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">We investigated whether the CYP46A1 gene, a neuronal-specific cytochrome P 450, responsible for the majority of brain cholesterol turnover, is subject to transcriptional modulation through modifications in histone acetylation.  We demonstrated that inhibition of histone deacetylase activity by trichostatin A (TSA), valproic acid and sodium butyrate caused a potent induction of both CYP46A1 promoter activity and endogenous expression.  Silencing of Sp transcription factors through specific small interfering RNAs, or impairing Sp binding to the proximal promoter, by site-directed mutagenesis, led to a significant decrease in TSA-mediated induction of CYP46A1 expression/promoter activity.  Electrophoretic mobility shift assay, DNA affinity pptn. assays and chromatin immunopptn. assays were used to det. the multiprotein complex recruited to the CYP46A1 promoter, upon TSA treatment.  Our data showed that a decrease in Sp3 binding at particular responsive elements, can shift the Sp1/Sp3/Sp4 ratio, and favor the detachment of histone deacetylase (HDAC) 1 and HDAC2 and the recruitment of p300/CBP.  Moreover, we obsd. a dynamic change in the chromatin structure upon TSA treatment, characterized by an increase in the local recruitment of euchromatic markers and RNA polymerase II.  Our results show the crit. participation of an epigenetic program in the control of CYP46A1 gene transcription, and suggest that brain cholesterol catabolism may be affected upon treatment with HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ5PM8_4MYYLVg90H21EOLACvtfcHk0ljss6oLwMLcWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVChtbg%253D&md5=4c495619589253be12656ad9ed0a9446</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2010.06612.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2010.06612.x%26sid%3Dliteratum%253Aachs%26aulast%3DNunes%26aufirst%3DM.%2BJ.%26aulast%3DMilagre%26aufirst%3DI.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DGama%26aufirst%3DM.%2BJ.%26aulast%3DDiederich%26aufirst%3DM.%26aulast%3DRodrigues%26aufirst%3DE.%26atitle%3DSp%2520proteins%2520play%2520a%2520critical%2520role%2520in%2520histone%2520deacetylase%2520inhibitor-mediated%2520derepression%2520of%2520cyp46a1%2520gene%2520transcription%26jtitle%3DJ.%2520Neurochem.%26date%3D2010%26volume%3D113%26spage%3D418%26epage%3D431%26doi%3D10.1111%2Fj.1471-4159.2010.06612.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Karius, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnekenburger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghelfi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, M.</span><span> </span><span class="NLM_article-title">Reversible epigenetic fingerprint-mediated glutathione-s-transferase p1 gene silencing in human leukemia cell lines</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1342</span><span class="refDoi"> DOI: 10.1016/j.bcp.2011.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.bcp.2011.03.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2011&pages=1329-1342&author=T.+Kariusauthor=M.+Schnekenburgerauthor=J.+Ghelfiauthor=J.+Walterauthor=M.+Dicatoauthor=M.+Diederich&title=Reversible+epigenetic+fingerprint-mediated+glutathione-s-transferase+p1+gene+silencing+in+human+leukemia+cell+lines&doi=10.1016%2Fj.bcp.2011.03.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DKarius%26aufirst%3DT.%26aulast%3DSchnekenburger%26aufirst%3DM.%26aulast%3DGhelfi%26aufirst%3DJ.%26aulast%3DWalter%26aufirst%3DJ.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DReversible%2520epigenetic%2520fingerprint-mediated%2520glutathione-s-transferase%2520p1%2520gene%2520silencing%2520in%2520human%2520leukemia%2520cell%2520lines%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D81%26spage%3D1329%26epage%3D1342%26doi%3D10.1016%2Fj.bcp.2011.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Pirotte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florence, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goffin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medeiros, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Tullio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebrun, P.</span><span> </span><span class="NLM_article-title">4-phenylureido/thioureido-substituted 2,2-dimethylchroman analogs of cromakalim bearing a bulky “carbamate” moiety at the 6-position as potent inhibitors of glucose-sensitive insulin secretion</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2016.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;key=10.1016%2Fj.ejmech.2016.05.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2016&pages=338-351&author=B.+Pirotteauthor=X.+Florenceauthor=E.+Goffinauthor=M.+B.+Medeirosauthor=P.+de+Tullioauthor=P.+Lebrun&title=4-phenylureido%2Fthioureido-substituted+2%2C2-dimethylchroman+analogs+of+cromakalim+bearing+a+bulky+%E2%80%9Ccarbamate%E2%80%9D+moiety+at+the+6-position+as+potent+inhibitors+of+glucose-sensitive+insulin+secretion&doi=10.1016%2Fj.ejmech.2016.05.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DFlorence%26aufirst%3DX.%26aulast%3DGoffin%26aufirst%3DE.%26aulast%3DMedeiros%26aufirst%3DM.%2BB.%26aulast%3Dde%2BTullio%26aufirst%3DP.%26aulast%3DLebrun%26aufirst%3DP.%26atitle%3D4-phenylureido%252Fthioureido-substituted%25202%252C2-dimethylchroman%2520analogs%2520of%2520cromakalim%2520bearing%2520a%2520bulky%2520%25E2%2580%259Ccarbamate%25E2%2580%259D%2520moiety%2520at%2520the%25206-position%2520as%2520potent%2520inhibitors%2520of%2520glucose-sensitive%2520insulin%2520secretion%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D121%26spage%3D338%26epage%3D351%26doi%3D10.1016%2Fj.ejmech.2016.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5I','PDB','4I5I'); return false;">PDB: 4I5I</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RMG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RMG','PDB','4RMG'); return false;">PDB: 4RMG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IG9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IG9','PDB','4IG9'); return false;">PDB: 4IG9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZZH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZZH','PDB','4ZZH'); return false;">PDB: 4ZZH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZZI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZZI','PDB','4ZZI'); return false;">PDB: 4ZZI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZZJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZZJ','PDB','4ZZJ'); return false;">PDB: 4ZZJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BTR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BTR','PDB','5BTR'); return false;">PDB: 5BTR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RMH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RMH','PDB','4RMH'); return false;">PDB: 4RMH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J8F" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J8F','PDB','1J8F'); return false;">PDB: 1J8F</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZGO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZGO','PDB','3ZGO'); return false;">PDB: 3ZGO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZGV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZGV','PDB','3ZGV'); return false;">PDB: 3ZGV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DY4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DY4','PDB','5DY4'); return false;">PDB: 5DY4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DY5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DY5','PDB','5DY5'); return false;">PDB: 5DY5</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i52"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00533">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_33136"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00533">10.1021/acs.jmedchem.7b00533</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional experimental details; docking model of selected compounds in SIRT1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5I">4I5I</a>) and SIRT2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RMG">4RMG</a>); in cellulo assessment of HDAC inhibition by compound <b>18</b> through the study of histone and α-tubulin acetylation levels; analysis of apoptosis induced by <b>18</b> in glioma cells; analysis of sub G1 population in glioblastoma cells treated with SIRTi; antitumor potential of compound <b>18</b>; summary of the IC<sub>50</sub> values obtained for compound <b>18</b> on various human cancer cell lines with acquired drug resistance; IC<sub>50</sub> values and biological data of newly described SIRT1 and/or SIRT2 inhibitors; supplementary references (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES representations and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_001.pdf">jm7b00533_si_001.pdf (2.12 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00533/suppl_file/jm7b00533_si_002.csv">jm7b00533_si_002.csv (3.85 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00533&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-11%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00533%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00533" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799e1b90ffa3cac","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
